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The neural crest (NC) is a multipotent embryonic cell type derived from the ectoderm during 
neurulation giving rise to a variety of cell lineages such as neurons, glia and pigment cells. Most 
genes associated with the correct initiation, differentiation and migration of the neural crest have 
been found through reverse genetics. Similarities between neural crest development and some 
features of cancer progression are remarkable. For instance, it has been suggested that some cancer 
types recapitulate NC processes in an unregulated manner such as epithelial-mesenchymal transition 
or active cell migration throughout the body to form distant metastases. However, to date very little 
is known about initiators and drivers that direct neural crest cell migration to specific target sites. 
The Medaka mutant hirame represents an interesting melanocyte specific migration defect on the 
yolk sac caused by a loss of functional Yes-associated protein (YAP). Medaka hirame mutants were 
initially studied for their profound changes in body morphology. Genomic mapping identified the 
causal mutation as a nonsense point mutation within the first WW domain in the Yes-associated 
protein 1 (YAP1), causing translation of a dysfunctional YAP protein. YAP is a downstream 
transcriptional co-activator of the recently discovered and evolutionarily conserved Hippo pathway. 
Alterations within Hippo signalling are linked to cell survival, proliferation and abnormal tissue 
overgrowth. 
We demonstrate that hirame melanocyte precursors (melanoblasts) are initially present in normal 
abundance, but show an early migration defect with a lack of melanoblasts on the yolk sac, and 
corresponding accumulation in the lateral parts of the body. Subsequently, we observe an overall 
decline in differentiated melanocyte numbers during late stage embryogenesis. We designed an 
overexpression cassette linking enhanced GFP to either wild type or a mutated activated version of 
YAP and present evidence that it can efficiently rescue the melanocyte defect after injection of 
mRNA into one-cell stage embryos. Furthermore, analysis of the yolk sac anatomy via transmission 
electron microscopy indicates that a fraction of yolk membrane cells undergo apoptosis and we 
propose that this may contribute to the establishment of altered environmental cues leading to 
abnormal melanoblast migration onto the yolk sac. Injection of yap mRNA directly into the yolk sac 
however, failed to rescue melanoblast patterning.   
To advance our study, we isolated and characterised a 3.6 kb Medaka dopachrome tautomerase (Dct) 
promoter fragment, and used it to drive expression of enhanced green fluorescent protein (eGFP) in 
vivo. We generated germline transgenics with this construct that showed lineage-specific expression 
of eGFP within early migrating melanoblasts, a phenotype that is maintained in differentiated 
melanocytes throughout embryogenesis. In addition, using this promoter we overexpressed our 
egfp-yap fusion cassette and established transgenic lines to assess the cell autonomy of YAP within 
iii 
 
the melanocyte lineage. However, no fluorescent signal could be detected in the latter transgenics, 
necessitating future experimentation to properly characterise these lines.  
Finally, we analysed a range of neural crest markers to examine the extent of the neural crest defects 
in hirame mutants. In addition to the melanocyte phenotype, we identified a dramatic reduction in 
xanthophore numbers, although early leucophore development appears unaffected. We also 
observed a decreased number of dorsal root ganglia in the peripheral nervous system as well as 
smaller and partly ectopic cranial neural crest ganglia populations within the epibranchial arches. The 
characterisation of a novel Medaka melanocyte specific promoter as well as additional novel NC 
markers will be widely applicable and useful to the wider Medaka research community as a tool for 
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1.1 Fish as a model organism 
Zebrafish and Medaka fish provide excellent model organisms because of their high fecundity – 
single Zebrafish females lay up to 200 eggs per week and Medaka up to 30 eggs daily and their easy 
husbandry in large numbers. Embryogenesis can be examined ex-utero over a time frame of 5 days in 
Zebrafish and 9 days in Medaka (Kimmel et al. 1995; Kinoshita, Murata & Naruse et al. 2009) thus, 
allowing an advantage of Medaka is that embryos provide an extended time for testing in which 
general embryogenic development is slower. In addition Zebrafish and Medaka fish embryogenesis 
has been extensively described in detail (Kimmel et al. 1995; Iwamatsu 2004) making it a good model 
in which to carry out replicable experiments (Appendix 4,5). Zebrafish and Medaka are two related 
teleost species with 115–200M years of independent evolution, thus making divergent and 
conserved principles of development easy to observe by comparison between them (Furutani-Seiki & 
Wittbrodt 2004). Furthermore, whole genome sequences are available for both species. 
Zebrafish (Danio rerio) is an established model organism originating as a small tropical freshwater 
fish from India.  It has been increasingly popular as a genetic system since the 1980´s (Streisinger et 
al. 1981; Driever et al. 1994). Systematic genome-wide mutagenesis screens published in 1996 by 
teams working in Tübingen and Boston were instrumental in augmenting the importance of Zebrafish 
as a vertebrate model organism to study embryogenesis, regeneration and human diseases. This 
project commonly referred to Tübingen/Boston screen described around 1500 mutations in more 
than 400 new genes that caused abnormal embryonic and early larval phenotypes (Nüsslein-Volhard 
2012). Later in 2001 the Sanger Institute started the genome sequencing project in Zebrafish from 
which it generated a high-quality sequence assembly to the human genome (Howe et al. 2013).  
Medaka (Oryzias latipes), is a small Asian freshwater teleost usually confined to rice paddys or 
shallow brooks primarily in Japan. Medaka is the first vertebrate in which Mendelian inheritance was 
proven valid (Ishikawa 2000). Around 80 spontaneous natural colour mutants exist such as orange-
red, albino or brown/grey wild-type (Tomita collection; Kelsh et al. 2004) and are maintained in a 
stock center for research (NRPB Medaka). There are two main advantages of Medaka in comparison 
to Zebrafish: firstly the small genome size of 800–1000 Mb being approximately half the size of the 
Zebrafish, and one-third that of the human genome (Lamatsch et al. 2000). Secondly, robust inbred 
strains are available which are as a results of their genetic consistency a useful tool for regards to 
mutagenesis screens and genetic mapping (Wittbrodt et al. 2002). In addition a large mutagenesis 
screen has been carried out identifying mutants with defects in organogenesis (Furutani-Seiki et al. 
2004).  
Those advantages make small laboratory teleosts an attractive model organism to work with, and a 
valuable source of obtaining experimental data, which can be related to human developmental 
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events. Many studies have used teleost models to explain fundamental basics of cell specification, 
organisation and migration (Nüsslein-Volhard 2012; Furutani-Seiki et al. 2004; Loosli et al. 2000). In 
addition, disease models help explain molecular drivers of oncogenic cell transformation and active 
metastases formation in human (Mione & Trede 2010). Our work focuses on the analysis of one 
Medaka fish model with striking implications for neural crest impairments during early 
embryogenesis.  
 
1.2 Onset of Gastrulation and cell arrangements 
leading to neurulation 
Although the basic events of gastrulation during early embryogenesis are similar in most species, cell 
organisation during late gastrula can differ between animals (Niehrs 2004). Here, I focus and explain 
briefly the anatomical processes leading up to, and subsequent during gastrulation found in teleosts 
such as Zebrafish (Danio rerio) or Medaka (Oryzias latipes), which will help to explain later 
interpretations of this thesis’ experimental data.   
After cleavage and late blastula stage, the blastoderm and yolk syncytium spreads in a thin layer over 
the yolk sac. This process termed “epiboly”, is completed once the entire yolk cell is engulfed by the 
blastoderm layer (Carvalho, 2007). The blastoderm is a general term, which includes deep cells 
(endoderm, mesoderm, ectoderm) and the enveloping layer, and an outermost layer of extra-
embryonic tissue. The cell arrangement within the blastoderm is as follows: mesoderm and 
endoderm together form the hypoblast between the yolk syncytial layer and the epiblast; the 
epiblast comprises cells forming the embryonic layer. Both hypoblast and epiblast are surrounded by 
the enveloping layer (Figure 1.1)(Carvalho & Heisenberg 2010). The three important germ layers 
which are present during this early process will later define and give rise to various tissues and 
organs. The endoderm develops organs of the digestive system and their epithelium such as the gut, 
liver and pancreasas as well as the lining of the respiratory system. The mesoderm forms somites, 
muscle, notochord, blood and vasculature endothelium, cartilage of the ribs and vertebrae, dermis 
and connective tissue. At last, the ectoderm comprises the neural crest, nerve tissue and forms the 
epidermis (Gilbert & Singer 2006). At the time of 60% epiboly, gastrulation begins in which the three 
germ layers undergo a dramatic change of re-organisation after which the fundamental body plan of 
the embryo is formed (Montero et al. 2005). Here the mesoderm and endoderm involute and 
internalise through the blastopore of the primitive streak, and move towards the animal pole, whilst 
the ectoderm remains outside. At that stage, the germ ring has formed and the embryonic organiser 
or “shield” is visible (Kimmel et al. 1990). The molecular drivers that control the onset of vertebrate 
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gastrulation include gradients of bone morphogenetic proteins (BMPs), Wnt/ β-catenin (Niehrs 
2004), and Nodal/TGF-beta signals, such as Squint (ndr1/ sqt) and Cyclops (ndr2/cyc) (Rebagliati et al. 
1998; Cells 1998; Erter et al. 1998). Other important signals are fibroblast growth factor (FGF) and 
retinoic acid (Böttcher & Niehrs 2005; Maden 2002). During mid-gastrulation, cells which do not 
internalise move towards the dorsal side of the embryo (convergence) and extend along the animal-
vegetal pole (extension) resulting in the embryonic anterior-posterior midline defined by the 
developed notochord from aggregated mesoderm. Shortly after gastrulation, the ectoderm folds 




Figure 1.1: Schematic representation of cell movements during gastrulation 
Anterior (animal pole) is to the top, vegetal pole is at the bottom (A-C). A) During epiboly (EPI) 
move towards the vegetal pole. At 60% epiboly hypoblast cells internalise (INT) at the margin 
and migrate towards the animal pole. B) At mid-gastrulation, cells converge (CON) towards the 
dorsal part, which subsequently extend (EXT) towards the animal-vegetal pole to form the 
anterior-posterior-midline and the embryo. Epiboly and internalisations continues until the 
blastoderm covers the entire yolk cell. C) Shield stage Zebrafish embryo (6 hpf) showing 
ventral (v, left) and dorsal (d, right) of the anterior-posterior midline. Green arrow indicates 
internalisation, black arrows symbolise epiboly movement. D) Cross section at the blastoderm 
margin shows the arrangements of yolk syncytial layer (YSL), hypoblast, epiblast and 




1.3 Neurulation and Neural crest 
It is during neurulation that the neural crest makes its first appears. Neural development begins with 
the formation of a neural plate, which subdivides into three distinct parts, the neuroectoderm, the 
non-neural ectoderm and the neural plate border. These three individual regions later give rise to the 
central nervous system, the epidermis and the neural crest cells.  
There are two different types of neurulation, primary and secondary (Holmdahl 1932). Primary 
neurulation occurs in amphibians, mammals and birds within the region of the brain and anterior 
future trunk  (Gammill & Bronner-Fraser 2003). Therein the neural plate folds inwards initially 
forming a neural groove from which the neural plate borders converge to form the neural tube 
(Figure 1.2A). Secondary neurulation in mammals occurs normally in the posterior tail region in 
which mesenchymal cells coalesce into a solid rod (the medullary cord) followed by the formation of 
the presumptive neuroepithelium. The neuroepithelium then develops a lumen to create the neural 
tube (Griffith et al. 1992). However in teleosts such as Zebrafish and Medaka, primary neurulation 
does not occur. Instead, the neural keel extends through the entire length of the embryo. Thereby 
the neural keel forms through an infolding of the neural plate at the midline, which changes into a 
neural neural rod in which a lumen is formed through cavitation. The lumen opens up as cells detach 
from each other along the midline to shape the neural tube (Figure 1.2B) (Miyayama & Fujimoto 
1977; Papan & Campos-Ortega 1994; Lowery & Sive 2004). During both types of neurulation, neural 
crest cells arise from the dorsal midline of the neural tube, go through an epithelial-mesenchymal-
transition (EMT) and migrate actively along the medial and dorsolateral pathway (Figure 1.2A) 





Figure 1.2: Primary and secondary neurulation and induction of the neural crest  
Primary (A) and secondary (B) neurulation: A) In primary neurulation the convergence of the 
neural plate borders creates first a neural fold which then closes up to form the neural tube 
underlying the non-neural ectoderm above. This process occurs in mammals and birds. B) 
Secondary neurulation seen in teleosts involves the infolding of the neural plate to form a 
neural keel which then develops into a neural rod. After mesenchymal cell re-arrangement a 
lumen is initiated from which the neural tube develops. Neural crest cells arise from the dorsal 
part of the neural tube in both types of neurulation. After initiation neural crest cell 
progenitors commit to their derivatives and migrate along the dorsalateral and medial 
pathways to distant sites within the body (represented in A, red dashed lines). Adapted and 
modified after (Gammill & Bronner-Fraser 2003) (Papan & Campos-Ortega 1994). 
 
1.4 Molecular initiation of neural crest, delamination 
and derivatives 
The induction of the neural crest comprises three major pathways, bone morphogenetic (BMP), 
fibroblast growth factors (FGF) and the Wnt signalling pathway (LaBonne & Bronner-Fraser 1998). 
Intermediate levels of BMP within the paraxial mesoderm are established through BMP antagonists 
such as chordin, noggin and follistatin. This gradient is one of the events thought to mediate NC 
induction at the neural plate borders (Marchant et al. 1998). Fibroblast growth factors such as fgf2 
7 
 
combined with BMP anatgonists can induce NC markers (Mayor et al. 1997), whereas fgf8 secreted 
from the paraxial mesoderm is sufficient to cause neural crest induction (Monsoro-Burq et al. 2003). 
Furthermore Wnt signalling, especially the canonical β-catenin-dependent pathway from the 
adjacent non-neuronal ectoderm and underlying mesoderm has been shown to be essential for NC 
induction (García-Castro et al. 2002; Lewis et al. 2004). In addition studies in frog and chick 
demonstrated the involvement of Delta-Notch in the promotion and restriction of neural crest 
formation to the neural plate border (Endo et al. 2002). Together, BMP, FGF, Wnt and possibly Notch 
then activate transcription factors, the so called neural plate border specifiers Zic, Msx1/2, Pax3 and 
Pax7 within the neural plate border (Spengler & Bronner-Fraser 2008; Bae et al. 2014). Together they 
synergistically trigger expression of transcription factors described as neural crest specifiers including 
foxd3, id, slug/snail, twist, sox9 and sox10 to name a few (Donoghue et al. 2008). Together, these 
neural crest specifiers define neural crest progenitors, which then delaminate from the dorsal neural 
tube via epithelial-mesenchymal transition (EMT) and migrate onto specified pathways within the 
body: the medial and the dorsolateral pathway (highlighted in Figure 1.2A).   
During and after cell migration, the neural crest differentiates into numerous cell types, grouped into 
the non-ectomesenchymal and ectomesenchymal lineages. Ectomesenchymal lineage derivatives 
include bone, connective tissue, cartilage and dentine. Non-ectomesenchymal derivatives comprise 
neurons, glia and diverse pigment cells (chromatophores) (Figure 1.3) (Donoghue et al. 2008). They 
also form and contribute to secretory cells and the outflow of the heart  (Gammill & Bronner-Fraser, 
2003). During migration neural crest cells are influenced and interact actively with surrounding 
extracellular matrix components for instance cadherins, integrins, matrix metalloproteases (ADAM-
10) and chemoattractants such as semaphorin and ephrins, which help to regulate directed cell 





Figure 1.3: Cell derivatives derived from the neural crest 
Neural crest derivatives form from an early neural crest progenitors into non-
ectomesenchymal and ectomesenchymal lineages which then further split apart into specific 
cell fate derivatives. Modified after Donoghue et al. 2008. 
 
1.5 Teleost pigment cell development 
In birds and mammals the neural crest develops into only one pigment cell type, the melanocyte; 
black, brown or pale in colouration (Uong & Zon 2010). In contrast, pigmentation patterns in teleosts 
are made from up to five chromatophore cell types. Zebrafish have black melanocytes, orange 
xanthophores, silver-reflective iridophores (Kelsh 2004) and a few white leucophores in adult tail fins 
(RN Kelsh pers. comm.). Medaka fish however develop a higher number of leucophores already 
during embryogenesis. Another cell type, cyanophores, also found in some teleosts, develops a blue 
biochrome and is only present in some species such as mandarinfish (Kelsh et al. 2004). The 
migration of chromatophores takes place on the medial and dorsolateral pathway as mentioned 
above. The final pigment pattern in Zebrafish and Medaka embryos consists of three distinct 
melanocyte stripes: the dorsal, lateral, and ventral stripe (Appendix 1). The fourth melanophore 
stripe in Zebrafish is the Yolk Sac Stripe which is replaced by a cluster of melanocytes on the yolk sac 
in Medaka (Lamoreux et al. 2005). Xanthophores and iridophores are predominantly located dorsally 
with some cells scattered along the lateral and ventral stripe (Kelsh et al. 2000b). In contrast, in 
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Medaka a minor population of iridophores are located within the lateral stripe. In addition, 
leucophores are very closely associated with melanocytes and are located within the ventral head 
and in the dorsal stripe (Lamoreux et al. 2005; Nagao et al. 2014). The neural crest specifier SRY-
related HMG-box 10 (Sox10) has been shown to control the neural crest non-ectomesenchmal cell 
fate and specifically influence the development of all three major pigment cell types in Zebrafish 
(Kelsh & Eisen 2000). 
 
1.5.1 Melanocyte development 
Mammals and birds develop only one kind of neural crest derived pigment cells, the melanocyte. 
Those black or brown melanocytes in colour produce two kinds of pigment: black/brown eumelanin 
and red/yellow pheomelanin (Kinoshita et al. 2009). However lower vertebrates such as Zebrafish 
and Medaka only synthesise eumelanin (Kelsh et al. 2000). Melanocytes develop from melanoblasts, 
an unpigmented precursor. Their migration away from premigratory neural crest positions leads 
them onto two pathways, the dorsolateral and the medial pathway. While they migrate towards 
their final destination within the embryo they differentiate and begin to produce melanin packed 
into organelles called melanosomes (Kelsh et al. 2000).  
The transcription factor SRY-related HMG-box 10 (Sox10) is one of the melanocyte specifiers in 
Zebrafish (Kelsh & Eisen 2000; Dutton et al. 2001). The receptor tyrosine kinase Kit and its ligands 
may play a role in melanocyte proliferation as well, as mice studies have shown that homozygous 
mutations in kit led to decreased fur colouration as well as germ cell and haematopoietic cell defects 
(Mackenzie et al. 1997). Kit regulates the phosphorylation status of microphthalmia transcription 
factor (mitf) via the Ras-Raf-Map kinase pathway in mammalian melanoma cell cultures (Hemesath 
et al. 1998; Price et al. 1998) making it therefore an essential factor during melanocyte development 
in Zebrafish (Van Otterloo et al. 2010). Supporting this, the Zebrafish c-kit homologue mutant sparse 
(spa) suggests a conserved role for kit in melanophore survival, proliferation and dispersal (Parichy et 
al. 1999; Kelsh et al. 2000b). The microphthalmia transcription factor (mitf) is known to be the 
master regulator of melanocyte development (Uong & Zon 2010). Mitf, a basic helix-loop-helix 
leucine zipper (BHLH-Zip) transcription factor, regulates the expression of melanogenic enzymes 
including dopachrome-tautomerase (Dct), tyrosinase-related protein 1 (tyrp1), the melanosome 
structural protein silver (si) and tyrosinase (tyr), which is a transmembrane protein in melanosomes 
controlling oxidation levels and production of melanin (Hodgkinson et al. 1993; Lister et al. 1999). 
The melanocyte-specific dopachrome tautomerase (Dct) has been used in this study to label 
melanocyte precursors and track melanoblast migration in vivo. In vitro studies in mouse melanoma 
cells have shown that dopachrome tautomerase (Dct), also known as tyrosinase-related protein 2 
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(Trp-2) resides in the melanosome plasma membrane part of the eumelanin biosynthetic pathway by 
catalysing dopachrome to 5,5-dihydroxyindole-2-carboxylic acid (DHICA) in melanogenic cells (Körner 
& Pawelek 1980). Dct transcription is regulated directly or synergistically by Pax3, Sox10 and 
microphthalmia transcription factor (Mitf) through a responsive sequence site on its promoter (Jiao 
et al. 2006; Kelsh & Schmid et al. 2000). It is known as one of the earliest markers labelling the 
melanocyte lineage in Zebrafish. Dct presence is notable at around 16 hpf (14-19 somites), first in 
progenitors of the early pigmented retinal epithelium (PRE) in the developing eye and then 5 hours 
later througout the outer layer of the retinal epithelium and within trunk and tail melanoblasts (Kelsh 
et al. 2000). In contrast, Medaka studies report Dct expression at 75 hpf (st.30) (Nagao et al. 2014). 
Earlier stages have not yet been described.   
  
1.5.2 Xanthophore development 
Xanthophores migrate exclusively on the dorsolateral pathway (Parichy et al. 2000; Kelsh 2004). They 
contain pteridine and carotenoid pigments, giving them a yellow-orange appearance. Pteridine 
pigments are visible by autofluorescence under UV light around 35 hpf and are visibly abundant by 
42 hpf in the trunk of Zebrafish embryos (Greenhill 2008; Kelsh 2004). Published lineage markers for 
xanthophore development and differentiation are the enzymes GTP-cyclohydrolase I (gch) and 
xanthine dehydrogenase (xdh), both required for pteridine synthesis. Gch converts guanosine 
triphosphate (GTP) to dihydroneopterin triphosphate and then into tetrahydrobiotin (BH4), a source 
for sepiapteridine pigments in xanthophores (Pelletier et al. 2001). BH4 also functions in eumelanin 
synthesis and helps to convert phenylalanine to tyrosinase as a co-factor for phenylalanine 
hydroxylase. Thus gch is also expressed within early melanoblasts of Zebrafish (Parichy et al. 2000). 
The main pathway in which xanthine dehydrogenase (xdh) is involved is not yet characterised in 
detail. However, it seems that xdh transforms and degrades pterins and is involved in molecular 
changes during pteridine synthesis (Ziegler 2003).  
In Medaka differentiated xanthophores are scattered over the trunk region with more cells dorsally 
than within the lateral stripe. They are first observable at 6 dpf, but can be seen earlier under UV 
light. Unlike in Zebrafish, gch and xdh are markers for both xanthophores and leucophores and 
appear not to be in melanoblasts (Nagao et al. 2014).  
 
1.5.3 Leucophore development 
Leucophores are of dull to cream-white appearance (Lamoreux et al. 2005). When exposed to 
wavelengths oflight between 488 and 600nm they are visible by autofluorescence (personal 
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ovservation). As far as we know, in Medaka, the migration pathway of leucophores has not been 
described.. However, leucophores are closely associated with melanocytes on the dorsal midline 
similar to iridophores in Zebrafis, therefore it is possible that leucophores migrate on the medial 
pathway as well (Nagao et al. 2014). Their appearance results from intracellular uric acid organelles 
based on similar purine-related substances such as guanine and hypoxanthine in iridophores (Hama 
1975). Later in development leucophores seem orange/gold because of an accumulation of 
drospterin (Oliphant & Hudon 1993). They first appear in the ventral head of 2 days old Medaka 
around stage 23 (personal ovservation), then form six bilaterally symmetrical spots at stage 25. By 5 
dpf they have formed a continuous lateral stripe in close association with melanocytes (Lamoreux et 
al. 2005). Medaka leucophores also express the xanthophore markers gch and xdh (Nagao et al. 
2014), which supports observations that both of these cell types contain pteridine pigments (Braasch 
et al. 2007). So far, it has been shown that on the genetic level, slc2a15 and slc2a11b play an 
important role for pteridine synthesis as Medaka mutants lf (slc2a15b) and wl (slc2a11b). Both show 
defects in pteridine containing xanthophores and leucophores (Kimura et al, unpublished data Nagao 
et al. 2014). Recent studies by (Nagao et al. 2014) demonstrated that xanthophores and leucophores 
share a common progenitor, in which sox5 can act as a regulator to control the fate switch between 
those two lineages.   
 
1.5.4 Iridophore development 
We mention iridophores here only very briefly since they are not a focus for this thesis. Iridophores 
migrate within the medial pathway to their final destination - predominantly the dorsal stripe with 
some scattered cells above the eye as well as in the lateral and ventral stripe (Kelsh 2004; Greenhill & 
Kelsh 2008). Their shiny iridescent appearance results from reflective guanine platelets visible around 
40 hpf in Zebrafish (Kelsh 2004). In Medaka, Iridophores are not as abundant as in Zebrafish. At 5 dpf, 
the first patches of iridescent cells appear above the eye and within the lateral stripe. They increase 
in cell number until hatching stage and overlap partly with xanthophores resulting in a golden yellow 
appearance (Lamoreux et al. 2005). In Zebrafish, they can be detected by markers such as leukocyte 
tyrosinase kinase (ltk), which play vital roles in this cell type (Parichy et al. 2000; Lopes et al. 2008). 
Iridophore specification is promoted by foxd3 repressing mitfa expression, which indicates 
melanocytes and iridophores originate from a common precursor in Zebrafish (Curran et al. 2011).  
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1.6 Migration of neural crest cells 
The migration of neural crest cells is largely controlled by factors directing migration and permissive 
factors of the extra-cellular matrix such as fibronectin, laminin and collagen which help to guide 
migrating cells along their respective pathways (Perris & Perissinotto 2000; Singh et al. 2010; 
McKeown et al. 2013). Neural crest cells migrate in large numbers, with multiple mechanisms 
regulating their route and terminal location, including chemotaxis, contact-inhibition locomotion and 
cell sorting.  
 
1.6.1 Signals guiding NC migration in the head  
The cranial neural crest (CCNC), including the cardiac NC, form in the neural plate from the 
diencephalon to the fourth somite (Mayor & Theveneau 2013). They contribute to a vast range of 
derivatives in the face and neck including the periocular skeleton around the eye, cartilage, a subset 
of pigment cells and the trigeminal ganglia (Le Douarin et al. 2004). In the hindbrain, neural crest 
emerges in an alternating fashion adjacent to rhombomere 2, 4 and 6 from which they form 3 
discrete migratory streams. These ventrally-migrating neural crest cells either accumulate to form 
the cranial ganglia or they invade the branchial arches adjacent to rhombomere 2, 4 and 6 and form 
craniofacial jaw bones, as well as giving rise to cardiac ganglion and the outflow tract of the heart  (Le 
Douarin & Kalcheim 1999).   
 
The Ephrin (Eph) subfamily of the receptor tyrosine kinases (RTKs) and their ephrin ligands have been 
described as regulators during CNCC migration. Migrating cranial NCCs have been shown to express 
Eph receptors, which are directed to their target sites by branchial arch expressing ephrin-B2 cells 
(Adams et al. 2001). Neural crest cell migration towards the second branchial arch is impaired in 
mouse mutants, lacking ephrin-B2, indicating a NC delamination defect within the neural tube of 
rhombomer 4/6 (Adams et al. 2001). The ligand ephrin-B1 has also been shown to have a role in 
directing NC migration into branchial arches as ephrin-B1 mouse mutants display a cleft palate (Davy 
et al. 2004).  
 
In addition, neuropilin-1 knockdown in chick NCCs results in a complete failure to invade the 
branchial arches, although the cells remain organised into distinct streams (McLennan & Kulesa 
2007). Another study has shown that neuropilin-2 receptor is expressed in neural folds and migrating 
cranial neural crest. Its repulsive semaphorin-3 ligand is expressed in a rhombomeric alternating 
pattern in mice. Both are essential  to guide neural crest cells through the cranial mesenchyme dorsal 
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to branchial arch 1 and 2 to form the trigeminal ganglion (Gammill et al. 2007). In addition 
semaphorin 3C has been shown to be involved in cranial neural crest migration towards the outflow 
tract of the heart as highlighted in mutant mice (Feiner et al. 2001).  
 
To guide and direct cranial neural crest, several studies suggest the involvement of positive guidance 
cues such as stromal cell-derived factor 1 (Sdf1 also named Cxcl12), vascular growth factor (VEGF), 
FGFs and glial cell-derived neurotrophic factor GNDF).  
 
Chemoattraction through stromal cell-derived factor (Sdf1) within the pharyngeal arch endoderm 
and optic stalk is a necessity for craniofacial development in Xenopus embryos  (Theveneau et al. 
2010). Whereas in Zebrafish it seems that a localised source and strict balance of Sdf1b signalling is 
required solely for directed and organised cranial NCC migration and not for overall cephalic NCC 
development  (Killian et al. 2009).   
 
Studies in chick have shown that cranial neural crest requires vascular growth factor (VEGFA) to 
migrate adjacent to rhombomere 2 to populate the 2nd branchial arch. However, it remains open 
how VEGFA functions adjacent to other rhombomeres (McLennan et al. 2010). Another group of 
factors controlling cranial NC migration are members of the fibroblast growth factors (FGF). In vitro 
organ plant cultures suggest that FGF2 functions as chemoattractant for mesenchephalic neural crest 
cells (Kubota & Ito 2000).  
 
Lastly, hindbrain vagal neural crest cells form the majority of enteric neurons throughout the entire 
gut - in mice, they populate the entire gut within 5 days.  In parallel, sacral trunk NCC’s delaminate 
and migrate ventrally to form extrinsic pelvic ganglia next to the hindgut from where they enter to 
contribute to enteric neurons and glia (Sasselli et al. 2012). One of the factors regulating this process 
seems to be the glial cell-derived neurotrophic factor (GDNF). Cultures of mouse tissue explants 
demonstrated the chemoattractive properties of GDNF promoting colonisation of enteric neural cells 
as well as directed axon outgrowth within the gastrointestinal tract (Young et al. 2001).  
 
1.6.2 Signals guiding NC migration in the trunk 
Trunk neural crest arises caudal to the fourth somite and form pigment cells, dorsal root and 
sympathetic ganglia of the peripheral nervous system and the endocrine cells of the adrenal gland 
(Mayor & Theveneau 2013). As mentioned earlier trunk neural crest cells delaminate from the 
embryonic neuroectoderm and disseminate onto two distinct pathways through the trunk region 
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namely the dorsolateral and ventromedial pathways to form the peripheral nervous system as well 
as pigment cell pattern (Kelsh et al. 2009). The dorsolateral pathway is exclusively used by pigment 
cells and the ventromedial pathway by pigment cells and neural crest cells forming the peripheral 
nervous system (Kuo & Erickson 2010).  
 
1.6.2.1 Ventromedial pathway 
Studies in mice have shown that neuropilin (NRP) 1 or 2 receptors and their ligands class 3 
semaphorin (SEMA3) play an important role in restricting peripheral neural crest neurons to their 
designated ventromedial pathways in mouse and chick. In detail, the NRP1 and SEMA3A prevent a 
first wave of trunk NCCs from entering an intersomitic niche and restricting them to the 
ventromedial pathway (Schwarz & Maden et al. 2009). During a second wave, the receptor NRP2 is 
expressed to the anterior part of the neural crest, whereas the ligand SEMA3F is located within the 
posterior somitic region, which results in NC repulsion from the posterior half and limits them to the 
anterior part of the sclerotome (Gammill et al. 2006; Schwarz & Maden et al. 2009).  
 
In addition, Ephrin receptors and their ligands seems to have an inhibitory role in neural crest 
guidance in the trunk regions. Studies in chick, mouse and rat embryos showed that EphB3 receptors 
are expressed by NCCs in the anterior half of the somites, whereas the transmembrane ligand 
ephrin-B1 and –B2 are expressed within the posterior region of the sclerotome (Theveneau & Mayor 
2012). This pattern leads to NCCs entering the anterior half, but avoiding the posterior half of each 
somitic sclerotome during migration on the medial pathway (Krull et al. 1997). The repulsive ability of 
ephrin-B1 and -2 was confirmed in vitro where NCCs explicitly avoided lanes coated in ephrin-B1. In 
addition in vivo studies confirmed that ephrin-B1 addition in ectopic positions disrupts segmental 
migration of NCCs within the sclerotome (Krull 1998).  
 
Furthermore, endothelin-3 is expressed by the endoderm and dermomyotome, whereas endothelin 
receptor EDNRB is expressed by neural crest cells stimulating ventral migration through somites and 
inhibiting early entry to the dorsolateral pathway at the same time (Kuo & Erickson 2010).    
The ventromedial pathway also expresses stromal-derived factor-1 (Sdf1), which is required for 
neural precursor expressing the receptor CXCR4 to migrate and coalesce into dorsal root ganglia 
(DRG) within the mouse spinal cord region (Belmadani et al. 2005). In comparison, in chick it is only 




Lastly, trunk neural crest cells expressing Robo 1 and 2 receptors and are exposed to Slit ligands in 
the ventral mesenchyme acting as chemorepellents. The combination of both has the potential to 
selectively inhibit caudal NC from populating the gut, while stimulating vagal NC to do so during the 
first wave of the ENS formation (De Bellard et al. 2003). Slit expression within the dermomyotome 
also seems to repel NCCs form early migration onto the dorsolateral pathway. When Robo receptors 
were upregulated neural crest cells were able to choose the dorsolateral pathway prematurely or 
ectopically (Jia et al. 2005).   
 
1.6.2.2 Dorsolateral pathway 
The migration of neural crest cells on both pathways in mice seem to happen at the same time, 
whereas in chick the migration onto the dorsolateral starts with a 24 h and in Zebrafish with a 5 h 
delay after first NCCs enter the ventromedial route (Kelsh et al. 2009). Regulators, including 
ephrin/Eph and endothelin signalling control the migration of neural crest cells along the dorsolateral 
pathway lying beneath the ectoderm. 
 
In chick, melanocytes have been shown to express EphB2 receptors, resulting in melanocytes being 
attracted to ephrin-B1 ligands along the dorsolateral route in contrast to the ventromedial pathway 
in which NC gets repelled (Santiago & Erickson 2002). Therefore, ephrin-B seems to be bifunctional as 
it first repels neural crest cells from migrating along the  dorsolateral pathway too early, and later 
promotes this same migration. 
 
Neural crest cells migrating ventrally express EDNRB preventing simultaneous entry onto the 
dorsolateral pathway. Later, neural crest cells within the melanocyte lineage downregulate EDNRB 
and upregulate EDNRB2. This switch in receptors allows them to migrate along the dorsolateral route 
(Kuo & Erickson 2010). In 2008 Harris et al. demonstrated through shRNA knockdown experiments 
that the level of receptors expressed by melanocytes on the dorsolateral pathway is important to 
overcome repulsive and non-permissive cues. Consequently, the specific presence of either EphB2 or 
EDNRB2 is not the crucial factor as either of them is redundant when the other one is overexpressed.    
Finally in mouse, melanocytes migrate along the dorsolateral pathway between the dermatome and 
the overlying ectoderm following the invasion of the dermis and accumulation in hair follicles 
(Slominski & Paus 1993). To do that, they require the combination of chemokines, for example CXCR4 
receptors in melanoblasts are attracted by Sdf-1 ligands which are abundant in the dermis, and thus 




1.6.3 ECM components and adhesion molecules affecting neural crest 
migration 
Collective studies from mouse and chick suggest that the main ECM components influencing cranial 
and trunk neural crest migration are laminins, fibronectin, collagen I and collagen IV, proteoglycans, 
vitronectins, versicans and hyaluron (Duband & Thiery 1987; Sternberg & Kimber 1986; Trainor 
2013). The importance of the ECM during neural crest cell migration and advances of the research in 
this particular field is highlighted below.   
 
Laminin isoforms 1 and 8 seems to be important for the onset of neural crest migration, whereas 
fibronectin might be an overall important soluble component for NC migration shown by in ovo 
blocking with antibodies or shRNA inhibition (Perris & Perissinotto 2000). However, cranial and trunk 
neural crest in Xenopus seem to prefer fibronectin above laminin as substrate, although both 
permissive molecules can efficiently support adhesion during migration (Alfandari et al. 2003).  
   
Integrin receptors have been studied extensively in vitro in regards to their cell adhesion ability. This 
revealed that migrating crest cells express at least 7 integrins: -vv, 
5 and  (McKeown et al. 2013). The relevance for integrins in vivo is less well understood and 
has mostly been studied in chick embryos. For example integrin 7 is expressed within a 
subpopulation of trunk neural crest cells which mediates migration on substrates such as fibronectin, 
laminin and vitronectin (Kil & Bronner-Fraser 1996). The exact functional partnership of integrins 
with other ECM components have been shown as follows in chick: integrin v3 binds to fibronectin, 
vitronectin and laminin; 55 binds to vitronectin and overall the  subunit interacts with , 3 
and 8 to promote migration on fibronectin and laminin-1 (reviewed by McKeown et al. 2013). 
However, alpha and beta subunits as well as different isoforms are possibly functionally redundant as 
knockout of 1 and  integrin subunits in mice had no neural crest migration defect (Gardner et al. 
1996). 
Additionally, recent studies have demonstrated that a number of Metalloproteases (MMPs) and 
ADAMs could play an important role in cell adhesion. Specifically a gradient of MMP-2 has been 
observed in migrating cranial neural crest in chick, in which only leading cells express MMP-2 
(McLennan et al. 2012). Another member, MMP-9 seems to play a role in delamination and 
migration events as well, since decreased levels reduced migration; conversely overexpression in in 
vitro cultures enhanced it. Substrates for MMP-9 included laminin and to a lesser degree, N-Cadherin 
(Monsonego-Ornan et al. 2012). Functions of ADAM-13, an ADAM family member, include cleavage 
of Cadherin-11 and fibronectin, therefore remodelling the extracellular matrix for efficient cell 
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migration. Studies have shown that the nuclear translocation domain of ADAM-13 in Xenopus seems 
to be essential for promoting cranial neural crest migration in vivo but could not be replicated in vitro 
indicating that ADAM-13 could be required for remodelling the ECM environment for neural crest 
cells (Cousin et al. 2012). Supplementary to this, ADAM-13 and ADAM-19 might share redundant 
functions as knockdown of both components together caused a stronger defect in NC migration in 
mouse compared to inhibiting them individually (Cousin et al. 2011). 
 
The chondroitin sulfate proteoglycans versican, mainly isoform variant V0 and V1 have been shown 
to be expressed within the caudal region of the sclerotome acting in a repulsive manner towards 
early neural crest migration whilst directing them to their appropriate target tissue (Dutt et al. 2006; 
Perissinotto et al. 2000; Landolt et al. 1995). One example of the effect versican has on neural crest 
migration can be found in the Pax3 mouse mutant (Moase & Trasler 1992). The Pax3 mouse mutant 
splotch is associated with a defect in neural crest migration leading to pigmentation abnormalities, 
altered number or size of dorsal root ganglia and a defect in the outflow tract of the heart (Serbedzija 
& McMahon 1997). Splotch mice also show increased levels of versican V1 and presumably V2, which 
seems to correlate with the absence of NC migration (Henderson et al. 1997). Controversially, 
isolated neural crest cells are able to migrate in vitro and minor population of cranial NCCs forming 
small streams still remains in vivo, which might suggest that decreased cell migration is not cell 
autonomous to the lack of Pax3, but rather is due to the extracellular environment (Conway et al. 
1997). In addition, overexpression of Pax3 in a human medulloblastoma cell line increased levels of 
spliced V2 and a decreased V3 variant (Mayanil et al. 2001). The correlation of versicans and Pax3 
might explain the splotch mutant phenotype; and provides evidence for the regulatory importance of 
low levels of versicans within the extracellular matrix surrounding migrating neural crest cells.   
 
Furthermore recent morpholino knockdown studies have shown that hyaluron synthase XHas2 
influences directionality and motility of trunk neural crest cells in vivo of Xenopus embryos (Casini et 
al. 2012) and has been shown to play a role for CNCC migration through binding to the cell surface 
marker CD44 (Ori et al. 2006).   
 
Lastly, transmembrane protein cadherins type I and II, which classically interact intracellularly with 
catenins, have been implicated in neural crest development and migration. For instance, cadherin6 is 
found to be expressed in mouse NCCs during delamination and migration (Inoue et al. 1997), 
whereas in chick cadherin7 is expressed mainly in migrating trunk neural crest cells forming dorsal 
root ganglia (Nakagawa & Takeichi 1995). In addition cadherin11 is expressed in Xenopus cranial 
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neural crest where inhibition led to a failure of NCCs invasion beyond the second branchial arches 
(Kashef et al. 2009).  
 
1.7 Models of human neural crest diseases 
1.7.1 Teleost models of Melanoma  
NCCs migrate extensively during embryogenesis in a manner similar to metastasis. Indeed cancers of 
NC-derived cells may be particularly prone to metastasis since embryological origin predisposes them 
to express migratory properties. On the other hand, they might reverse to a more progenitor cell 
state and therefore exhibit full potential for cell transformation properties. One highly metastatic 
disease with a cell type originating from neural crest progenitors is melanoma (Uong & Zon 2010). 
Malignant melanoma is the most aggressive form, which can be cured if excised at an early stage. 
However once melanoma metastasises to distant organs, the median survival of melanoma patients 
drops below 9 months (Gogas et al. 2007). Although melanoma accounts for only 4 percent of all 
dermatological cancers, it is responsible for 80 percent of deaths from skin cancer; only 14 percent of 
patients with metastatic melanoma survive for over five years (Miller & Mihm 2006). Melanocyte 
transformation can occur either from de novo single melanocytes or from an already existing naevi, 
such as dysplastic or giant congenital naevi (Clark et al. 1984). The severity and progression of 
melanoma is pathologically described in thickness by the Clark level or Breslow thickness, but is 
commonly described as a step-wise categorisation: nevus, dysplasia, melanoma with radial growth 
phase, vertical growth which is associated with the invasion of the basal membrane and 
subsequently metastasis (Clark et al. 1984). Melanocytic transformation is thought to occur through 
sequential accumulation of genetic and molecular alterations. The transformation itself is thought to 
happen on a cellular level through either genetic (gene mutations, deletion, amplifications or 
translocation) or epigenetic (a heritable change other than in the DNA sequence, generally 
transcriptional modulation by DNA methylation and/or by chromatin alteration such as histone 
modification) (Gruber et al. 2008). As a result, melanocytic clones acquire a growth advantage over 
surrounding cells.  
Several molecular signalling pathways have been shown to either regulate melanoma tumour growth 
or be required to initiate primary melanocyte transformation. One of the main pathways is the MEK 
pathway, which is constitutively activated by a mutation of either BRAF or NRAS leading to 
constitutive phosphorylation of cytoplasmic serine–threonine kinases. Substitution of glutamic acid 
to valine at residue 599 (referred to V600E) in BRAF is the most frequently mutated defect and seen 
in 50-60% in melanoma tumours (Davies et al. 2002). Somatic N-Ras mutations occur in around 15%-
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25% of melanomas usually in form of substitution of leucine for glutamine at residue 61 of NRAS 
(Albino et al. 1989). This alteration leads to an inhibition in GTP hydrolysis and constitutive protein 
activation (Dahl & Guldberg 2007). However, in human BRAF and NRAS mutations have also been 
found in naevi, which suggests that BRAF and NRAS is necessary for the initial melanocytic 
development and/or maintanance,  but not for the actual transformation into a cutaneaous 
melanoma. This implies that the activation of MAPK signalling is a necessary event for melanoma 
development, but this does not initiate malignant transformation (Kumar et al. 2004). 
Zebrafish and Medaka provide an excellent model for studying cancer because of advantages such as 
genetic modifications and easy husbandry. The first teleost melanoma model was reported in the 
1920s when certain hybrids of Xiphosphorus maculatus and Xiphosphorus hellerii were backcrossed 
and developed spontaneous melanoma (Mione & Trede 2010; Dimitrijevic et al. 1998). Subsequent 
gene mapping yielded the Xiphophorus melanoma receptor kinase (Xmrk), which is homologous to 
the human epidermal growth factor (EGF) receptor (Wittbrodt et al. 1989).  The oncogenic potential 
of Xmrk results from an altered 5’ upstream sequence harbouring two mutations causing receptor 
activation and ligand-independent intracellular signalling (Meierjohann & Schartl 2006).  
Several teleost melanoma models have been established since which mostly rely on overexpression 
of oncogenes under tissue-specific or ubiquitous promoters (Mione & Trede 2010). Most of these are 
tabulated below (Table 1.1). 
 
Table 1.1: Melanoma teleost models 
Melanoma 
model 
NC promoter Gene Onset of 
melanoma  
Reference 




4 months Patton et al. 2005 
Zebrafish Mitf promoter HRASG12V 6 months (can 
be accelerated 
with p53-/- 
Michailidou et al. 
2009 
Zebrafish Kita promoter (eGFP)-HRASV12 
transgenic 
3-4 weeks Anelli et al. 2009; 
Santoriello et al. 
2010 
Medaka Mitf promoter Xmrk (oncogenic 
receptor tyrosinase 








1.7.2 Mammalian and teleost models of Neurocristopathies  
Problems of neural crest cell fate specification and migration form the basis of a variety of congenital 
diseases either including pigmentation and hearing loss called Waardenburg syndomes type I-IV or 
defects of the colon and rectum, such as in Hirschsprungs’s disease (Mayor & Theveneau 2013). 
Neural crest deficiencies resulting in abnormalities of pigmentation and deafness are called 
Waardenburg syndrome, which can be categorised into four types (Table 1.2), some of which include 
additional syndromes of Hirschsprung’s disease.  Hirschsprung’s disease (HD) was described in 1888 
by Harald Hirschsprung and affects 1 in 5000 live births today. It is characterised by aganglionosis in 
the submucosal and myoenteric plexus due to a failure of neural crest cell migration, proliferation, 
differentiation or survival during the development of the enteric nervous system (ENS). The impaired 
enteric nervous system leads first to malfunctional contraction, whereas a complete lack causes 
permanent closure of terminal bowel largely within the proximal rectum that results in widening of 
the bowel, hence the term ‘congenital megacolon’ associated with HD.   
 
Table 1.2: Types of Waardenburg syndrome with phenotypic and genetic characteristics as well as 





Animal model  Reference 
Waardenburg 




Appearance of a 
widened nasal bridge 
due to a lateral 
displacement of the 






Splotch mice (sp –
Pax3 gene)  
















(Tassabehji et al. 
1994; Nobukuni 
et al. 1996; Lister 
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et al. 1999; 




III (WS III; Klein-
Waardenburg 
syndrome) 
WS I defects and 
additional 
musculoskeletal 
abnormalities such as 
Upper limb defects 
,hypoplasia, flexion 
contractures, fusion of 
the carpal bones, 
syndactyly  






-  (maybe Pax3 
mouse?) 
(Tremblay et al. 
1998; Zlotogora 
et al. 1995) 
Waardenburg 
syndrome type 




Shah syndrome has 
features of 
Hirschsprung’s disease 





(cls – Sox10); 
Piebald-lethal mice 
(s1- Ednrb gene); 
Lethal spotting mice 
(ls- Edn3 gene); 
Dominant 
megacolon mice 
(Dom –Sox10 gene); 
Japanese Fancy 





depending on the 
gene) 
(Bondurand et al. 
2007; Edery et al. 
1996; Carney et 
al. 2006; Kapur et 
al. 1995; 
Tachibana et al. 
2003; Koide et al. 
1998; Kikkawa et 
al. 2001; Herbarth 
et al. 1998; 
Dutton et al. 
2001; Elworthy 






1.8 Mutant screen and identification of hirame 
phenotype 
To date, the majority of large-scale genetic studies have been confined to forward genetics in 
Zebrafish (Driever et al. 1996; Kelsh et al. 1996; Haffter et al. 1996), in which the genetic basis of a 
given phenotype is characterised, whilst in reverse genetics, the phenotype associated with a given 
allele is characterised. Zebrafish has several advantages such as cost-effective husbandry, large 
quantities of offspring and easy micro-manipulation of translucent fish embryos; benefits found in 
the Japanese rice fish Medaka (Oryzias latipes) as well. Yet Medaka is evolutionary distant from 
Zebrafish, and differences in functional overlap of genes between the two species permits 
identification of mutations as yet unknown in Zebrafish.  
In 2004, Furutani-Seiki et al. published mutants established in a random mutagenesis screen using a 
forward genetics approach. This was the first large scale mutagenesis screen in Medaka (Oryzias 
latipes). As in the Zebrafish screen, mutagenesis was induced in sperms using N-ethyl-N-nitrosourea 
(ENU), which were then cryopreserved and progressively screened for distinct phenotypes such as 
organ malformations induced by the resulting point mutations in the DNA sequences. Resulting from 
this large screen, a unique mutant named hirame with a mutation on allele j50-20C was first 
described (Furutani-Seiki et al. 2004; Watanabe et al. 2004; Kitagawa et al. 2004). Furutani-Seiki 
describes hiramej50-20C as mutant with a defective converging subset of cells towards the dorsal axis in 
which the cellular movement in the hypoblast is drastically impaired resulting in reduced dorso-
ventral thickness of the tissue along the body axis. In parallel, Watanabe describes hiramej50-20C 
mutants as phenotypically flat with coinciding liver defects and terminally embryonic lethality. A 
general failure to develop the correct liver size possibly resulted from initial misalignment of the 
epithelium. This in turn might have caused a defect in the primary endodermal convergence causing 
a misconstruction of the endodermal rod. The mutant also exhibits mislocated tissues such as the 
heart and the lens. Lastly, Kitagawa defines hirame as a mutant with differentiation defects; 
flattened CNS, forebrain dysmorphology and a beating heart located next to the ears as well as 
compressed general body morphology in their screen for mutants with forebrain malformations.  
Because its unique phenotype is unlike any other mutant previously described in Medaka and 
Zebrafish (Taniguchi et al. 2006; Watanabe et al. 2004), Furutani-Seiki went on to make this mutant 
his main focus of research. After intensive work using positional cloning, he identified a non-sense 
point mutation within the first WW domain in the Yes-associated protein 1 (YAP1 -1 out of 2) 
exchanging leucine to a stop codon in the 164th position in allele j54-20C (L164X) ( 
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Figure 1.4A). Medaka yap1 (out of 2) is a homologue for the two WW domain-containing human 
YAP1 (YAP65) and is referred to in this thesis as “yap”, whereas yap 2 (out of 2) corresponds to the 
single WW domain human TAZ. YAP is a transcriptional co-activator downstream of the Hippo 
Signalling Pathway which promotes cell survival, proliferation and maintenance of the 3-dimensional 
tissue structure (Jiang et al. 2009; Sudol et al. 1995; Lian et al. 2010; Huang et al. 2005). YAP itself is 
widely expressed in embryonic and adult tissue, and in mammals YAP loss-of function mutants are 
embryonic lethal and difficult to study in utero. In contrast, the hirame (hir) embryo can survive until 
4 days post fertilisation (dpf) during embryogenesis (corresponding to Iwamatsu’s stage 32), which 
can be monitored in real-time under a microscope. In hirame the patterning along the anterior-
posterior and dorsal-ventral axes up to 34  hpf (st.21) mid-neurulation develops normally, thanks to 
the maternal and zygotic YAP contribution, as indicated by Zebrafish YAP knockdown experiments  
(Jiang et al. 2009). However, from stage 21 onwards the body of the hir mutant embryos gradually 
collapses, and mutant embryos exhibit a peculiar body flattening and dislocation of several tissues 
including retina, lens and heart ( 
Figure 1.4B). Since the yap mutation is a zygotic recessive mutation, all references to hirame (hir) in 





Figure 1.4 Schematic representation of YAP protein domains and images of wild type and hirame 
embryos at 2.5 dpf (st.26) 
A) Schematic representation of YAP and its protein domains including TEAD binding domain, 
14-3-3 protein binding site, two WW domains, SH3 binding site, transactivation coding region 
(TAc) and a PDZ binding site. The nonsense point mutation causing the hirame phenotype is a 
leucine to stop amino acid codon exchange in the amino acid 164 within the first WW domain 
(L164X). B) Comparison between wild type (top row) and hirame mutant (bottom row) at 54  
hpf (st. 26).  Lateral view shows the flattened body morphology in hirame from st. 22 onwards 
as described in Watanabe et al, 2004 and Kitagawa et al., 2004. Note the tail of hirame 
embryos is sometimes seemingly grown inside the yolk sac due to soft yolk layers. Dorsal view 
onto embryos highlights organ abnormalities such as the dislocation of lens compartments of 
the eye (arrows). Anterior (head) is left. Scale bar = 500µm.  
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1.9  Hippo pathway signalling and its main regulators 
YAP is a downstream effector of the recently discovered Hippo pathway. The core kinase cascade of 
the Hippo pathway was originally found in a genetic screen for Drosophila melanogaster overgrowth 
mutants (Wu et al. 2003). In this study, the discovery of additional upstream component Hippo (Hpo) 
could be linked to previous studies that have already established a connection between Salvador 
(Sav) and the downstream-most factor Warts (Wts) in regulating organ size through cell proliferation 
and modulation of downstream effectors cell cycle regulator CycE and apoptosis inhibitor Diap1 
(Tapon et al. 2002). They also demonstrated that a dysfunctional Hippo pathway consistently led to 
tissue overgrowth such as enlarged eye imaginal discs, and excess head epidermis (Udan et al. 2003). 
Subsequent studies have revealed additional members of the Hippo pathway including the upstream 
Expanded (Ex), Kibra and Merlin (Mer) components (Hamaratoglu et al. 2006), the core kinase 
component Mats (Lai et al. 2005) and downstream transcriptional co-activator Yorkie (Yki) (Huang et 
al. 2005). The pathway is evolutionary conserved in vertebrates and the majority of research has 
been carried out in mammals. In humans the equivalent core kinase cascade consists of mammalian 
sterile 20 -1 and -2 (Mst1/2) which is the homologue of Drosophila Hpo, while Salvador 1 (Sav1) is 
homologous to Sav, Large tumour suppressor 1 and 2 (Lats1/2) correlates to Wts and the scaffold 
protein Msp-one binder Mob1 is Mats (Figure 1.5). Subsequent studies revealed upstream 
components Kibra and Merlin (NF2) (Saucedo & Edgar 2007; Pan 2010), in which Kibra has been 
shown to regulate Lats1/2 directly (Xiao et al. 2011). 
When the Hippo pathway is active, Mst1/2 forms a complex with the scaffolding protein Sav1 and 
together with Mob1 they phosphorylate the large tumour suppressor protein Lats1/2. Activated 
Lats1/2 subsequently phosphorylates and inactivates the transcriptional co-activator Yes-associated 
protein (YAP) at Ser127 and its human paralogue TAZ (also known as WW domain containing 
transcription regulator 1 (WWTR1)) (Hao et al. 2008; Kanai et al. 2000). Phosphorylation leads to 
cytoplasmic retention and hinders YAP and TAZ from entering the nucleus (Zhao et al. 2007). YAP 
(also known as YAP1 or YAP65) is characterized by two WW domains, whereas the paralogue TAZ 
only carries one WW domain and an additional PDZ domain (Sudol et al. 1995; Kanai et al. 2000). 
Additional phosphorylation of YAP at Ser381, and TAZ at Ser89 by 14-3-3 proteins leads to ubiquitin-
mediated proteosomal cytoplasmic retention and degradation (Zhao et al. 2010). When the Hippo 
pathway is inactive, YAP/TAZ stays in an unphosphorylated state and both transcriptional co-
activators translocate to the nucleus. Because YAP and TAZ do not have DNA binding domains they 
depend on TEAD family transcription factors (1-4) to induce downstream target genes (Vassilev et al. 
2001; Zhao et al. 2010). The nuclear activity of YAP and TAZ induces expression of a variety of genes 
concerned with proliferation, cell migration, cell cycle division and suppression of anoikis, a special 
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form of apoptosis in which cells first detach from the surrounding extracellular matrix (ECM) 
substrate and then initiate programmed cell death (Pan 2010). Comprehensive expression profiling 
studies have revealed target genes of YAP, including IAP family member BIRC5 (Dong et al. 2007), the 
secreted Cystein-rich protein connective tissue growth factor (CTGF) (Zhao et al. 2007), FGF1, GLI-2 
and amphiregulin (AREG), which is an EGF family member.  Other proteins, such as BDNF, ITGB2, 
IGFBP3, PDGFβ and CyclinD are upregulated by YAP overexpression, whereas p57, RASSF4, prolactin 
and BMP2 are down regulated (Zhao et al. 2007; Hao et al. 2008). 
Other regulatory elements influencing the activity of the Hippo pathway are regularly found and 
added to the core network. For instance the adaptor protein Ajuba has been shown to inhibit the 
Hippo pathway by physically interacting with Lats and Sav1, thus blocking YAP phosphorylation 
(Thakur et al. 2010). Ajuba normally localises to adherens junctions through an association with α-
catenin during the establishment of cell contacts. This implies that recruitment of Ajuba to the cell 
membrane may contribute to contact dependent inhibition of YAP and TAZ  (Marie et al. 2003). α-
catenin  has also been shown to be regulated independently of the activity of the Hippo pathway by 
recruiting phosphorylated YAP to adherens junctions (Schlegelmilch et al. 2011). In addition, Merlin 
has been found to competitively complex with Angiomotin (Amot) at tight junctions. This binding 
releases Rich1 from the inhibitory Angiomotin complex and allows Rich1 to activate Rac1 (Yi et al. 
2011). Angiomotin also seems to directly regulate YAP activity by sequestering it into the cytoplasm 
or through Lats1/2 phorshorylation, therefore excluding it from the nucleus and blocking its 
transcriptional activity (Zhao et al. 2011; Paramasivam et al. 2011).    
Furthermore RASSF1 which usually binds to Ras-GTPs, has been shown to interact and activate Mst1 
(Khokhlatchev et al. 2002), resulting in apoptosis which can be abrogated through Raf-1 (Neill et al. 
2004). Another study demonstrated that upon DNA damage RASSF1 is phosphorylated by ATM; a 
main sensor of double stranded DNA breaks. This interaction results in apoptosis through activation 
of MST1 and Lats1 (Hamilton et al. 2009). Another factor influencing and controlling the Hippo 
pathway are stress signals induced by contact inhibition. Thereby YAP translocates into the nucleus 
when epithelial cells are cultured in low density, whereas cytoplasmic YAP was found predominantly 
when cultured in high density (Ota & Sasaki 2008). Additionally, cell-surface hyaluron receptor CD44 
has been placed upstream of the Hippo pathway as upon activation of CD44 or stress induced 
oxidation with H2O2, Mst1/2 was found to be phosphorylated, activating downstream kinases (Xu et 
al. 2010). Lastly, Mst1/2 seem to associate with, and monitor changes in actin polymerisation and 
regulates downstream effectors c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) 
and cyclin-dependent kinase inhibitor 1 (p21) (Densham et al. 2009). As well as that, hormonal cues 
are received by a G-protein-coupled receptor (GPCR), mediated through F-actin to stimulate the 
activity of Lats1/2 which inhibit YAP and TAZ depending on the kind of GPCR involved (Mo et al. 
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2014). This would indicate that the Hippo pathway responds to cytoskeleton disruption, mechanical 
stretching and/or shear stress.  
 
 
Figure 1.5: Schematic of the mammalian Hippo pathway and some of its components 
Core features of the mammalian Hippo kinase cascade and some of its effectors influencing 
nuclear localisation and transcriptional activity of co-activators YAP and TAZ within the 
nucleus. The signalling pathway includes Merlin (Mer); Kibra; Salvador 1 (Sav1); mammalian 
sterile 20 like 1 and 2 (Mst1/2); Large tumour suppressor 1 and 2 (Lats1/2); Msp1 binder 1 
(Mob1A/B); Yes-associated protein (YAP) and its paralogue TAZ; TEA domain transcription 
factor TEAD as well as cell-surface hyaluron receptor CD44, Ajuba (Ajub), αCatenin, 
Angiomotin (Amot), Ras-associated factor Rassf and the G-protein-coupled receptor (GPCR). 
Cytoskeleton changes and induced cellular stress levels also influence the Hippo pathway. TJ, 
tight junctions; AJ, adherens junction. Pointed arrows indicate activation; blunt arrows show 
inhibitory function (modified after Halder & Johnson 2011). 
 
Overall, the discovery of the Hippo pathway provided a chance to address enduring questions about 




1.10 Effects of Hippo-YAP signalling on tissue 
physiology 
1.10.1 Dysregulation of Hippo pathway components cause cell 
transformation and cancer growth in mammals   
In humans, amplifications of the 11q22 locus causing yap overexpression has been reported in 
several tumour types, such as oral and esophageal squamous cell carcinoma, cancer of the liver, 
breast, pancreas and lung (Lorenzetto et al. 2014). TAZ/WWTR1 has been found to be overexpressed 
in papillary thyroid carcinoma possibly controlled by the RAS/RAF/MEK (mitogen-activated protein 
kinase)/ERK (extracellular-signal-regulated kinase) signalling pathway (Cristofaro et al. 2011). Specific 
mutations in members of the Hippo pathway are rare in human cancers (Pan 2010) and have only 
been found in Merlin (neurofibromin 2, NF2) in neurofibromatosis type 2 and in cDNA of Mob1 
isolated from human melanoma and mammary carcinoma (Lai et al. 2005). Additionally, gene 
deletions of salvador1 were detected in two renal cancer cell lines (Tapon et al. 2002). And strong 
YAP protein expression was found in various cancer types, for example ovarian serous 
cystadenocarcinoma, esophageal squamous cell carcinoma, colonic, lung, pancreatic, hepatocellular 
and prostate adenocarcinoma (Steinhardt et al. 2008). Interestingly, there are reports describing 
hypermethylation events in Hippo pathway members, which suggest that epigenetic silencing could 
be another mechanism by which core components regulate tissue homeostasis. For instance, Mst1/2 
in soft sarcoma (Seidel et al. 2007) and Lats1/2 in breast cancer (Takahashi et al. 2005) as well as 
astrocytomas (Jiang et al. 2006) have been described to be hypermethylated. Also, upstream 
regulator RASSF is frequently hypermethylated in wide range of human cancer (Richter et al. 2009), 
which might affect  Mst1/2. Furthermore miRNA-mediated silencing of Lats2 through miR372 and 
miR373 has been described in testicular germ cell tumours (Voorhoeve et al. 2006).   
Hippo pathway signalling has been shown to control tissue growth in mammals. Remarkably, 
transgenic mice with tissue specific YAP induction developed enlarged livers which after prolonged 
YAP exposure advanced into hepatocellular carcinoma (Camargo et al. 2007; Dong et al. 2007). This 
effect was partly reversible through repression of yap expression, confirming that the Hippo 
signalling controls organ size by inhibiting nuclear function of oncogenic YAP. In addition to 
regulation of cell growth in various cell types, YAP expression is known to modulate cell 
differentiation capacity. YAP, together with its transcriptional binding partner TEAD2, has been 
reported to maintain self-renewal properties and prevents mouse ES stem cell differentiation (Tamm 
et al. 2011). In mouse intestine, expression of endogenous YAP was shown to be restricted to the 
progenitor/stem cell compartment and overexpression of yap expanded the multipotent 
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undifferentiated progenitor cell population (Camargo et al. 2007). In addition, overexpression of YAP 
or TAZ can induce anchorage-independent growth and epithelial-mesenchymal transition (EMT) of 
immortalized mammary and pancreatic epithelial cells in vitro, which are hallmarks for cancer 
progression and the onset of metastasis (Overholtzer et al., 2006; Zhao et al., 2008; Zhang et al., 
2009a; Chan et al., 2009; Dong et al., 2007). 
In contrast, YAP can also induce apoptosis in response to DNA-damage by binding to the 
transcription factor p73, a p53 family member (Strano et al. 2001). Thereby, the pro-apoptotic role of 
YAP seems to depend on the regulation of its upstream components (Hamilton et al. 2009; Oka et al. 
2008). 
 
1.10.2 YAP as regulator of cell migration 
Active cell migration is a feature of the neural crest cells and is a main hallmark of cancer progression 
and metastasis. As mentioned above overexpression of YAP induced EMT in non-cancerous cell 
cultures (Overholtzer et al. 2006). In vivo studies confirmed the oncogenic potential of YAP to 
transform cell behaviour. The constitutively active form of YAP (5SA) being mutated in five 
phosphorylation sites, increased the overall proliferation and migration of ovarian cancer cells in 
vitro and in vivo, possibly by increasing epithelial-mesenchymal transition leading to accelerated cell 
motility. Promoted cell migration was assessed in vitro by both a colony forming transwell migration 
assay and a wound-healing assay, and in vivo by metastasis formation within lungs after caudal vein 
injection (Xia et al. 2014). In addition, increased YAP levels were found in adult granulosa cell 
tumours, whereby increased expression levels correlated with an incline in cell proliferation. Further 
tests concluded that overexpression of constitutive active YAP in isolated granulosa tumour cells 
resulted in increased proliferation and motility of individual cells in vitro (Fu et al. 2014).  
Lamar et al. in 2012 provided the first report suggesting YAP involvement in the melanocyte 
transformation. Their mouse in vivo studies showed that through interaction with the DNA-binding 
domain TEAD, YAP mediated a 60% increase in melanoma tumour growth after sub cutaneous 
injection and enhanced the number of lung metastases following tail-vein injection. The effect 
observed included cell invasion and migration, highlighting pro-metastatic potential in melanoma 
cells (Lamar et al. 2012).  In agreement, in 2014 Nallet-Staub's functional studies showed that 
overexpression of YAP increased the anchorage-independent growth in cutaneous melanoma 
cultures in soft agar. Conversely, specific knockdown of either of these Hippo effectors led to 
reduced clonogenic and invasive capacity in vitro, and reduced their tendency to metastasise to lungs 
following tail-vein injection in nude mice. This could implicate YAP in contributing to the invasive and 
metastatic capacity of melanoma cells.  
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These studies provide an indication of the importance of Hippo-YAP signalling as driver for in vivo cell 
growth and migration.  
 
1.10.3   Connecting YAP with neural crest development 
Because our study focuses on the analysis of YAP within the neural crest development, we were 
intrigued to find out about existing experiments implying regulation of neural progenitor cell 
proliferation and/or differentiation via the Hippo-Pathway. In mouse TEAD2 transcription factor 
binds to the Pax3 neural crest enhancer sequence NCE2 which promotes its activity during neural 
crest cells development (Milewski et al. 2004). Overexpression of a dominant negative form of Tead2 
under a Wnt1 promoter reduced Pax3 expression within the neural crest derivatives and resulted in 
smaller dorsal root ganglia. They also showed a remarkable overlap of PAX3, Tead2 and YAP in the 
dorsal neural tube ventricular zone, which suggests that co-transcriptional partner YAP together with 
TEAD DNA binding might act to positively regulate Pax3 expression (Milewski et al. 2004).  
In 2008 Cao et al. demonstrated that the YAP-TEAD interaction mediated by the upstream kinase 
cascade regulates the Sox2 positive neuronal progenitor population of the neural tube during chick 
embryogenesis. Thus, the Yap expression domain correlated with the ventricular progenitor zone and 
co-localised with neural progenitor marker Sox2 and theTEAD transcription factor. Overexpression of 
constitutive active YAP within the neural tube decreased neuronal differentiation and increased the 
number of Sox2 positive progenitor cells. This suggests that YAP could maintain the neuronal stem 
cell population, increases proliferation and depresses neuronal differentiation. Increased 
proliferation of neural progenitor cells also caused overgrowth in a rosette-like fashion, resembling 
Homer-Wright rosettes present in various neurological tumours (Dyer 2004). To confirm if TEAD 
mediates its function through YAP, a transcriptionally active version of TEAD was expressed to 
recapitulate the YAP phenotype described above. The increased transcriptionally TEAD activity 
resembled the YAP overexpression outcome, including expansion of progenitor cells, reduced 
differentiation and tumour-like overgrowth, confirming their interaction (Cao et al. 2008). 
Supporting data came from Xenopus studies. Gee et al. showed that YAP gain-of-function expands 
the Sox2+ progenitor cells within the neural plate and inhibits neuronal differentiation. It also 
enlarged the Pax3+ neural plate border cells during late gastrulation, which inhibited markers 
required for neural crest development (zic1, foxd3), pre-placodal ectoderm and hatching gland 
differentiation. The regulation of Pax expression and neuronal cell fate by YAP was shown to be 
through an interaction with TEAD transcription factors (Gee et al. 2011).         
Dysregulation of Hippo signalling upstream components, specifically fat cadherin family members, 
have also been proposed to control the neural tube progenitor pool through the regulation of YAP. In 
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Drosophila transmembrane receptor Fatd has been shown to regulate tissue size and planal cell 
polarity by deregulating Hippo target genes such as cyclin E and diap1 (Willecke et al. 2006; 
Matakatsu & Blair 2004). In mice, the deletion of Fat4 (also called FatJ) led to a consistent increase in 
neural tube progenitor cell number within the neural tube causing a widening of the spinal cord, but 
did not inhibited neuronal differentiation. The authors suggest a link to Hippo-YAP as simultaneous 
knockdown of YAP and Tead4 rescued the FatJ phenotype, indicating a functional connection (Van 
Hateren et al. 2011).  
So far the most relevant report tying together aspects of neural crest development to the Hippo 
pathway comes from Jiang et al. published in 2009. Therein yap knockdown in Zebrafish embryos 
caused reduced numbers of elavl3+ cells in mid- and hindbrain and fewer abnormally distributed 
craniofacial cartilages in the branchial arches. Analysis of the neural crest marker crestin revealed 
weaker expression throughout the embryo, whereby some periocular located cranial NC 
accumulated near the developing retina and the lens mesenchyme (Jiang et al. 2009). However, the 
outcome and quality of the data might have been masked by embryonic developmental defects 
caused by high morpholino dosages.  
Therefore, the question still remains open whether the Hippo pathway is essential to neural crest 














1.11  Aims 
As outlined previously a failure of Hippo signalling has been linked to tumorigenic cell alterations, 
increased cancer growth, migration and metastasis in numerous cancer types in vitro and in vivo. 
Especially interesting for us are investigations concerning melanoma development, as melanoma 
metastasis is characterized by features such as epithelial-mesenchymal transition (EMT) and 
intensive migration over long distances thought to recapitulate some of the neural crest cell 
properties found during embryogenesis. Furthermore, there are reports linking the Hippo pathway 
directly to a neural crest cell progenitor population within the dorsal tube, which seemed to be 
regulated by precise levels of Hippo downstream effector Yes-associated protein (YAP). In parallel, a 
mutagenesis screen carried out in the Japanese rice fish Medaka led to the discovery of a mutant 
named hirame with astonishing developmental abnormalities (Furutani-Seiki et al. 2004). Further 
investigations revealed that hirame carries a non-sense point mutation in yap resulting in a non-
functional protein (Fututani-Seiki unpubl. data). One of hirame’s characteristics is a decrease in 
differentiated melanocytes observed in late stage embryos.    
Together, this seemed like a fantastic opportunity to investigate the role of Hippo downstream 
effector YAP in neural crest development in this Medaka loss-of-functional YAP mutant.  We aimed 
to: 
1.) analyse the abnormal melanocyte phenotype at different stages to highlight when and where 
the abnormality  starts during embryogenesis.  
2.) establish and carefully characterise a Medaka melanocyte specific promoter, with which we 
could potentially address questions concerning cell behaviour, proliferation and melanocyte 
survival in hirame embryos. 
3.) overexpress YAP and validate its cell autonomy within the melanocyte lineage in an attempt 
to rescue the hirame phenotype. The melanocyte specific expression could also confirm 
YAP’s oncogenic potential in vivo. 
4.) characterise a wider range of unpublished Medaka neural crest markers spanning different 
neural crest derivatives. First describing those markers in wild type embryos, we would then 
move on to analyse them in hirame mutants to reveal whether YAP causes changes to other 
neural crest cell lineages as well.  
Together, these results could shed light on the role of YAP during Medaka neural crest development. 
During the course of experiments, we expect to establish and verify new tools such as neural crest 
specific promoter fragments or in situ hybridisation probes that could be useful to the wider Medaka 

















2 Chapter: Material and Methods  
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2.1 Materials  
Materials used and sources are listed below in categories. 
2.1.1 Chemical Reagents 
UltraPureTM Agarose      Invitrogen Life Technologies, UK   
Low Melting Agarose     Invitrogen Life Technologies, UK 
IPTG       Melford Labs Ltd, Suffolk, UK 
Luria Agar/Broth Base     Invitrogen Life Technologies, UK 
Methylcellulose      Sigma Chemical Co, St Louis, MO, USA 
Phenol/Chlorophorm/isoamyl alcohol   Sigma Chemical Co, St Louis, MO, USA 
Tricaine (Ethyl 3-aminobenzoate methanesulfonate)  Fluka Analytical, Sigma Aldrich, Germany  
Tween 20      Sigma Aldrich, Germany  
Luria Agar       Sigma Life Science, Germany 
Luria Broth      Sigma Life Science, Germany 
Formaldehyde      Sigma Aldrich, Germany 
Ethanol       Sigma Aldrich, Germany  
Methanol      Fluka Analytical, Sigma Aldrich, Germany 
PBS       Fisher Scientific, UK 
DPX mounting medium      Fisher Scientific, UK 
Heparin      Sigma, Aldrich, Germany 
 
2.1.2 Kits and Miscellaneous Materials 
Technovit 8100 Cold-curing resin kit   Kulzer, Germany 
DIG RNA labelling kit SP6/T7    Roche Diagnostics GmbH, Germany  
NucleoBond® Xtra Midi      Macherey-Nagel, Germany    
Gel DNA Recovery kit     Zymo Research, USA 
DNA Clean & Concentrator (PCR purification kit)  Zymo Research, USA 
mMESSENGER RNA synthesising kit SP6   Ambion Inc Texas, USA  
 
2.1.3 Antibodies 
Anti-DIG      Roche Diagnostics, Germany 
Anti-Fluorescein     Roche Diagnostics, Germany 
35 
 
YAP1 polyclonal (rabbit) #13584    Proteintech (ptglab), UK  
YAP1 polyclonal (rabbit) #4912    Cell Signalling, UK 
 
2.1.4 Antibiotics, Indicators and Dyes 
Ampicillin      Sigma Chemical Co, St Louis, MO, USA 
Ethidium Bromide     Sigma Chemical Co, St Louis, MO, USA 
Kanamycin      Sigma Chemical Co, St Louis, MO, USA 
Phenol Red      Sigma Chemical Co, St Louis, MO, USA 
X-gal       Sigma Chemical Co, St Louis, MO, USA 
Neutral Red      Sigma Chemical Co, St Louis, MO, USA 
Histo-Clear (Xylene substitute)    National Diagnostics, UK 
Harris Haematoxylin     Raymond A Lamb Ltd, UK 
Mayer´s Heamatoxylin      Sigma-Aldrich Chemie GmbH, Germany 
Eosin 1% Aqueous     Raymond A Lamb Ltd, UK 
Fast Red tablets     Roche Diagnostics, Germany 
NCB/BCIP      Roche Diagnostics, Germany 
 
2.1.5 Enzymes 
Proteinase K      Fisher Scientific, UK 
RNase A      Promega, UK 
RNase Inhibitor      Promega, UK 
Pronase      Sigma Aldrich, Germany 
Shrimp Alkaline Phosphatase    Promega, UK 
T4 Ligase      Promega, UK 
Go Tag Polymerase     Promega, UK 
KOD Hot Start DNA Polymerase    Novagen, USA  
Restriction enzymes were supplied with specific buffers and reactions were done according to 
manufacturer’s inctructions (Promega, UK or New England BioLabs, UK) 
 
2.1.6 Nucleic Acids 
dNTP mix      Promega, UK 
Yeast tRNA      Invitrogen Life Technologies, UK 
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DIG labelled digoxygenin    Roche Diagnostics, Germany 
DNA ladder 100bp     New England BioLabs, UK or Promega, UK 
DNA ladder 1kb      New England BioLabs, UK  
 
2.1.7 Bacterial Strains and Cloning Vectors 
The MAX Efficiency® DH5α™ Competent Cell bacterial strain used for general plasmid preparation 
and cloning was originally purchased from England BioLabs. From there all following stocks of 
competent cells were made in-house following the protocol given by Dr. K.Kaji (Appendix 2) in which 
transformation efficiencies up to 1 × 109 transformants/µg plasmid DNA can be achieved. DH5α™ 
competent cells containing the recA1 and endA1 mutations increase insert stability, improve yield 
and quality of plasmid DNA preparion as well as blue/white screening capability (lacZΔM15) (England 
BioLabs, Life technologies, Cat# 18258-012. 
 
2.1.8 Frequently used cloning vectors  
Cloning vectors used in this thesis are tabulated (Table 2.1) and illustrated below. 
Table 2.1: Cloning plasmids used throughout this thesis 
Plasmid name Supplier 
pGEM®T-Easy  Promega, Madison, WI 
pEGFP-1 
 
obtained in-house, but can also be purchased 
from BD Bioscience Clontech 
pCS2+ 
obtained in-house, but can also be purchased 
from Addgene 
pEGFP-C3 
obtained in-house, but can also be purchased 





Figure 2.1: pGEM®-TEasy vector map 
A plasmid map of pGEM®-T Easy Vector featuring the TA-nucleotide overhang for TA-cloning of PCR products 
enclosed by a multiple cloning site (MCS) with common restriction enzyme recognition sites for further cloning 
approaches.  It also features the T7 and SP6 polymerase recognition sites frequently used for in-vitro transcription 
of RNA probes. The pGEM®-T Easy Vector carries a Ampicillin resistant genes. The handling protocol was obtained 
from Promega.   
 
 
Figure 2.2: Map and MCS sequence of pEGFP-C1 
38 
 
Restriction map (top) and multiple cloning site (bottom) of pEGFP-1. All restriction sites shown 
are unique. pEGFP-1 is a promoterless eGFP vector used to monitor transcription from 
different enhancers/promoters. Desired sequences are inserted into the MCS located 
upstream of the EGFP coding sequence. pEGFP-1 encodes a red-shifted variant of wild-type 
GFP (1-3) which has been optimised for brighter fluorescence (Excitation maximum= 488nm; 
emission maximum= 507nm). A bacterial promoter confers kanamycin resistance in E.coli. The 
backbone also provides a pUC origin of replication in E.coli and an f1 origin for single-stranded 






Figure 2.3: Map of pCS2
+
 plasmid 
Restriction map of the 4095bp pCS2+ multipurpose expression vector. A strong CMV IW94 
promoter is coupled to the first polylinker followed by a SV40 late polyadenylation site. Within 
that polylinker there is a 5’-3’ SP6 promoter at the start and and reverse oriented T7 promoter 
at the end.  A second polylinker follows with more unique restriction enzyme sites and a T3 
promoter region used for RNA in-vitro transcription and translation. The vector backbone itself 
includes an ampicillin resistance gene and an f1 origin to produce single stranded DNA 







Figure 2.4: Map of EGFP-C3 plasmid 
Plasmid restriction map of the 4.7kb pEGFP-C3 vector enabling insertion of DNA fragments in 
C-terminally to EGFP with help of a multiple cloning site (MCS) followed by a SV40 late 
polyadenylation site. A strong CMV promoter drives expression of EGFP or the EGFP fusion 
gene. Other regulatory elements within the backbone are an F1 origin, SV40 origin and 
Kanamycin/Neomycin resistance gene expression cassette followed by HSV poly A and pUC 
origin sequence. (map from http://www.biosubway.com/?product=pegfp-c3)  
 
 
2.1.9 Solutions and Buffer  
Phosphate buffered saline (PBS) 
2.7 mM KCl 
137 mM NaCl 
In distilled water 
 
Tween phosphate buffered saline (PBST) 







20 mg/ml stock solution of Pronase (Protease from Streptomyces griseus, Sigma-Aldrich, England, 
Cat# P8811) in PBS 
 
Paraformaldehyde (PFA) 
4 % (w/v) paraformaldehyde in PBS 
Autoclaved PBS is firstly warmed to 60°C and then PFA is added, pH adjusted to 7.0 and immediately 




300 nM sodium citrate 
Dissolve in Milli-Q water and adjust pH to 7.0 with 1M HCl  
 
Hybridisation mix (HM) 
50 % (v/v) Formamide 
5X SSC 
50 ng/ml Heparin 
500 ng/ml yeast tRNA 
 
Antibody Blocking solution 
0.2 % BSA 
2 % Goat serum 
In PBS 
 
Alkaline phosphatase (AP) buffer 
100 mM Tris-HCl pH 9.5 
100mM NaCl 
In distilled water 
 
1x TAE 
40mM Tris HCl 
20mM sodium acetate 
2mM EDTA 
In distilled water 
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Adjust to pH 7.8 with glacial acid 
 
Tricaine stock solution (3-amino benzoic acidethylester) 
400mg tricaine powder 
87.9ml dd water 
~2.1ml 1M Tris (pH 9). Adjust pH to ~7 
To use tricaine as an anesthetic combine the following in a 250ml beaker:  
4.2ml tricaine solution 
~ 100ml clean tank water 
 
Embryo medium (50X stock solution) 
0.5 µM NaCl 
0.17 µM KCl 
0.33 µM CaCl 
0.33 MgSO4 
0.1 % methylene blue 
In distilled water 
 
SOB (Super Optimal Broth) 
0.5% (w/v) yeast extract  
2% (w/v) tryptone  
10 mM NaCl  
2.5 mM KCl  
20 mM MgSO4  
Per liter:  
5 g yeast extract  
20 g tryptone  
0.584 g NaCl  
0.186 g KCl  
2.4 g MgSO4  
Adjust to pH 7.5 prior to use. This requires approximately 25 ml of 1M NaOH per liter. 
 
SOC (Super Optimal broth with Catabolite repression) 
1l SOB  




Luria Agar (L-agar) 
3.7% (w/v) Luria agar base in distilled water, autoclave 
 
Luria broth (L-broth) 
2.5% (w/v) Luria broth base in distilled water, autoclave 
 
Lysis Buffer 
5ml 1M TrisHCl pH 8.0 
2ml 5M NaCl 
0.5ml 10% SDS 
0.5ml 0.5M EDTA 
- fill up to 50ml with dH2O 
 




Put PIPES, CaCl2-2H2O and KCl into 400ml ddH2O 
Adjust pH to 6.7-6.8 using 5N KOH 
Add 5.45g MnCl2-4H2O 
Fill up to 500ml and filter sterilise 
 
SOB (competent cells) 
200ml LB 
0.5ml 1M KCl 
2ml 2M MgCl2 (sterilise using filter) 









2.2.1 Preparation of DNA samples 
2.2.1.1 Bacterial Growth 
Glycerol stocks or agar stabs of bacterial stocks were propagated by streaking on LB-agar plates 
containing appropriate selective antibiotics and incubated overnight at 37°C. 
Bacterial cultures were grown in LB-medium supplemented with required antibiotics. Antibiotic 
concentrations used were as follows: Ampicillin: 50µg/ml and/or Kanamycin: 25µg/ml. After 
inoculation with a single colony, the culture was incubated overnight at appropriate temperature in a 
shaking incubator.  
 
2.2.1.2 Plasmid Preparation 
Plasmid preparation for multiple colony screening through digestion or PCR was either accomplished 
by using an in-house protocol (Appendix 2) or using an industrial high quality Plasmid and DNA 
purification kit such as the NucleoBond® Xtra Midi (Macherey-Nagel, Germany).  Thereby bacterial 
pellet was lysed by alkali and loaded onto the provided column. Following extensive washing of the 
column, the plasmid DNA was eluted in water and DNA concentration was measured with the 
IMPLEN DNA spectrophotometer (Geneflow, UK). 
 
2.2.1.3 Isolation of genomic DNA from Medaka fish embryos for cloning  
Medaka genomic DNA was isolated from 30 - 50 anaesthetised wild type HB32C embryos at early 9 
dpf by incubating them overnight at 37°C in 1ml of lysis buffer supplemented with 20µl of 20mg/ml 
ProteinaseK. This step was repeated ending up with 2ml in total. Solution was carefully taken up and 
phenol/chlorophorm followed by ethanol precipitation was carried out. Note: when starting ethanol 
precipitation, genomic DNA can be seen as white aggregates after ethanol addition to the solution. 
Take up the DNA carefully with a blunt glass needle and transfer in new tube. Carry on with 70% 
ethanol wash step within precipitation protocol. Air dry the pellet and dissolve in 20µl TE or water.  
 
2.2.1.4 Isolation of genomic DNA from Medaka fish embryos for PCR genotyping 
Single embryos before hatching stage were washed in PBS and dissociated by boiling in 60µl of 
100mM NaOH for 20min. After cooling down solution was neutralised in 10µl of 1M TrisHCl pH8.5 
and 1µl was taken for PCR reaction.  
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2.2.2 Molecular Techniques 
2.2.2.1 Restriction Digests 
Digestion of DNA by restriction enzymes was performed in a minimal volume, using reaction 
conditions recommended by the manufacturer. Five/one units of restriction enzyme were added per 
one µg of DNA, ensuring that the volume of enzyme never exceeded 1/10 of the total reaction 
volume. When required, BSA was added to a final concentration of 100µg/ml respectively. Where 
required, heat inactivation at 65°C was carried out or the reaction was cleaned up by running on an 
agarose gel or Phenol/Clorophorm precipitation. 
 
2.2.2.2 Separation of DNA molecules through Agarose electroporation  
Size fractionation of DNA was performed by submarine gel electrophoresis on 0.8-1.5% (w/v) agarose 
gels in 1x TAE supplemented with ethidium bromide to 100mg/ml. Samples wereloaded with 1x 
loading buffer and electrophoresed at 120V. The gel was exposed to UV light to visualise DNA, which 
could then be photographed with a gel documentation system connected to a camera and computer. 
 
2.2.2.3 Recovery of DNA from Agarose Gel 
The band of interest was cut out from the gel and DNA isolated using the Gel DNA Recovery kit 
(Zymo Research, USA) according to manufacturer instructions. Briefly, the agarose block was 
dissolved by heating for 5-10 min at 55°C in the provided buffer, and the resulting mixture loaded 
onto the supplied column. Following washings of the column, the DNA was eluted in water and ready 
to use.  
 
2.2.2.4 Purification of DNA 
Using Phenol/Chloroform Extraction 
DNA solutions were made up to a minimum volume of 100µl with water and adding an equal volume 
of phenol/chloroform/isoamyl alcohol (25:24:1 with 10mM Tris, pH 8.0, 1mM EDTA). The emulsion 
was centrifuged at 1300x rpm for 5 min and the upper aqueous phase transferred into a new 1.5 ml 
centrifuge tube. Next, and equal volume of chloroform was added to the remaining solution and 
centrifuged for another 5 min at 1300x rpm. The upper aqueous phase after in the tube was 





Using DNA purification kit 
To purify DNA from enzymatic reactions the DNA Clean & Concentrator (Zymo Research, USA) was 
employed as per manufacturer instructions. Briefly, the reaction mix was diluted with water or 
provided buffer and applied onto the provided column. The column was then washed with the 
provided buffer and DNA eluted in water.  
 
Ethanol precipitation of DNA and RNA 
DNA and RNA samples were precipitated by adding 2.5x volume of 100% ethanol and of 3M sodium 
acetate pH 5.2 to a final concentration of 0.1M. The DNA or RNA was then centrifuged at 1300x rpm 
for 30min at 4°C. The supernatant was removed and the DNA/RNA was washed with 70% ethanol by 
centrifugation at 1300x rpm for 15min. The remaining pelleted was air dried and DNA eluted in water 
and RNA eluted in water plus 1µl of 100µg/ml RNAse.   
 
2.2.2.5 Determination of DNA and RNA concentration 
DNA and RNA concentrations were determined by UV Nanospectrophotometry at a wavelength of 
230nm, 260nm and 280nm to determine the quality of DNA and RNA sequences. Thus a ratio of 
A260/280  around 2.0 indicates that the sample is “pure”. If this ratio is lower it may indicate the 
presence of protein, phenol, change of pH or other contaminants with strong absorbance at or 
around 280nm. Values between 2.0-2.2 from the A260/230 output suggest high purity of nucleotide 
molecules. Lower ratios may be a result of EDTA, carbohydrate, TRIzol or phenol contaminations, all 
absorbing at 230nm (Nano & Drop Technologies website 2007). DNA and/or RNA concentration and 
purity was either tested on the Genflow Nano spectrophotometer or BioRad Nano 
spectrophotometer. 
 
2.2.2.6 Messenger RNA (mRNA) synthesis 
mRNA was synthesised using the mMESSENGER RNA kit with SP6 polymerase (Ambion Inc Texas, 
USA) followed by Phenol/Chloroform  and subsequent ethanol precipitation. Precipitated RNA was 
eluted in a small amount of RNAse free ddH2O and kept at -80°C until use.   
 
2.2.2.7 Polymerase Chain Reaction (PCR) 
PCRs were performed in a 15µl sample reaction volume containing the following supplements: 
0.2mM each of dATP, dCTP, dGTP and dTTP; 1x PCR reaction buffer containing the optimal MgCl2 
concentration specifically for the used Polymerase enzyme; 0.5-1µM of each forward and reverse 
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primer; 2.5 U of GoTaq or Kod polymerase and DNA template. Amplification was performed in a 
heat-controlled PCR amplification cycler (G-Storm, GRI Ltd, England). PCR programme consists of an 
initial template denaturation at 94°C for 2min, followed by 35-40 PCR cycles including denaturation 
at 94°C for 30s, primer annealing for 1min at a primer specific temperature and final extension at 
72°C for 23-90s depending on the expected band product length, followed by one-off final extension 
at 72°C for 5min after all cycles are completed.  
Primers were purchased either from SourceBioscience, Eurofins or ThermoScientific  and some major 
ones are listed in Table 2.2.  
Table 2.2: Primer sequences frequently used or essential for some experiments 
Primer description Primer sequence 
FW_MF_Dct pro 5‘- ACA TTG TAG TAG GTG TAA GGG CTG T -3‘ 
RV_MF_Dct pro 3’- CTT AGC GGT CAA TTA GTT CCT CTT A -5’  
FW_ClaISpeI_gfp 5’- ata tct agt CGC CAC CAT GGT GAG CAA GGG -3’ 
RV_egfpFLClaI 3’-taa tcg atg gct tcc gcc gcc acc gga ccc acc tcc gcc aga gcc acc gcc acc 
aga CTT GTA CAG CTC GTC CAT GCC -5’ 
Genot FW_inner_hir 5’- ACG CAA AGC CCT GCT CCA GTA -3’ 
Genot RV_ inner_wt 3’- TAC TGG GAG GGG TAG CCT GGT TCA -5’ 
Genot FW_common1 5’- ACA GGG ATT GAT TTC ATC AAG GAG TC -3’ 
Genot RV_common1 3’- TAC GCC TGA GTC TTA CAT CAC CTA G -5’ 
FW_MF_YAP1 5’- ATT CCA GAC AAG CTA GCA CTG ATG C -3’  
RV_MF_YAP1 3’- CAT CTG CTG CAG CCT CAT CTG GT -5’  
FW_EGFP(470) 5’- GCA GAA GAA CGG CAT CAA -3’ 
RV_YAP(786) 3’- CAT CTG CTG CAG CCT CAT CTG GT -5’ 
 
2.2.2.8 Genotyping with Tetra-primers ARMS-PCR amplification 
Genotyping was carried out using a similar approach to the tetra-primer ARMS-PCR amplification 
system (Figure 2.5) (Ye et al. 2001; Piccioli et al. 2006) to detect the single nucleotide polymorphisms 
(SNPs) in Medaka j50-20C embryos. This multiplex PCR facilitates two primer pairs amplifying two 
different alleles around a SNP, therefore amplifying both the wild type and mutant allele in a single 
reaction. The region flanking the hirame mutation at 491bp exchanging thymine to adenine is 
amplified by 2 common outer primers (Genot FW_common1, Genot RV_common1) resulting in a 
none-allele specific fragment for wild type and mutant alleles. Then, two allele-specific inner primers 
for hirame mutation (Genot FW_inner_hir) and wild type nucleotide (Genot RV_ inner_wt) 
simultaneously amplify inner regions of the allele in combination with outer primers. The two inner 
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amplicons from wild type and hirame are easily distinguishable because of their different fragment 
length. This particular PCR method was applied to genotype mRNA injected single embryos after in 
situ hybridisation. Size fractionation after genotyping will then indicate in three bands which 
genotype the individual embryo harboured.  For example, the upper fragment represents the non-
specific allele amplified by outer primers, the middle band indicates the hirame allele with primers 
recognising the SNP and the lower band shows the wild type allele (Figure 2.6). If the embryo was 
heterozygous carrier for j50-20C,  we would find all three bands at once.  
 
Figure 2.5: Schemata of adapted Multiplex tetra-primer ARMS-PCR amplification used for 
genotyping 
Schematic presentation of the tetra-primer ARMS-PCR method in which an outer primer pair 
amplifies a non-allele specific bigger amplicon. The asymmetrically located inner primers 
simultaneously produce an amplicon from either the wild type or the hirame SNP allele in 
combination with the outer primer set. This results in a middle and smaller fragment. Redrawn 





Figure 2.6: Example of tetra-primer ARMS PCR with Medaka embryos 
Example of tetra-primer ARMS-PCR to genotype Medakaj50-20C sibling embryos at any stage of 
development to examine their genotype. Both primer pairs were designed to result in 
distinguishably different amplicon lengths after agarose gel electrophoresis. Outer primers 
give upper band with at 458bp, middle band represents hirame allele present in hirame 
mutants only and wild type heterozygous siblings and lower band highlights the wild type 
allele in heterozygous and homozygous wild type siblings. Ladder = 1KB (Thermo Scientific).  
 
2.2.2.9 DNA Sequencing and sequence analysis 
General DNA sequencing runs were performed through Thermo Fisher Scientific and Eurofins in-
house next-generation sequencing (NGS) platforms.  Analysis of raw sequences and chromatograms, 
compilation of contigs and sequence comparisons were performed using the free online download 
software package ApE.  
 
2.2.2.10 In-situ probe synthesis 
Prior to probe synthesis 5µg of midi-prep plasmid DNA containing the cDNA of interest was linearised 
by digesting the 3´end of the antisense sequence. The reaction is cleaned using 
phenol/chloroform/isoamyl alcohol (25:24:1 with 10mM Tris, pH 8.0, 1mM EDTA) extraction 
followed by ethanol precipitation.   
In vitro RNA probe synthesis used to label the in-situ hybridisation probes either with digoxigenin 
using the DIG RNA Labelling Kit (Roche, Mannheim, Germany, Cat# 11175025910). 
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Probe fractionation was performed to optimize probe permeabilisation and performance within the 
specimen following the Parichy laboratory protocol. Therefore an alkaline hydrolysis was used to 
fragment probes of length greater than 300 nucleotides (nt) with adding 1/5th of 0.4M sodium 
bicarbonate, 1/5th of 0.6M sodium carbonate and a 60°C heat incubation. The length of the heat step 
is calculated as follows:  
Time (min) = (starting kb – desired kb) / (0.11 x starting kb x desired kb).  
Calculated examples of hydrolysis times were taken out of the ISH protocol from the Parichy 
laboratory at the University of Washington at Seattle (Parichy 2011) and is tabulated within the 
appendix (Appendix 7).  
 
2.2.3 Cloning strategies 
DNA fragments for ligation were generated by complete restriction, followed by heat inactivation of 
the restriction enzyme where possible. Dephosphorylation of DNA ends, when required, was 
achieved by adding 2 units of Shrimp Alkaline Phosphatase directly to the restriction enzyme 
reaction. If required, the desired fragment was purified by recovery from an agarose gel. 
Vector DNA for use in ligations was digested with the appropriate restriction enzymes and purified 
through either Phenol/Chlorophorm precipitation or a manufacturer column with DNA Clean & 
Concentrator (Zymo Research, USA).  
 
2.2.3.1 Ligations 
Ligations were performed using 50-100ng of vector DNA and a three molar excess of insert DNA, 
catalysed by 10 units of T4 DNA ligase in 10µl reaction volume (following manufacturers instruction). 
Ligations were incubated at 4°C overnight or 2h at RT. PCR products were mostly cloned into pGEM-T 
Easy vector following Promega instructions. 
 
2.2.3.2 Preparation and Transformation of Competent E.coli 
Competent cells of the DH5α E.coli strain were prepared in-house following the protocol from Dr K. 
Kaji (Appendix 2), which yields transformation efficiencies up to 1 × 109 transformants/µg plasmid 
DNA. Introduction of plasmid DNA into E.coli was performed by the calcium chloride method as per 
Sambrook (SAMBROOK et al. 1989). Thereby a maximum plasmid DNA volume of 1/10 was incubated 
with DH5α competent cells for 20min on ice followed by a 45s heat shock at 42°C. Following 
transformation bacteria cells were incubated in 1ml SOC for 1h at 37°C with gentle shaking before 
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spreading on LB-agar plates containing required antibiotics. Plates were incubated upside-down 
overnight at 37°C. Where colour selection of colonies was necessary (e.g. p-GEM T-EASY cloning) 
prior spreading, plates were prepared with 200µg/ml X-gal and 160µg/ml IPTG was added.  
 
 
2.2.4 Medaka Fish and Zebrafish Methods 
2.2.4.1 Aquarium System, water and room conditions 
The water condition of our fish facility is pH 6.8-7.5, 200-450mS/cm, 26-28°C, NH4 <0.2mg/L, NO2 
<0.05mg/L, NO3 <20mg/L. Whilst Medaka is more tolerant of varying water quality than Zebrafish, 
weak inbred strains, such as the transparent strain HNI prefer soft water (300S/cm) compared to 
Zebrafish (700S/cm). As the natural habitats of Medaka are rice fields and streams with little water 
flow, Medaka are stressed in a strong water flow such as that in which Zebrafish are kept. Thus, 
water flow to tanks needs to be adjusted to a minimum. 
Since Medaka is native to regions of East Asia with four seasons, it tolerates wide ranges of 
temperature (4-38°C) and salinity. The fish room is kept at 25-28°C, with 14 hours of light and 10 
hours of darkness. Medaka spawns better in relatively strong light (at least 100 lux). 
 
2.2.4.2 Fish husbandry of Medaka fish and Zebrafish 
Embryos were obtained through crosses of wild type, mutant and transgenic fish lines kept in the 
University of Bath Zebrafish facility. Breeding Zebrafish adults were kept separate from soft shelled 
eggs falling down to the bottom of the tank. Medaka pairs can be kept together in mouse cages as 
eggs are hardy and stay close to the female’s body and do not fall down immediately. Refer to HO 
Project license: PPL30/2937.  
 
2.2.4.3 Raising of Zebrafish embryos 
Zebrafish embryos were raised and stages according to Kimmel et al. 1995 (Appendix 4). 
Dechorionation was either performed with Watchmakers’ No.5 forceps or with 20µg/ml Pronase for 
embryos older than 18hpf. For further manipulation of embryos older than 15hpf, tricaine was added 
to the embryo medium to a final concentration of 0.2% v/v to immobilise the specimen.  Note 




2.2.4.4 Raising of Medaka embryos 
Medaka fish lay their eggs in clusters held together by filaments, which are attached on the egg 
chorion. Eggs are cleaned up by unclustering with forceps. To determine the embryonic development 
of Medaka fish embryos after fertilisation, eggs are incubated at 27°C and staged according to the 
Iwamatsu’s staging (Iwamatsu 2004) (Appendix 5). To accelerate the growth temperature shifting can 
be done occasionally to facilitate experimental procedures. Hence, the Temperature-Stage-
Correlation matrix (provided by Dr M. Furutani-Seiki) (Appendix 6) needs to be taken into 
consideration so that embryos can be incubated between a temperature range of 4°C and 33°C, 
without compromising their health.   
 
2.2.4.5 Injection of Zebrafish and Medaka embryos 
To calculate the micropipette injection volume I placed one drop on a micrometer slide (Fisher, 12-
561-SM1) and measured the diameter of the drop. The value 100 on the micrometer slide 
corresponds to 1mm (1mm3 = 1µl). We have measured our drop to be 15, which means 0.15mm3. 
Taking the formula of a spherical object, we would result in V(µl) = (4/3)π (d/2)3= (π x d3)/6= (π x 
0.153)/6 = 1.76nl injected into 1-cell stage embryos. 
Before starting injection an agarose plate was prepared to hold individual eggs. Hot 1.5% agarose 
was poured into a 10cm petri dish in which a custom made ridged plexiglass mould was dropped in. 
After the agarose solidified, the mould is removed to reveal the sketch shape of the mould to hold 
the embryos.  
Injection of Medaka embryos was carried out with borosilicate glass capillaries 1.0mm O.D. x 0.58mm 
I.D. (standard wall without filament) from Harvard Apparatus Ltd, UK. For injections into Zebrafish 
embryos I used thin walled filamentous glass capillaries 1.0mm O.D. x 0.75mm I.D. (World Precision 
Instruments, Inc., USA). Needles for injection were made by pulling glass capillaries on a Micropipette 
puller (Narishige model PC-10, Japan). Injections were performed under a dissecting microscope 
using a WPI Pneumatic PicoPump Nanoinjector into the cytoplasm on 1-cell stage Medaka embryos 
or the yolk sac of Zebrafish embryos. Occasionally, 0.1% Red was added  to the DNA solutions if 
needed.  
 
2.2.4.6 Removing the chorion of Zebrafish and Medaka embryos 
Freshly layed and fertilised eggs in Medaka differ in appearance to Zebrafish eggs. Filaments on the 
chorion which can be cleaned up by unclustering using forceps hold them together. The chorion of 
Zebrafish embryos is much softer and can be removed manually with forceps or by incubation in 
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20µg/ml Pronase. Medaka embryos however are surrounded by a much harder chorion consisting 
out of a soft inner layer and a harder outer layer, meaning that manual dechorionation is impossible 
when the embryos morphology has to stay intact.  
It is necessary to dechorinate embyros for detailed observation of embryogenesis or for other 
protocols like cell transplantation, in-situ hybridisation or antibody staining, resulting in better 
imaging quality and accuracy. To achieve this, unclustered eggs are transferred onto fine waterproof 
sandpaper (p2000) and gently rolled, using the forefinger to remove any filaments on the chorion. 
Embryos can either be incubated for 40 min in pronase (20mg/ml) to remove the inner softer layer of 
the chorion, followed by quick washes in embryo medium or directly placed into freshly made 
hatching enzyme. Hatching enzyme is obtained from late stage embryos and is necessary to remove 
the outer chorion, which can take up to 30min on living specimen. 
For further manipulation of dechorionated embryos older than stage 23, tricaine was added to the 
embryo medium to a final concentration of 0.2% v/v. A low concentration of tricaine in this case 
allowed experimental procedures such as live-imaging due to anaesthetised immobile embryos.   
 
2.2.5 Whole-mount in-situ hybridisation(WISH) 
Dechorinated embryos are fixed in 4% PFA for 1-10 days at 4°C depending on its developmental 
stage, whereby older embryos are fixed for a longer period. After fixation, embryos are washed three 
times in PBST before dehydrating through a Methanol series beginning with 25%, followed by 50%, 
75% and 100% Methanol in PBST. Dehydrated embryos can be stored at -20°C until needed. All 
washes were done under gentle agitation in 2ml round bottom centrifuge tubes throughout the 
protocol.  
The first step of the in-situ hybridisation protocol is to rehydrate the embyros in a reverse Methanol 
in PBST series of 75%, 50% and 25% for 5 min each, followed by three 5 min washes in PBST only. 
Embryos are then incubated in Proteinase K (10µg/ml) 10µg/ml Proteinase K/PBST to permeabilise 
cell walls to allow effective probe penetration before commencing with in situ hybridisation (WISH) 
technique. Thereby the incubation time with Proteinase K depends on individual developmental 
stages as well as spatial and temporal projection of the specific anti-sense probe used for each WISH 








Table 2.3: ProteinaseK incubation times for Medaka embryos at different developmental stages 
Developmental stage Incubation time with ProteinaseK  
Stage 20 - stage 22 Rinsing 
Stage 23 - stage 24 3 min 
Stage 25 - stage 27 5 min 
Stage 28 - stage 29 ~ 8 min 
Stage 30 - stage 32 ~ 10 min 
Stage 33 - stage 34 ~ 15 min 
Stage 35- stage 36 ~ 20 min 
Stage 37 ~ 30 min 
Stage 38 ~ 40 min 
Stage 39 ~ 45 min 
 
To stop the kinase reaction fixed embryos are washed twice in PBST and re-fixed in 4% PFA for 2 
hours at RT. To remove the samples from PFA three washes in PBST are applied. Embryos are then 
pre-hybridised for 1.5 hours in a 100% hybridisation mix (HM) at 65°C before incubating them 
overnight at 65°C in approximately 200µl of pre-heated synthesised probe in 100% hybridisation mix. 
The next day, embryos are washed with 66% HM in 33% 2X SSC, then 33% HM in 66% 2X SSC, 
followed by 2X SSC washes for 10 min each in 65°C before leaving them twice for 30 min at 65°C in 
0,1% 2X SSC in Milli-Q water. Afterwards embryos are washed twice in PBST for 5 min to remove 
traces of SSC. Blocking solution is added for one hour at RT, before resting the embryos overnight at 
4°C with anti-DIG antibodies (1:500d dilution in blocking solution). 
The following day, embryos are periodically washed in PBST over duration of 5 hours under gentle 
agitation. After the last washing step, embryos are rinsed three times in freshly prepared AP buffer. 
To accomplish purple staining samples are transferred to  NBT/BCIP (Roche, Mannheim, Germany 
Cat# 11681451001) solution until the signal was strong enough or background started to appear. The 
reaction can be stopped by rinsing twice with PBST and re-fixation for 2h in 4% PFA at RT. For storage 
at 4°C samples undergo a glycerol series of 30%, 50% and 80% glycerol in water. 
For in situ double staining embryos had to be incubated simultaneously with a DIG and Fluorescein 
anti-sense probe. After development of the first staining, the active alkaline phosphatase from anti-
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DIG was inactivated by acid treatment with 0.1M glycine-HCL pH 2.2 for 30min. This was then 
followed by extensive washing with PBST. Another blocking step was carried out and the anti-
Fluorescein antibody was incubated overnight at 4°C, before clearing the samples up from any 
residues of that by washing them with PBST. The anti-fluorescein can either be imaged directly or 
incubated with NBT/BCIP or Fast Red prepared using manufacturer’s instruction.  
 
2.2.6 Whole-mount Antibody Staining of Medaka embryos  
Embryos were fixed for 2h at RT or overnight at 4°C. The following day samples were cleared of PFA 
by washing them in PBST three times for 10min, followed by a permeabilisation step in 0.5% Triton X-
100/PBS overnight at 4°C with gentle shaking. Traces of Triton were removed by washing the 
embryos in PBST three times for 10min at RT. A blocking step was carried out in blocking solution  
(49ml PBST, 1ml 2% sheep serum, 0.1g BSA) for 2 hours at room temperature before incubation with 
the primary antibody in blocking solution at 4°C overnight (usually in a 1:100-1:2000 dilution). First 
antibody was removed by washing the samples three times in PBST, 10min each at RT. The secondary 
antibody diluted in blocking solution was applied and left overnight at 4°C. After removing the 
second antibody samples were washed with PBST as outlined before. The embryos can then be 
mounted and visualised depending on the wavelength of the fluorescent dye. 
 
2.2.7 Resin embedding and section of Medaka embryos  
Resin sections have been prepared using Kulzer Technovit® 8100 Cold-curing resin kit (Germany). 
This HEMA-based plastic embedding system is suitable for producing uniform sections up to 1 micron 
thin revealing a clear morphology of the tissue and cell structures, observable under light 
microscopy. The cold polymerisation process during embedding prevents sample shrinkage, thus 
decrease dye leakage after in situ hybridisation has been carried out. The resin polymerisation step is 
oxygen sensitive, therefore the embedding process must be performed fast and must be sealed for 
the final hardening (Emgrid Pty 2013). A detailed in-house protocol from Dr T. Sambe-Adachi is laid 
out in Appendix 2. Resin sections were placed onto Superfrost Plus glass slides (Menzel, Germany) as 
these have been tested to be of much greater adherence during subsequent staining procedures 
(Appendix 3). Some sections have been counterstained with 1% Neutral Red to label and highlight 




2.2.8 Embryo mounting and microscope techniques 
Low power microscopic analysis and general embryo handling was mostly performed under an 
MZ12-FL dissecting microscope (Leica). Anaesthetised embryos were placed either in 3% 
methylcellulose or 100% glycerol on a cavity slide and orientated with forceps to prevent rolling. 
Snap shot imaging was performed either on the Eclipse E800 (Nikon) microscope using Nomarski 
optics and a colour SPOT digital camera (Diagnostic Instruments) or the Zeiss fluorescence dissecting 
microscope using bright field or fluorescence combined with a black and white Zeiss camera.  
For static Z-stack imaging embryos had to be immobilised in 1% low melting agarose to prevent 
rolling and movements and subsequently imaged on the Zeiss microscope. 
All images were analysed, contrasted and enhanced using PhotoshopTM edition CS3 (Adobe) obtained 
with a personal licence.  
 
2.3 Statistical Methods 
2.3.1 2-Sample t-Test 
To determine significance of counted melanoblasts and melanophores a Student´s 2-Sample t-Test 
was conducted with the Minitab statistics programme. Herein, T-values compare responses between 
two independent groups such as hirame and wild type with normal distributions (dt) (tested with dt 
plot). Herein p<0.05 is indicated by one *, p<0.01 = ** and p<0.001 = ***. 
 
2.3.2 Chi-Square Test 
The Chi-Square (X2) test investigates in general whether distributions of variables in different 
categories differ from one another. It compares the actual counts of categorical outputs between 
two (or more) independent groups. This for example was used to determine the distribution of 
melanoblast counts within the same set of resin sections within different categories. 
 
2.3.3 Bonferroni-correction 
This statistical test is used to take into consideration multiple comparisons. It adjusts the P values of 
several dependent or independent concurrent statistical tests on a single set of data by dividing the P 
value by the number of comparisons being made, thus increasing the probability of a significant 
output. It therefore reduces the chance of false-positive results on statistical comparisons on a single 
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set of data. The Bonferroni correction was also used to determine statistically the distribution of 
melanoblast counts within resin sections and significant values were indicated as follows: p<0.01 = *, 













































3 Chapter: Characterisation of the 
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3.1.1 Importance of YAP in melanocytes  
In humans, melanocytes are found in a number of locations including the eyes, ears, and particularly 
in the skin, at the junction of dermis and epidermis. In humans, they populate the basement 
membrane in a density of around 1000 cell per square millimeter. Their function is to synthesise 
melanin and transport it in melanosomes the upper epidermal keratinocytes, which helps to protect 
underlying layers from cell damaging ultraviolet light (UV) (Kim et al. 2013). In teleosts, especially 
Zebrafish and Medaka, melanin producing melanocytes can be found in three distinguishable stripes 
on the embryonic body, the dorsal, lateral and ventral stripe (Lamoreux et al. 2005; Kelsh & Schmid 
et al. 2000). Next to protection, melanin or the pigment cell patterning in fish has also the function of 
camouflage (Kelsh 2004). Several of the genetic requirements for neural crest embryonic melanocyte 
pattern, have been demonstrated to be important in melanoma, a deadly highly pro-metastatic 
cancer originating from melanocytes, such as ECM, migration, proliferation and growth (Uong & Zon 
2010).     
One hypothesis is that the Hippo pathway is a key regulator in melanocyte growth, transformation 
and/or migration. Supporting data comes from melanoma studies investigating the contribution of 
Hippo signalling in regard to melanoma transforming properties.  
The first study reporting about YAP involvement in the transformation of melanocytes into cancerous 
melanoma cells was provided by Lamar et al. in 2012. Their in vivo studies showed that through 
interaction with the TEAD DNA-binding domain, YAP mediates tumour growth and metastasis, 
including invasion and migration in a cell-autonomous fashion. The activated version of YAP S127A, in 
which LATS mediated phosphorylation is hindered by exchanging serine to alanine at position 127aa, 
enhanced the growth of transplanted melanoma cell lines in vivo and increased the number and size 
of metastases after tail-vein injection to 60% (Lamar et al. 2012). In addition and supporting these 
findings Nallet-Staub et al. showed in 2014 that overexpression of YAP increased the anchorage-
independent growth in cutaneous melanoma cultures in soft agar, thus identifying YAP´s metastatic 
potential (Nallet-Staub et al. 2014). Furthermore, they carried out knockdowns of YAP and TAZ in 
vitro through small hairpin RNA, which specifically repressed melanoma cell tumorigenicity and 
invasiveness, represented by decreased colony formation in anchorage-independent growth assays 
on soft matrigel. Here YAP had a greater effect than TAZ without inhibition of cell proliferation. In 
vivo analyses revealed that knockdown of yap and taz reduced the depth of invasiveness into the 
basal layer after xenotransplantation and also dramatically inhibited not only the occurrence, but 
also the actual size of lung metastases after tail-vein injections with melanoma cultures. Out of 6 
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injections 1-2 mice formed metastases compared to five out of six in the positive control. Knockdown 
of YAP and TAZ directly decreased the transcriptional levels of CTGF encoded by CCN2, a TEAD 
mediated transcription factor target gene, while overexpression had the opposite effect (Zhang et al., 
2009). Herein downregulation of TAZ had a much greater effect than YAP on its downstream target 
genes (Nallet-Staub et al. 2014). Therein, observed differences in individual melanoma cell cultures 
might be due to dissimilar endogenous expression levels of YAP and TAZ, both factors have been 
shown to act redundantly. Therefore, overexpression of one component might not have an effect on 
transforming cell properties in mammalian studies, if the paralogue is already present in high levels.  
To summarise, these studies link higher transcript and protein levels of YAP and activated variants of 
YAP to an increased cell migration potential. Thus, we suggest that intrinsic YAP might be required 
for normal melanocyte migration within vertebrates. To investigate this, we utilised the unique 
Medaka hirame mutant. Observations made from 3 dpf hirame embryos indicated a melanocyte 
defect, specifically in form of reduced numbers on the yolk sac area. We speculated that the loss of 
YAP might do the opposite and slow cell movement to the extent that individual melanocytes might 
struggle to escape from the embryo and move on the yolk sac. In this chapter, we analyse thoroughly 
the melanocyte phenotype in hirame from its arising until embryonic death.   
 
3.2 Results 
3.2.1 Crossing Cabj50-20C into HB32C to enhance melanogenesis  
The mutagenesis screen in Medaka lead by Furutani-Seiki 2004, was mainly carried out in the Cab, 
Heino and Kaga strains. The Cab strain originated from a Southern population of Medaka and was 
once obtained from the Carolina Biological supply, North Carolina (Kinoshita et al. 2009) After that it 
was maintained as an inbred strain at the Wittbrodt laboratory in Germany (Loosli et al. 2000). It was 
used for that particular screen in Japan. The Kaga strain originated from a Northern population and 
was used for genetic linkage analysis in Furutani-Seiki´s study, whereas the albino Heino strain was 
mainly used for specific locus tests (Furutani-Seiki et al. 2004). Hirame j50-20C is maintained in the Cab 
strain, exhibiting weakly melanised to amelanotic melanocytes due to its homozygosity for the 
recessive b’ allele at the B locus. The B locus encodes for solute carrier family 45 member 2 (slc45a2) 
gene, a Membrane-associated transporter protein also known as melanoma antigen AIM1 which 
mediates melanin synthesis through microphthalmia-associated transcription factor. The original Cab 
strain contains a mutation within the promoter region of slc45a2 leading to a pale skin phenotype 
only, whereas other pigment mutants are characterised by coding changes within the slc45a2 gene 
sequence (Fukamachi et al. 2008). The phenotype named hiMedaka, associated with that strain is 
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orange-red as xanthophore differentiation is unaffected. In comparison the HB32C strain is a wild 
type strain in which the melanocyte lineage synthesises high amounts of melanin.  This strain was 
originally collected near Chiba City and first bred at Chiba University around 1970.  It was then 
established as an inbred strain by Hyodo Taguchi at the National Institute of Radiological Sciences 
(NIRS) (Hyodo-Taguchi 1996).  
 
Initial microscopic observations of 3 dpf (st.28) hirame embryos bred in the Cab background hinted 
towards a defect in the melanocyte neural crest lineage due to reduced numbers of melanocytes on 
the yolk sac compared to its wild type siblings (RN Kelsh personal communication,  
Figure 1.4). However, in this particular strain fully differentiated melanocytes are weakly melanised, 
which makes it more difficult to identify and quantify this cell type by light microscopy. Therefore, I 
crossed heterozygous hirame carrier onto the HB32C wild type background in which melanocytes 
produce an increased amount of melanin, resulting in darker grey-brown and more distinguishable 
differentiated melanocytes. When bred onto the HB32C background, and selected for B, we 
observed that hirame (hir) mutants indeed had fewer melanocytes on the body and yolk sac in 3 dpf 
embryos compared to its wild type sibling (Figure 3.1C,D).  
This simple observation confirmed the validity of our hypothesis that melanocyte differentiation was 
disrupted in hirame mutants. Differentiated melanocytes can be directly identified after 9 somites 
(st.22) through their accumulation of melanin in melanosomes (Lamoreux et al. 2005). In order to 
assess their unmelanised progenitor melanoblasts prior to stage 28, I analysed the pigment cell 
marker dopachrome tautomerase (Dct) expression pattern in sequential developmental stages. This 
would provide us insights about asked when melanocyte patterning first becomes distinguishable 






Figure 3.1: Comparison of 3 dpf (st.28) wild type and hirame embryos in Cab with weakly melanised 
melanocytes and in HB32C with strong dark brown melanophores 
A,B) Melanocytes are hardly distinguishable and unquantifiable under normal light microscopy 
in wild type and hirame with Cab background. C,D) Hiramej50-20C was crossed into HB32C 
background to visualise differentiated melanin-rich melanocytes. Now, numbers of 
melanocytes in HB32C wild type embryos could easily be quantified and the defect in hirame 




3.2.2 Analysis of Dopachrome tautomerase (Dct) expression in wild 
type and hirame embryos  
3.2.2.1 Observing the melanocyte pattern through in situ hybridisation (ISH) 
Dopachrome tautomerase (Dct), also known as tyrosinase-related protein 2 (Trp-2) acts downstream 
of tyrosinase and collaborates in the biosynthetic pathway of eumelanin by catalysing the conversion 
of dopachrome to 5,5-dihydroxyindole-2-carboxylic acid (DHICA) in pigment cells (Kelsh et al. 2000).   
Studies in Zebrafish and mouse have shown Dct to be one of the earliest markers of the melanocyte 
lineage (Kelsh et al. 2000; Steel et al. 1992). In Zebrafish it was shown that dopachrome tautomerase 
transcriptional levels can be detected as early as 16 hpf (14-19 somites) within progenitors of the 
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early pigmented retinal epithelium (PRE) in the developing eye. Then over the next 5 hours Dct 
expression was detected throughout the outer layer of the retinal epithelium and within melanocyte 
precursors (melanoblasts) in the trunk and tail of 21 hpf embryos (Kelsh et al. 2000). In comparison 
to Zebrafish, Medaka studies have reported Dct expression only at 75 hpf (4dpf, st.30) (Nagao et al. 
2014). Nagao et al. published a Dct in situ probe showing no overlap with the xanthine 
dehydrogenase (xdh) expression pattern, a marker for early xanthophores and leucophores in 
Medaka. They classified the Dct anti-sense probe as melanocyte cell specific, because it matched the 
Dct pattern and distribution comparable to published work in Zebrafish (Van Otterloo et al. 2010).  
With this background and probe information, we asked the question, “how early can we see a 
melanocyte patterning defect in hirame embryos compared to normal wild type embryos?” To 
answer that I examined a series of developmental stages starting from stage 20 (1 dpf 7.5h and 4 
somites) to stage 32 (4 dpf 5h and somite completion), in which I used in situ hybridisation (ISH) with 
an anti-sense probe against Dct, detecting early unmelanised melanoblasts in whole-mount embryos. 
Appendix 8 shows all individual stages analysed in this series, whereas detailed analysis was carried 





Figure 3.2: ISH of Dct in st.21, 24 and 28 wild type and hirame embryos showing the early melanoblast and 
later differentiated melanocyte patterning defect 
Dopachrome tautomerase (Dct) WISH to highlight the melanocyte lineage in wild type and hirame. 
Series of embryonic stages (st. 21, st. 24, st. 28) are represented in panels A/A’, B/B’ and C/C’ with 
embryos in dorsal and lateral view and anterior to the left. The overall pattern seem to indicate that 
unmelanised melanoblasts in early stages (st.21) and melanised melanocytes in later stages (st.24, 
st.28) are present within the body and on the yolk sac.  The overall amount of cells seem to be 
reduced on the yolk sac throughout. Melanoblast location on the yolk sac of st.21 and st.24 
embryos suggest a slower migration of remaining Dct+ cells in hirame compared to wild type 
siblings (indicated by dashed green lines). Scale bar = 500µm. 
 
We observed that early in embryonic development and prior to melanisation (st. 21, 1d 10 hpf), wild 
type embryos exhibited melanoblasts within the body as well as migrating melanoblasts dispersed on 
the dorsal part of the yolk sac (Figure 3.2A, A’). At that stage hirame melanoblast numbers within the 
body appeared normally (A’ dorsal) whereas numbers on the yolk sac (A’ dorsal, sagittal) seemed to 
be reduced. In addition wild type melanoblasts dispersed progressively more ventrally on the yolk, 
but this process appeared delayed in hirame mutants where both the numbers and the ventral 
spread of melanoblasts were decreased (indicated by dashed green lines). At higher magnification it 
is more obvious that melanoblasts in hirame embryos accumulated alongside the body axis (Figure 




Figure 3.3: Melanoblasts in hirame reside in close proximity to the body axis at st.21 
Close-ups of st.21 wild type (WT) and hirame (Hir) whole-mount embryos after in situ 
hybridisation for dopachrome tautomerase (Dct). Black rectangles enclose the area in which 
melanoblasts (arrow) seem to be accumulated in hirame embryos (B) compared to wild type 
embryos (A). Note also the increased numbers in yolk sac melanoblasts in WT embryos. Scale 
bar = 100µm. 
 
Over the next 10 hours up to stage 24 wild type Dct expressing melanoblasts increased in numbers 
and migrated ventrally away from the body. In contrast, in hirame the melanoblast numbers on the 
yolk sac remained dramatically reduced; although some more Dct+ cells migrated further away from 
the body. This ventral progression was still slower than in wild type (indicated by dashed green lines, 
Figure 3.2B’ sagital). Meanwhile melanoblasts differentiated and synthesised visible melanin. 
Melanocyte migration onto the yolk sac was completed by stage 28 in wild type (Figure 3.2C) (2d 16 
hpf), but numbers in hirame embryos still remained low (C’). To further characterise these effects, I 
carried out cell counts in both, hirame and wild type embryos after Dct ISH.  
 
3.2.2.2 Quantification of melanocytes in wild type and hirame 
Cell counts in hirame mutants and wild type siblings were carried out under the dissecting 
microscope and were noted separately for both, body and yolk sac (Graph 3.1).   
These data revealed that the number of Dct positive cells on the body (Graph 3.1 A) of hirame was 
significantly higher than in wild type siblings at stage 21, and those on the yolk sac fewer, although 
the total number of cells were comparable. The increased number in the body of hirame remained at 
stage 24, but was reversed by stage 28, in which body melanocytes in hirame showed a dramatic 
reduction to 126.8 cells compared to its wild type siblings with around 301.1 cells. 
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Concerning melanoblast numbers on the yolk sac (Graph 3.1 B), cell counts confirmed our initial 
observation that in hirame an overall melanoblast and later melanocyte reduction on the yolk sac 
existed throughout all featured embryonic stages.  
Surprisingly, in hirame the total cell number presented within the third section (Graph 3.1 C) 
indicated no significant difference in melanoblast numbers from wild type siblings at early stage 21.  
In contrast, beyond st.21 Dct+ cell numbers were persistently lower in hirame compared to wild type.      
 
These counts affirmed that before stage 21 wild type and hirame embryos exhibited the same 
quantities of melanoblasts. This changed from stage 21 onwards when total numbers of 
melanoblasts in hirame were significantly reduced throughout. Interestingly, even so at st.21 there is 
no quantitative difference in Dct+ cell numbers, melanoblasts resided more within the body, which 
was supported by visual examination of melanoblasts located in close proximity alongside the body 
axis.  
However, the transition from body mesoderm to yolk sac epidermis can be difficult to distinguish 
when counting Dct positive cells under a dissecting microscope, which means that cell counts might 
not represent actual numbers in those two areas of interest at st.21. To obtain accurate quantities of 
melanoblasts at stage 21 within the body and on the yolk sac of hirame and wild type, I carried out 
consecutive resin sections showing the spatio-temporal position of cells within different tissue 





Graph 3.1: Numbers of melanoblasts and early differentiated melanocytes of wild type and hirame 
embryos counted at stage 21,24 and 28 after in situ hybridisation with Dct-antisense probe 
A) Hirame exhibited more melanoblasts in the body compared to wild type at stage 21 (N=17) and 
stage 24 (N=12). In contrast, at st.28 in wild type (N=10) melanoblast numbers have risen up to 
around 300 cells, whereas hirame (N= 8) retained around 150 cells. B) Throughout embryonic 
development hirame possessed significantly lower quantities of yolk sac melanoblasts compared 
to wild type siblings. C) Despite the differences in cell number distribution, the total number of Dct 
positive cells at stage 21 in hirame and wild type is the same. At later stages (24, 28) the total 
number of melanoblasts is lower in hirame. All data are means ± SEM. 2-Sample-t-test: *p<0.05 , 
**p<0.01 or ***p<0.001; numbers within bars represent the average melanocyte counts within 





3.2.2.3 Distribution of MC within the body of stage 21 embryos 
Our WISH data suggested that at least initially during early stages of embryogenesis melanoblast 
distribution, specifically migration onto the yolk sac, may be defective. In order to determine the 
location of individual Dct positive melanoblasts within the embryo and whether those cells are 
accumulated within a specific area, consecutive cross sectioning from resin embedded embryos were 
performed. With that approach we set out to determine where within the body and whether 
melanoblasts can be found on the ventromedial or the lateral pathway. As we know, the neural crest 
precursors arise dorsally within the neural tube as premigratory neural crest from where cell 
commitment begins and melanocyte precursors can be detected. From this pre-migratory position 
melanoblasts migrate throughout the body initially on a medial pathway towards ventral position 
through mesodermal tissue laterally alongside the neural tube. Some melanoblasts then migrate 
from those ventral locations laterally along the outside of the mesoderm towards the top and 
migrate onto the yolk sac. A second wave of melanoblasts arising from pre-migratory positions 
migrate on a dorsolateral pathway to final positions within the body as well as contributing to yolk 
sac patterning (Raible & Eisen 1994). The schematic (Figure 3.4) illustrates anatomical features found 
in cross sections of the trunk region of an embryo at stage 21 (31 hpf), including the migration 
pathways of neural crest cell precursors and differentiated melanocytes.  
Embedding tissue in resin has several advantages compared to frozen or paraffin embedding. Sample 
tissue retains a better morphology with less shrinkage, and the width of an individual section may be 
thinner; benefits we aimed for when planning this experiment. We generated 15 consecutive 8µm 
trunk sections starting from somite 2 onwards from 19 wild type and 18 hirame individual resin-
embedded embryos to obtain a significant sample size. Single Dct positive cells were scored in 5 
positions as outlined in Figure 3.4A; premigratory, medial/ventral/intra-somitic, dorso-lateral, 
contact with yolk/epidermis/mesoderm, and melanocytes on the yolk sac itself.  
Graph: 3.2 represents those cell counts for each area. In total, four of five areas indicate significant 
statistical differences of melanoblasts between wild type (left columns) and hirame (right columns) 
either with *p<0.01 or **p<0.001 obtained after Chi-Square test, Mann-Whitney test and Bonferroni-
Correction. We observed a decline in melanoblasts on the yolk sac in hirame mutants, which was 
accompanied with elevated numbers in close proximity to the lateral mesoderm of the body axis 
reaching out to the yolk sac epidermis (area of named yolk/epidermis/mesoderm). In addition, we 
could detect a significant difference in pre-migratory and dorsolateral positions. Within the pre-
migratory location, numbers were lower in hirame, whereas on the dorsolateral pathway Dct+ cells 
were higher.  
Taken together, at stage 21 melanoblasts accumulated within the mesodermal tissue and presented 
a dramatic decrease on the yolk sac itself. These counts support our previous melanoblast cell counts 
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in WISH showing an increase of numbers within the body. The asymmetry of cell distribution 
unaffected by total cell numbers, suggest a failure of melanoblast migration on the yolk sac in hirame 
embryos at stage 21.  
Our next hypothesis was that the loss of YAP could also affect cell differentiation, especially in 
melanocytes. To further investigate this idea, we decided to carefully dissect the onset of 




Figure 3.4: Schematic representation of internal and external melanoblast locations used for scoring 
and representative images of wild type and hirame resin cross sections at st.21 
A) Schematic of a resin cross section of Medaka embryos at st.21 to indicate possible 
melanoblast locations distinguished  and referred to in our analysis. Five categories were set 
to score melanoblast presence within 15 consecutive section in wild type and hirame: 
premigratory, medial/ventral/intra-somitic, dorso-lateral, contact with 
yolk/epidermis/mesoderm and melanocytes on the yolk sac itself. Taken this outline, 
melanoblasts from cross sections were then identified and placed in those categories to 
analyse their distribution within the embryo. B/C) Representative resin sections for wild type 
(B) and hirame (C) at st. 21 after in situ hybridisation with Dct as melanoblast marker and 




Graph: 3.2: Single cell quantification of melanoblasts in Dct st.21 embryos sections 
Single cell quantifications of melanoblasts within 15 consecutive resin sections of 19 wild type 
(left plain columns) and 18  hirame (right  speckled columns)  st.21 embryos after in situ 
hybridisation with Dct followed by neutral red nuclei staining. Cells were separated and 
quantified in those 5 categories displayed in Figure 3.4A.  4 categories presented significant 
differences after Chi-Square test, Mann-Whitney test and Bonferroni-Correction *p<0.01; 
**p<0.001.   The data indicates an asymmetric distribution of melanoblasts in hirame towards 
the edge of the mesoderm. The incline in Dct+ cells corresponds with the decrease on the yolk 
sac making this a specific migration defect at stage21. All data are means ± SEM. 
 
3.2.3 Evaluating the onset of melanocyte differentiation     
As previously noted hirame embryos develop differentiated melanocytes in late stages beyond 2 dpf. 
However, we do not know if the beginning of the differentiation process is happening in a similar 
fashion to wild type embryos with functional YAP protein present. Therefore, I investigated if the loss 
of functional YAP protein in hirame is affecting the onset of melanisation by scoring the overall 
presence of visible melanin in melanosomes synthesised during melanocyte cell differentiation.  
Offspring from HB32C heterozygous and homozygous carriers for the hirame allele j50-20C were 
staged carefully at 7 somite to 14 somite stages and photographed after fixation. As seen in Figure 
3.5 and Figure 3.6 visible brown melanin accumulated in melanosomes and is first detectable at the 8 
somite stage in wild type increasing until the 10th somite. Melanisation was also observed in hirame 
mutants during the same time window. Furthermore, consistent with our studies of Dct positive cells, 
we saw similar defects in dispersion of pigmented melanocytes on the yolk sac of hirame mutants 
from 8 somites onwards wherein melanocytes reside in close proximity to the lateral body axis 
compared to wild type siblings. Taken together, these data suggest that while migration of 
melanoblasts onto the yolk sac is impaired in hirame mutant, the timing of differentiation is not.  
However, to confirm this statement, we were determined to affirm the staging my analysing the 




Figure 3.5: Onset of melanisation in wild type and hirame in differentiating melanocytes  in both 
begins  during 8 somite stage 
Magnified brightfield images of fixed Medaka embryos at 7 somite stage up to 14 somites to 
investigate the onset of melanisation upon melanin detection in wild type (top row) and 
hirame (bottom row) embryos. Differentiation of melanoblasts into melanocytes occurs 
between 8 and 10 somite stage in wild type as well as hirame embryos. Although in hirame 
melanocyte distribution is abnormal and  their localisation is close to the lateral body axis 
compared to wild  type in which they spread away from the body. Again the onset of 




Figure 3.6: Onset of melanisation in wild type and hirame in differentiating melanocytes (whole-
mount) 
Lower magnified images of embryos as in Figure 3.5, in which onset of melanisation in wild 
type (left) and hirame (right) occurred between somite 8 and 10. Note, melanocytes disperse 
onto the yolk sac in wild type, but stay close to the body in hirame embryos. Scale bar = 500µm 
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3.2.3.1 Somite staging to investigate developmental progress 
One ongoing concern throughout these studies was the possibility that melanocyte developmental 
defects could be a secondary effect resulting from general retardation of embryonic developmental 
mechanisms. Hirame mutants do not show general retardation and dislocation of organs prior to 
stage 22 (1d 17 hpf), however internal structural analysis has not been carried out to exclude this 
possibility.    
Typically, in mouse the number of somites is used as a reference for age in a developing embryo. 
Somites are transient structures and give rise to the vertebrae, cartilage, tendons, skeletal muscle 
and the dermis in vertebrates during a process called somitogenesis. Established during gastrulation 
somites segregate from an unsegmented presomitic mesoderm (PSM) also called paraxial mesoderm 
which runs lateral to the neural tube of the neurulating embryo. They are formed by “budding off” as 
somitomeres of paraxial mesodermal cells. Around each developing somite the outer cells undergo a 
mesenchymal–epithelial transition (MET) to form an epithelium also known as the dermomyotome, 
while the inner cell mass remains mesenchyme. The immature somites are then compacted and 
separated into distinct parts. Somites are formed sequentially and simultaneously from head to tail 
of the developing embryo on the caudal side of an already existing somite. Their tight regulated 
formation depends on a temporal periodicity controlled by a molecular oscillator, the segmentation 
clock. Phenotypically they are bilaterally paired blocks of mesoderm along the embryos anterior-
posterior axis. However the number of somites is only given as a guide to what might be expected of 
typical embryos as the true range of development can be wider depending on minute time intervals 
(Downs & Davies 1993). In addition, mutations affecting segmentation could cause a wide range of 
symptoms including complete or partial absence of whole somite structures or incomplete somite 
boundaries. 
For our purpose, we decided to use the segmentation clock as general criterion to evaluate 
developmental retardation in hirame mutants. Analysis of somitogenesis and somite quantification 
was carried out on age-matched hirame and wild type sibling  embryos after in situ hybridisation with 
a mixture of pax3 and foxd3  anti-sense probes (hand gift of Dr H Hashimoto) to label mesodermal 
somite structures. The paired-domain transcription factor Pax3 was shown to play an important role 
for normal myogenesis and neural crest development in the developing embryo (Nelms & Labosky 
2010b). It activates several Myogenic factor 5 (myf5) enhancers and is thought to control the 
transcription factor myogenic differentiation1 (myoD) expression (directly or indirectly); both myf5 
and myoD are early markers for myogenic differentiation. Pax3 is expressed in the unsegmented 
paraxial mesoderm (UPM) and epithelial somite, being confined first to the dermomyotome and later 
to its ventrolateral half (Tajbakhsh et al. 1997; Rawls & Olson 1997). Fork head domain 3 (fkd3) also 
known as foxd3 is expressed early on in the neural plate border during gastrulation, as well as in the 
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mesoderm of the posterior and ventral tail bud and briefly in the developing floor plate (Odenthal & 
Nüsslein-Volhard 1998). It specifies premigratory neural crest cells for several lineages such as 
neuronal, glial or cartilage fate and represses melanogenesis, by regulating lineage-associated 
transcription factors (Nelms & Labosky 2010a). In later stages foxd3 can be monitored in 
premigratory neural crest cells of the head and trunk, in forming somites and in newly formed 
peripheral glia in Zebrafish ( Kelsh et al. 2000).  
In Medaka, foxd3 shows mild expression during early somite myogenesis, but is strongly expressed in 
mature somites (data not shown). By combining pax3 and foxd3 anti-sense probes during in situ 
hybridisation, the detection level and clarity of somatic structures was improved and therefore used 
to assist somite counting. Figure 3.7 represents the same embryos used in Figure 3.6 labelling pax3 
and foxd3 mRNA to highlight paired somitic structures (indicated by asterisks). The staging between 
7 and 14 somites is based on nominal somite counts in wild type siblings before fixation. The results 
show that the number of somites in hirame is the same as in wild type embryos in all developmental 
stages during somitogenesis between 7 and 14 somites. This indicates that hirame is not 
developmentally retarded at stage 21 (6 somites). 
We concluded that, although mesodermal somite structures seem to be irregularly sized and shaped 
in hirame and some somite boundaries are not very clear compared to wild type siblings, the process 
of somitogenesis follows a normal course in terms of somite segmentation up to at least 14 somites. 
 
To summarise, although the onset of melanocyte differentiation in hirame is not impaired, the 
migration onto specific areas of the embryo i.e. yolk sac is. For a sophisticated approach to record 
cell migration and survival, we aimed for a transgenic line during our next step in which we could 






Figure 3.7: Developmental progress in hirame and wild type is non-different revealed by ISH of somite 
structures  
In situ hybridisation (ISH) with pax3 and foxd3 anti-sense probes to visualise somite structures 
and quantify their numbers used for staging in 3.2.3. Asterisks indicate individual horizontal 
pairs of somites. The number of somites in wild type matches the number in hirame embryos 
despite morphological differences in width and length. Scale bar = 100µm. 
 
3.2.4 Cloning the Medaka Dct promoter  
To better understand the Medaka melanocyte lineage, its origin, migration behaviour, proliferation 
and survival, I desired a transgenic line in which melanocyte lineage cells were readily detectable at 
all stages during embryogenesis.  
Although, a previous study carried out by Martinez-Morales et al. in 2009 established a 3kb long 
Medaka tyrosinase promoter fused to GFP (tyr:gfp), which seemed to be melanocyte specific beyond 
3dpf, it had not been characterised in any more detail (Martinez-Morales et al. 2009). Using the 
already established tyrosinase promoter was one possibility to carry out functional studies of YAP 
within the melanocyte lineage. However, due to uncertaintly about the tyr promoter at earlier stages 
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and the inpurity of the tyr probe itself, we decided not to pursue with this option. In addition, the Dct 
probe we already established and analysed was overwhelmingly clear and lineage-specific to 
melanoblasts at early stages as well as melanocytes beyond 3dpf (Dr H. Hashimoto, (Nagao et al. 
2014). Moreover, Dct expression was first detected in early melanoblasts within the body as early as 
st.18-19 (1-2 somite, data not shown), which has not been reported yet. 
These are the reasons why I decided to clone the Medaka Dct promoter to use it for future 
melanophore studies in regards to YAP protein functionality. I aimed to clone the promoter and 
couple it to a fluorescence marker, the enhanced green fluorescence protein eGFP to be able to trace 
the melanocyte lineage during embryogenesis. 
As starting point, I decided to use the amino acid sequence from the 1884 bp Zebrafish dopachrome 
tautomerase (Dct) mRNA (actual size is 1538bp from first ATG to stop codon) found on chromosome 
9 annotated in NCBI with NM_131555.2. Using BLASTX in search of Dct against the Oryzias latipes 
genome on the ensemble.org website, I identified a region which is most likely the Medaka 
homologue for the Zebrafish Dct coding region, which also matched the construct for the Dct anti-
sense probe obtained by Dr H. Hashimoto (Nagao et al. 2014). This region on chromosome 21 
defined in ensemble as dopachrome tautomerase (25,518,211-25,522,729 / ENSORLG00000017760) 
with a transcript of 1714bp and protein length of 518aa. I increased the 5’ flanking region before the 
first ATG by 3700bp only as previous promoter studies have demonstrated that a promoter length of 
3-5kb is likely to contain sufficient promoter regulatory elements (Martinez-Morales et al. 2009; 
Carney et al. 2006). We obtained the Medaka dopachrome tautomerase (Dct) promoter as genomic 
DNA fragment by polymerase chain reaction, allowing us to isolate a 3607bp genomic DNA fragment 
using a specific primer pair (Figure 3.8). After amplifying the desired region from the Medaka 
genome, the purified PCR product (Figure 3.9A) was then cloned into a pGEM T-Easy vector (Figure 
2.1) via the TA-cloning strategy after an extra adenylation step. I decided to introduce the promoter 
into the pEGFP-1 vector containing a multiple cloning site (MCS) allowing insertion of enhancer or 
promoter sequences, which consequently drives the enhanced GFP reporter gene. This would allow 
me to assess the promoter cell specificity easily by fluorescence analysis in vivo. To achieve that, I 
had to re-amplify the Dct promoter region with the same primer set previously used. However those 
primers contained additional unique restriction enzyme sites matching the target vector’s MCS 
Eco47III (also called AfeI) was added to the forward primer and SalI to the reverse primer. The full 





Figure 3.8: Medaka dopachrome tautomerase promoter and its cloning primers 
Nucleotide sequence of the 3607bp long Medaka dopachrome tautomerase (Dct) with 5’ and 
3’ flanking regions resulting from an ensemble BLASTX search with the Zebrafish Dct protein 
amino acid sequence. The matching sequence of Dct from Zebrafish chromosome 9 is found on 
chromosome 21. Forward and reverse primers to clone the promoter region are indicated in 






Figure 3.9: Medaka Dct genomic DNA amplification and cloning into target vector to obtain Medaka 
Dct:eGFP 
A) Total PCR product on 1% agarose gel visualised under UV with ethidium bromide before gel 
extraction. Amplified DNA band shows approximately the expected band size of 3.6kb.  
B) Map of the Medaka Dct:eGFP plasmid featuring the Medaka dopachrome tautomerase 3.6kb 
promoter sequence (orange) transcribing eGFP (green). Other regulatory elements are the simian 
virus SV40 polyA signal (blue) for termination of transcription, F1 bacteriophage origin (grey) for 
DNA replication of viral strand synthesis and termination allowing synthesis of single-stranded 
DNA (not needed in my case) and ColE1 origin (grey) for double-stranded bacteria vector 
replication. SV40 promoter driving expression of selectable marker kanamycin resistance gene in 
E.coli.  Restriction enzymes Eco47III (AfeI) and SalI were used for direct cloning of the Medaka Dct 
promoter PCR fragment into the pEGFP-1 plasmid backbone. 
To test the construct, we purified the plasmid by plasmid midiprep and injected it as 20ng/µl working 
solution into one-cell stage embryos to obtain 20-40pg total amount of intracellular DNA. Through 
live observation in transient transgenics, I could verify its transient expression within the melanocyte 
lineage (data not shown). This meant that our promoter could be used for further usage to establish 
a Dct:eGFP transgenic line in Cabj50-20C  strain.  
  
 
3.2.5 Establishing the Dct:eGFP Medaka transgenic line 
The Medaka Dct:eGFP construct described and verified within Chapter 3.2.4 was now used to 
establish stable transgenic Medaka strains. This plasmid was linearised with BglI and 20ng/µl working 
solution (total amount of 20-40pg DNA) was injected directly into cells of one-cell stage embryos of 
Cab hiramej50-20C.  
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Injecting it into this strain meant that it was most likely to obtain hemizygous founders for the j50-
20C allele after transgenesis voiding having to backcross founders. We obtained compatible results 
from 20 separate sets of injections (data combined in  
Table 3.1). In total 2301 eggs were injected from which 662 were viable after 72hpi (3dpi). This high 
death rate of 71% was expected due to the high concentration of injected DNA used to maximise 
DNA integration into the genome of chimeras. However, the process of microinjection of any kind of 
solution into Medaka one-cell stage embryos itself is a delicate procedure. When not carefully 
handled, it can lead to disruption of the yolk syncytial layer through either the injection of too much 
volume or the damage of the egg chorion, which then changes pressure conditions for the oil 
containing egg leading to leakage and death. Another reason for the high death rate might be the 
breaking of the syncytial layer with the capillary needle itself. 
From those 662 embryos, 121 eGFP positive chimeras were selected prior to 8 dpf hatching stage as 
putative founders and consequently grown up. These transient chimeras exhibited an overall high 
amount of visible eGFP expression either exclusively in melanocytes, which was mostly the case, or 
they represented some additional ectopic epidermal skin cell expression. However, this observation 
did not concern us, as previous studies reported about ectopic cell expression whilst establishing 
transgenic lines as well (Carney et al. 2006; Thummel et al. 2006). In addition Medaka Dct is not 
expressed in epidermal cells, which might suggest that the transgene was located near an epidermal 
enhancer resulting in eGFP expression in ectopic locations. 
Only 66 larvae hatched after 9 dpf and could be transferred into growing tanks. In general, it is not 
uncommon that Medaka embryos do not survive until 9 dpf. Such an outcome depends on various 
negative factors such as bacteria or fungal contamination in the embryo media, developmental 
retardations or difficulties with motor skills required during the hatching process.   
From those, 50 survived the first month and were raised to sexual maturity. After three months, 48 
adult fish remained from which 44 were fertile. These adult chimera were set up with Cab wild type 
or Cab heterozygous j50-20C of similar age to test for germline transmission of the transgene. The 
offspring, mostly 2-15 eggs daily, was then screened under a fluorescence microscope for cellular 
eGFP expression. If none of the F1 embryos scored had any eGFP positive expression, the parental 
generation was deemed not to be transmitting through their germline and were subsequently 
euthanized. If, however, some of the embryos did display eGFP expression we knew that the 
outcrossed parent was able to transmit the transgene and so was selected as a founder. These 
embryos were then grown up as the hemizygous F1 generation for the transgene and named as 
separate Tg(Dct:eGFP) lines depending on the parental gender and number. Through fluorescence 
microscopy we identified eGFP positive offspring out of 10 individual founders showing expression 
within melanocytes. 8 out of those 10 founders carrying the transgene were selected for further 
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evaluation and detailed characterisation. The remaining two founders gave offspring with very high 
ubiquitous background expression and therefore excluded from further analysis. The total number of 
founders obtained though injection of linearised DNA indicate a transgene transmission rate of up to 
22.7%.   
 
Table 3.1: Summary of the F0 Medaka fish Dct:eGFP generation from microinjection up to the finding 
of founders of the transgene 
Experimental process in G0 founder generation Corresponding number of individual 
chimeras 
Injected embryos 2301 
Survival after 3dpi 662 
Grown up to 8 dpf after eGFP selection 121 
9 dpf hatchlings 66 
Survived 1st months  50 
Survived till adulthood 48 
Screened for eGFP if fertile/laying 44 




3.2.6 Characterising Dct:eGFP transgenic lines for melanocyte 
specificity 
 
3.2.6.1 Initial characterisation of Cab Dct:eGFP founders 
The selection, maintenance and characterisation of those 8 out of 10 founders mentioned in 3.2.5 is 
described below. Normally it is not necessary to grow up all founders to decide which strain to keep 
for further experiments. However, the low germline transmission, short time frame of fertility and 
low number of progeny made it risky to examine the F1 generation immediately in detail. Therefore, I 
attempted to grow up around 50 transgenic offspring from each of those 8 individual founders as a 
necessary precaution and analyses the F2 generation instead. In reality, this could not be achieved 
and a quantity of 2 to 33 progeny of each individual founder was obtained and raised. Table 3.2 
summarises the total number of transgenics being transferred as juvenile into the fish facility system 
from separate transgenic Dct:eGFP lines. They were inbred with each other if possible depending on 
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male and female ratio. The F2 offspring of each new line was then analysed as regards to melanocyte 
cell specificity. Appendix 9 shows the gender and description of the original founder and referral to 
the new line name. 
 
Table 3.2: Number of germline transmitting transgenics in F1 pool of offspring after 1 month growing 
period. When the ratio of progenies was low as in the case of line 4 or line 5 and the gender ratio was 
not suitable, then F1 adults were backcrossed to adult wild type Cab for further analyses. 
Tg(Dct:eGFP) line individually Number of transgenic F1 progeny grown up 
Line 1 33 
Line 2 5 
Line 3 17 
Line 4 3 
Line 5 2 
Line 6 32 
Line 7 27 
Line 8 28 
 
Prior to choosing which lines to maintain and use for further experiments, I performed in situ 
hybridisation on 4 dpf (st.32) wild type embryos to highlight the melanocyte, xanthophore and 
leucophore cell distribution at that chosen stage of development (Figure 3.10A,B and Figure 3.12A,B). 
This was done as a comparison to the prospective eGFP expression driven by the Medaka Dct 
promoter. The melanocyte lineage was labelled using dopachrome tautomerase (Dct) and the 
xanthophore/ leucophore cell lineage through a GTP cyclohydrolase 1 (gch) anti-sense probe. The 
melanocyte pattern seen in Figure 3.10A is very similar to the characteristic pattern seen in Zebrafish 
featuring the characteristic dorsal, lateral and ventral stripes (Kelsh et al. 2000) as well as a minor 
subpopulation of differentiated melanocytes on the yolk sac itself. In contrast, the gch pattern is 
readily distinguishable (Figure 3.10B). As reported by Nagao et al. in 2014 gch (XM_004085058) is 
expressed in unpigmented and pigmented xanthophores and in ventral head leucophores only. It 
does not overlap with the melanophore marker expression of dopachrome tautomerase (Dct, 
XM_004081789) (Nagao et al. 2014). Close-ups of the dorsal head epidermis show again the 
difference in cell distribution and number of melanocytes and xanthophores at stage 32 (Figure 3.12 
A,B). Therefore, we were confident that we could identify and ascribe eGFP positive cells to the 
melanocyte lineage when analysing the Dct:eGFP transgenic lines for the expected patterning. One 
found consideration is that leucophores exhibit autofluorescence in the head and dorsal stripe when 
excited by 488 to 546nm, emitting green and red light resulting in orange-red colouration, which 
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needs to be taken into account when analysing the transgenic lines. We note that leucophores show 
signals in both the red and green channels, whereas eGFP is only detectable in the green channel 
enabling us to distinguish them from each other. The autofluorescence of leucophores appears when 
light reflects from crystal of uric acid, purine-related intracellular organelles similar to iridophore 
guanine and hypoxanthine in Zebrafish (Hama 1975). Figure 3.10C and Figure 3.12C/D represent z-
stack images of wild type embryos emitting autofluorescencing leucophores in the head and dorsal 
stripe when excited by 488 to 546nm, emitting green and red light, which  as mentioned needs to be 
taken into account when analysing the transgenic lines.    
 
Figure 3.10: Representation of pigment cell patterns and negative control as non-transgenic in 4 days 
old embryos (st.32) 
A-B) In situ hybridisation (ISH) for pigment cell markers, A) dopachrome tautomerase (Dct) 
anti-sense probe labelling melanocyte lineage B) GTP cyclohydrolase I (gch) anti-sense probe 
marking laterally migrating xanthopores together with leucophores in the ventral head region 
C) Merged image of Differential interference contrast (DIC) microscopy (Nomarski) and 
excitation range of autofluorescence leucophores displayed as orange cells, a combination out 
of green and red emitting channels mainly in the ventral head and some in the dorsal stripe. 




Dechorionated, agarose embedded embryos from F1 incrosses were scored for the expected 
melanocyte pattern at 4 dpf (st. 32). Incrossing also checks for recessive effects, such as death and 
malformation rates, but we did not see any evidence of these effects in our transgenics. Outcrossing 
to Cab j50-20C was performed when the male/female ratio was not suitable. Of those 8 transgenic lines 
incrossed or outcrossed into wild type Cab adults, all of them gave eGFP positive embryos within 
progeny of F1. Although the levels of eGFP expression under the Dct promoter were variable 
between those 8 Tg(Dct:eGFP) transgenic lines, the emission intensity was generally strong and cells 
were easily detectable. 6 lines exhibited similar expression patterns, containing eGFP expression 
seemingly within the melanocyte lineage (Figure 3.11A-F). Two lines had an incomplete pattern 
(Figure 3.11G,H) and were not expressed in all differentiated melanocytes, which could indicate a 
silencing effect in proliferating melanophore clones. Figure 3.12 shows a close up of the dorsal head 
and the melanocyte distribution in the epidermis, which highlights the difference between 
individuals with complete patterning in Figure 3.12E-J, and the incomplete patterning in Figure 
3.12K/L.  However, direct assessment of eGFP in melanised melanocytes is not possible in the Cab 
background due to its recessive b allele causing in amelanotic melanocyte phenotype. Therefore I 
conducted further analyses after crossing one Tg(Dct:eGFP) line originated from founder “line 1” 
onto the HB32C background where the b allele in the B locus is normal, resulting in strong melanin 





Figure 3.11: eGFP expression in Tg(Dct:eGFP) transgenic lines is consistent with sites of endogenous 
Dct expression 
Lateral view of 4 days old whole embryos (st.32). A-F) represent individuals of Tg (Dct:eGFP) F1 
progeny matching the desired melanocyte pattern shown in figure Figure 3.10A and not the 
xanthophore cell distribution. G-H) are transgenic lines with incomplete eGFP expression in 








Figure 3.12: eGFP expression in Tg(Dct:eGFP) transgenic lines is consistent with sites of endogenous 
Dct expression 
Dorsal view of heads of 4 days old embryos (st.32). A-B) ISH of Dct and gch showing the 
chromatophore arrangement on the head C-D) non-transgenic wild type embryos highlighting 
the endogenous excitation of autofluorescent leucophores in the ventral head. (C) bright field, 
D) 488-546nm excitation) E-J) 6 out of 8 Tg(Dct:eGFP) transgenic lines characterised show 
distinct melanocyte specific patterning, whereas two (K,L) show melanocyte specific 
expression, but with missing eGFP levels in some melanocyte positions. Scale bar A-B= 50µm, 
C-L= 100µm.  
 
3.2.6.2 Extended characterisation of the Dct:eGFP pattern in melanised HB32Cto proof cell 
specificity 
To make valid conclusions about the cell specificity of the Medaka Dct promoter and the obtained 
transgenic lines described in 3.2.1, I crossed adults from the F1 generation of Tg(Dct:eGFP) line 1 with 
individuals of HB32C wild type. The HB32C strain exerts a higher amount of melanin production 
resulting in a phenotype with darker differentiated melanised melanocytes. This approach would 
show precisely if eGFP co-localises with those strongly melanised cells. Figure 3.13 shows a wild type 
embryo at 3 dpf in a lateral view as a whole (upper panel) and dorsal view of the head region (lower 
panel). The Dct promoter controlled eGFP co-localised with melanised melanocytes in a very cell 
specific manner in all positions such as on the head, yolk and dorsal stripe (Figure 3.14). It is also 
persistent throughout embryonic development until 9 dpf, the time where embryos hatch out of 
their chorion and begin free swimming (Figure 3.15). The weaker emission signal at later stages is 
explained by increased amount of melanin which is produced and accumulates within differentiated 
melanocytes, masking the signal of green fluorescence proteins. Importantly, I saw no ectopic cell 
expression in any embryo at any developmental stage throughout these experiments. From our 
obtained data we concluded that the Medaka promoter demonstrates correct spatio-temporal 
expression properties and would be highly suitable for visualising Medaka melanocytes 
development.   
In summary, our data demonstrates successfully the construction and characterisation of a novel 
Medaka dopachrome tautomerase (Dct) which is cell specific to the neural crest melanocyte lineage 
throughout embryogenesis. Because Medaka represents a wide range of natural pigmentation 
mutants (Kelsh et al. 2004) providing this promoter offers a valuable tool for the Medaka community 
to study pigment cell development in more detail. One of the possibilities and questions still to 
answer in hirame would be, if the remaining melanocytes on the yolk sac do migrate in a directed 
and polarised fashion or not as well as the speed of cell movement towards the ventral side of the 
yolk sac. Queries which could be attempted by real-time analysis on live embryos as eGFP 




Figure 3.13 Embryos of Tg(Dct:eGFP) in HB32C background after 3 dpf showing co-localisation of eGFP 
in all melanised melanocytes 
No ectopic cell expression could be observed meaning the tissue specificity of the dopachrome 
tautomerase (Dct) promoter and its final validation. Upper panel A1-A4) shows a lateral view 
of whole embryos and lower panel B1-B4) a dorsal view onto the head in bright field (BF), 
under green fluorescence (GFP) and red fluorescence (GFP) filter as well as all channels 
merged (Merge). Autofluorescent leucophores mainly positioned in the ventral head emit 





Figure 3.14 eGFP expression is specific to the melanocyte lineage 
Strong overlap of eGFP in melanocytes on the head (A1-A4) and the yolk (B1-B4) of 3 dpf 
embryos as well as on the dorsal stripe (C1-C4) of 9 dpf embryos could be detected. 
Autofluorescence leucophores emit within the green and red spectrum resulting in an orange-
red combined cell colour within merged images. However, they do not express eGFP as seen in 





Figure 3.15 Co-localisation of eGFP within melanocytes throughout embryogenesis  
Expression pattern of eGFP is tissue specific and co-localises with the melanocyte lineage 
throughout embryonic development until 9 dpf hatching stage without any ectopic cell 
expression. Strong expression of melanin in later stages 7 dpf and 9 dpf is masking the 




3.2.7 Tg(Dct:eGFP) as tool for melanoblast time-lapse studies 
One of the advantages when establishing this unique Dct:eGFP Medaka transgenic line is that we can 
monitor melanocyte and even early melanoblast behaviour. To test this hypothesis I carried out a 
pilot study in which real-time snapshots were taken from one wild type and two hirame embryos of 
Tg(Dct:eGFP) line 1 progeny. Briefly, dechorionated and agarose embedded embryos were incubated 
at 28°C and subsequently z-stacked images were taken on the Zeiss dissecting microscope every 
30min. Although fluorescence signals become apparent at stage 18-19 (data not shown), I decided to 
choose stage 20 (1d 7h 30min, 4 somite stage) because the distance of melanoblast migration can be 
imaged without having to rotate the embryo manually and intracellular eGFP is sufficiently 
accumulated and strong. In addition, embryo epiboly is completed and most, if not all, convergence-
extension cell movements should have been completed. Figure 3.16 shows merged snapshots of 
those images in real-time.  As indicated in circles (red in wild type, top panel and purple in hirame, 
bottom panel) individual green fluorescent melanoblasts can be observed and monitored during 
active migration from a location close to the body at the 4 somite stage (0 min) to areas further away 
from to the body at 6 somite stage (180 min). Our results suggest that in hirame first melanoblasts 
migrating ventrally are slower compared to wild type melanoblasts. However, more cells need to be 
analyses and the distance of migration needs to be measured accurately. However, it would be 
interesting to analyse progeny of characterised F3 transgenic Dct:eGFPj50-20C lines for either real time 
studies  under a dissecting or high magnification confocal live microscope. A series of images could 
then be taken and analysed for cell movement activities using for instance cell tracking software. 
Investigating living embryos also opens up possibilities to measure the actual speed of migration, the 
spacial distribution in this area, individual cell morphology and polarisation during directed cell 
migration.   
Even so, this pilot study could yield interesting results, the practicalities of handling living Medaka 
embryos makes live imaging complex, numerous and complicated. One reason for that is, the yolk 
fluid in Medaka embryos is constantly in circulation, and this flow causes a yolk contraction and 
therefore movement of the yolk sac membrane. This makes it difficult to perform z-stack imaging 
precisely, because cell locations change from a viewer´s point. This means, numerous pictures have 
to be obtained from several embryos to get significant data showing actual melanoblast migration on 





Figure 3.16 Time-lapse analysis of Tg(Dct:eGFP) reveals delayed melanocyte migration in 
hirame  
Merged images of fluorescence z-stacks of time-lapse analysis of Tg(Dct:eGFP) line 1 
from 4 somite to 6 somite stage to track melanoblast migration in wild type (left column 
row left to right) and hirame (bottom row) embryos. Pictures were taken every 30min 
starting from 4 somite to 6 somite stage. Coloured circles, red in wild type and purple in 
hirame, highlight the distance of an individual melanoblast through active cell migration. 




3.3.1 Abnormal cell distribution of melanoblasts in hirame   
Our initial observations in 3 dpf embryos suggested a neural crest defect in the differentiated 
melanocyte lineage. To investigate this phenotype we performed a series of whole-mount in situ 
hybridisations for an early marker for melanocyte precursors, dopachrome tautomerase (Dct). We 
demonstrated that the abundant absence of functional Yes-associated protein 1 (YAP1) affects the 
melanoblast distribution in different locations within the embryo, whereas our initial experiments 
suggested a major reduction of Dct+ cells on the yolk sac. Cell quantifications in hirame embryos 
revealed a dramatic decrease in melanoblast numbers, especially on the yolk throughout all 
developmental stages, and in the body itself beyond 2 dpf. Cross sections of stage 21 embryos 
revealed that an increased number of melanoblasts reside and accumulate within the mesodermal 
tissue lateral to the anterior-posterior bodyline, which contrasted to decreased numbers on the yolk 
sac area. In addition, few melanocytes did migrate towards the ventral side of the yolk sac, which 
was however delayed compared to wild type siblings. It strongly suggests that individual melanocytes 
lacking YAP migrate slower than wild type sibling embryos expressing functional YAP protein. 
Interestingly, our melanoblast cell quantifications confirmed that despite local differences, the total 
amount of Dct+ cells is similar between hirame and wild type siblings at stage 21. Beyond that, a 
permanent decrease of total melanocytes was seen in hirame mutants on the yolk sac.  
The reason for the quantitative change of MCs on the yolk sac at stage 21 despite the overall 
similarities in total MC numbers, and the sudden decrease afterwards could be explained first with a 
decrease in mRNA levels. Porazinski described in his thesis that maternal yap transcript levels in 
hirame mutants drop after stage 20 and are absent by stage 22 compared to ubiquitous mRNA yap 
levels in wild type siblings (Porazinski 2013). Undetectable yap transcript levels might be due to a 
mechanism called nonsense-mediated mRNA decay (NMD), which allows the elimination of mRNA 
transcripts containing premature stop codons, which is the case in the hirame allele after the amino 
acid exchange of leucine to a stop codon in position 164 within the first WW domain. In principal the 
maternal to zygotic mRNA transition during hirame embryonic development is suddenly disrupted by 
a loss of functional YAP protein; thereby impairing important developmental processes such as 
organogenesis. This explains why hirame exhibits organ dislocation such as failure of both lens 
invagination and Cuvierian duct endothelial vessel formation, or the general thickness of the 
embryonic body after 2 dpf (Watanabe et al. 2004; Kitagawa et al. 2004; Porazinski 2013), which 
corresponds with a dramatic decrease of MCs after our analysis.  
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It could mean that low levels of YAP or even a lack of functional YAP protein beyond stage 21 in 
hirame is likely to cause a melanoblast migration defect affecting melanoblast distribution, as fewer 
melanoblasts migrate onto the yolk sac and the once which do seem to be slower.  
We have also shown that the Dct patterning defect starts as early as stage 20 (1d 7.5h) and even as 
early as stage 18-19 (1d 3.5h, 2 somites) (data not shown). However, during that time maternal yap 
transcripts are still present and detectable (Porazinski et al.2003), which could mean the quantity of 
YAP influences first MC migration and then development and/or proliferation at later stages. One 
possibility during stage 21 is that maternal transcript levels are just about to drop and the threshold 
is not sufficient to maintain neural crest cell migration. It seems that this drop has not been picked 
up as the regular RT-PCR-amplification product of the yap transcript at stage 20 is still relatively 
strong before total loss at stage 22. It might have been that the product within the conventional RT-
PCR reached its plateau, which can be between 20-40 cycles and therefore is unreliable when it 
comes to representing the maternal mRNA decrease accurately. A better and much more accurate 
approach would be quantitatively real-time quantitative polymerase chain reaction (qPCR), in which 
the targeted product gets amplified and simultaneously measured either by absolute or relative 
quantification. Absolute quantification detects exact numbers of target cDNA molecules by taking 
DNA standards through calibration curves into consideration, whereas relative quantification is in 
reference to a control housekeeping gene and is determined in fold-changes. QPCR measures in-
depth the accumulation of fluorescent signals emitted when a DNA-binding fluorophore is activated 
upon binding to the double stranded DNA produced during the exponential phase of qPCR, leading to 
a much more precise and objective analysis.  
Furthermore, we have shown that beyond st.21 when a lack of hirame transcripts is abundant, 
melanoblasts are persistently reduced in total numbers. This might also be a result of either a lack of 
melanoblast proliferation or survival. Supporting data for the requirement of YAP for cell 
proliferation comes from several overexpression studies. As outlined earlier, tissue expands when 
yap is overexpressed in a tissue specific manner, which can be seen as the opposite effect of our 
observation in hirame, indicating a requirement for YAP in cell growth. Increased levels of YAP, for 
instance, was able to expand liver tissue (Camargo et al. 2007; Dong et al. 2007) and neural 
progenitor populations within the neural tube (Milewski et al. 2004; Dyer 2004; Gee et al. 2011; Cao 
et al. 2008). The question if YAP restricts melanocyte proliferation in hirame could be determined by 
BrdU proliferation assay. One the other hand the decrease in melanocyte numbers might be due to 
decreased melanocyte survival. Studies have shown that c-Abl directly binds phosphorylated YAP 
resulting in protein stabilisation which caused selective binding to p73, which is required for induced 
apoptosis (Levy et al. 2008). To test for cell apoptosis we could either perform terminal transferase 
dUTP nick end labelling (TUNEL) and analyse for co-localisation within melanoblasts. Furthermore, 
93 
 
we could perform antibody staining for anti-caspases, because caspases play a major role for 
intracellular apoptotic signals concerning their induction, transduction and amplification of 
intracellular apoptotic signals (Fan et al. 2005). 
 
In summary, this capital implies that a lack of functional protein YAP has an influence on specific 
melanoblast migration on the yolk sac, which might implicate that YAP is required in a cell-
autonomous fashion for the development of correct melanocyte patterning in vivo. This idea is 
investigated within the next chapter in this thesis.  
 
3.3.2 Differences in transgene integration results in varied 
melanocyte lineage specificity and GFP intensity  
When generating multiple Dct:eGFP transgenic lines, we observed a germline transmission rate of 
22.7%, which is thought to be high for transgenesis attempts where circular or linear DNA fragments 
normally reach up to 16%  (Thermes et al. 2002). However transgenic progeny obtained from 
founders were only few in numbers making it sometimes difficult to establish individual transgenic 
lines from different chimeric founders. This is down to mosaicism of germline integration (Stuart et 
al. 1988; Gaiano et al. 1996). Over the range of 9 founders only between 2 and 33 individuals could 
be grown up to adulthood for those lines and maintained as F1 generation for detailed studies. This 
was sometimes laborious and risky, as we cannot predict female to male ratios when growing the 
embryos needed for future incrossing. This raises the question of whether another technique might 
have generated transgenesis more efficiently yielding a higher number of founders and their 
offspring.   
In recent years, the two most common methods of creating transgenic Zebrafish lines with a gene of 
interest are 1) transposon mediated transgenesis and 2) I-SceI meganuclease-mediated 
transformation. Tol2 is a transposable element. It was first identified as an autonomous and naturally 
active regulatory component in the Japanese Medaka fish, Oryzias latipes genome. Transposition 
techniques are widely used in the Zebrafish, chick and mouse communities. The transposon 
constructs requires a 5’ 200bp and 3’ 150bp DNA flanking region of the Tol2 sequence used as 
recognition sites for the coinjected transposase. The transposase is encoded as synthetic mRNA, 
which gets translated within the embryo and integrates foreign DNA up to 11kb as single-copy 
entries. The Tol2 insertion becomes stable once the injected transposase mRNA degrades and the 
protein activity declines. Studies have shown germline transmission of 12-16% (Parinov et al. 2004; 
Kawakami 2007), and some report from 3-100% germline transmission (Kawakami 2007). However, 
in Medaka fish itself the transpositional activity of exogenously introduced Tol2 is found to be far 
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more inefficient and therefore has not been established as a sophisticated genetic tool for 
transgenesis. It was suggested that the Tol2 transposase may have an extranuclear localization signal 
only active in Medaka cells which hinders its nuclear transpositional function (Kawakami 2007) or the 
endogenous Tol2 transposase might actively displace the transgene continuously within the genome, 
exerting an effect on reporter gene expression (H. Hashimoto, personal communication). Because of 
that reason, we did not consider using a Tol2 transgenesis approach for establishing the Dct:eGFP 
lines.   
Conversely, the other approach is based on the I-Sce technique. Studies have claimed that 
coinjection of the I-SceI meganuclease with a reporter construct including I-SceI flanking regions 
increases transgenesis frequency up to 45% in Zebrafish compared to 5% or less without, as well as 
promising earlier transgene integration in F0 with up to a 50% increase in germline transmission 
frequency in their progeny (Soroldoni et al. 2009). In addition, the 18bp long endonuclease I-SceI 
sequence originally from Saccharomyces cervisiae allows a single integration of the transgene at low 
copy numbers. The mechanism is based on the coinjection of I-SceI meganuclease and a reporter 
vector with I-SceI flanking sites, in which the endonuclease remains attached to its flanking regions 
counteracting concatamerisation by blocking endogenous ligases within the early embryo. This might 
be the cause for lower transient mosaicism and a higher transgenesis frequency in F0 chimeras 
(Soroldoni et al. 2009). Indeed some Medaka researchers do make use of the I-SceI meganuclease 
approach. In 2002, Thermes tested the meganuclease as tool specifically for Medaka, where they 
present two lines in which the transgenesis frequency could be raised to 30.7% with half of the 
progeny expressing the transgene in F0 generation due to early integration of the transgene into the 
embryo. When injected as linear and circular vector DNA the germline transmission rate was 
between 5.9 and 15.6% with about 15% of offspring being germline transmitters (Thermes et al. 
2002). Furthermore, the Schartl laboratory used I-SceI when establishing the mitf::xmrk melanoma 
model in Medaka fish (Schartl et al. 2010). His paper describes a germline transmission into 8 
individual adult F0 founders out of 105, which is a transmission frequency of 7.6% (Schartl et al. 
2010). In contrast, the Dct:eGFP transgenesis conducted and described in this thesis had a germline 
transmission of frequency 22.7%, which is 3-times higher achieved without an I-Sce site. This might 
be due the careful selection of strong GFP positive chimeras which were placed aside to be grown up, 
thus increasing the chance of transgene integration into germline precursor cells. 6 out of 8 analysed 
Dct:eGFP transgenic lines recapitulate the endogenous Dct expression pattern with eGFP. It seems 
that some researchers do obtain promising results with I-SceI technology and some do not and 
further analysis of this transgenesis technology might be one of the useful options to clarify its 
compatibility and advantages for the Medaka research field.  
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If our approach not to use any I-Sce meganuclease is right or wrong, is debatable. To our 
understanding in the Zebrafish community, the conventional microinjection of coiled or linearised 
plasmid DNA is now seen to be outdated, because of its drawbacks such as mosaic distribution of the 
injected transgene with long concatamer DNA formation, late transgene integration during late 
cleavages, low transgenesis frequency). However, this approach is still used frequently in the Medaka 
field (personal communication Furutani-Seiki 2011, Hashimoto & Adachi 2013), which justifies our 
approach to exclude a Tol2 or I-Sce sequence in our target vectors.  
In addition we have observed an incomplete eGFP expression pattern within the melanocyte lineage 
in two of our transgenic Dct:eGFP lines. One hypothesis is that it might be due to silencing in early 
clonogenic melanocytes, which might be associated with short multi-copies of the inserted transgene 
often seen in mice transgenics (Calero-Nieto et al. 2010). Gene silencing is an epigenetic mechanism 
to regulate gene expression either during transcription or translation. However, in our case it needs 
to be investigated if this silencing effect happened in clonogenic melanocytes on a transcriptional or 
translational level, which might be possible by carrying out in situ hybridisation against the eGFP 
transcript in F2 offspring.  
We also observed minor variation in eGFP intensities between those 8 Dct:eGFP transgenic lines, 
which might be due to different chromosomal insertion points of the transgene. Supporting, Day et 
al. have shown that expression level can vary up to 10-fold difference depending on the insertion site 
(Day 2000) . This strengthens the view that the chromosomal integration site can have an effect of 
the level of gene expression and that reproducible insertion into the same chromosome position is 
capable of generating the same expression levels.  
Importantly, I saw no ectopic cell expression in any embryo at any developmental stage throughout 
these experiments in those 8 characteristic lines. From this data set we concluded that the Medaka 
promoter had the correct spatio-temporal expression properties and would be highly suitable for use 
in visualising Medaka melanocytes. It would also be an excellent choice for manipulating gene 
expression within melanocytes.  
 
3.3.3 Summary 
We aimed to explore the melanocyte pattern of hirame mutants in detail and draw conclusion about 
the timing when this patterning defects is established. We have shown in this chapter that hirame 
embryos lacking functional Yes-associated protein 1 (YAP1) exhibit an abnormal melanocyte 
patterning as early as stage 20. In fact, the melanoblast numbers are particularly reduced on the yolk 
sac indicating a migration defect. To broaden our analysis of melanoblast behaviour, we elected to 
establish transgenics using the Dct promoter we made ourselves mimicking the endogenous 
96 
 
melanocyte pattern. After successfully establishing several transgenic Dct:eGFP lines, one had been 
backcrossed into a wild type HB32C strain expressing strong levels of melanin in melanocytes. This 
presented us with the chance to analyse co-expression of eGFP in the melanocyte lineage and 
confirmed that our isolated Medaka dopachrome tautomerase promoter is melanocyte specific. In 
addition we could detect and monitor melanoblasts as soon as somitogenesis began, allowing real-
time observations of individual cell migration, potentially also of cell division and survival. Careful 
exploration of a particular promoter also enables researchers to use it to its full potential with 









































4 Chapter: Designing, testing and 
establishing yap overexpression 













4.1.1 Cell autonomy or non-cell autonomy as classical approaches to 
study gene function 
In the previous chapter, we reported about the dramatic reduction of melanocytes with a strong 
melanoblast migration defect in hirame embryos, particularly during early embryogenesis. However, 
the question remains if this melanocyte defect is cell-autonomous or non-cell autonomous with 
regards to missing YAP activity. Cell-autonomy describes a genetic trait, which changes the 
phenotype and/or cell behaviour of a mutated individual or a subpopulation of cells. These changes 
are only present in mutated cells, and they cannot be found or transferred to surrounding normal 
cells. Conversely, a non-cell autonomous trait describes a situation in which genotypically mutant 
cells are able to transform surrounding cells, regardless of their genotype, to display a mutant 
phenotype. In other words, mutant cells can transform normal neighbouring cells to exhibit altered 
cell behaviour. However, the opposite can occur as well, wherein a normal environment can re-
normalise the behaviour of genotypically altered cells, for instance, after transplantation 
experiments into normal wild type hosts. Characterisation of cell autonomy and non-cell autonomy is 
classically described as mosaic analysis and has been carried out in a wide range of organisms such as 
Caenorhabditis elegans, Drosophila melanogaster, mice and Zebrafish to study individual gene 
function (Carmany-Rampey & Moens 2006). An example of cell autonomy was delivered in 1990 by 
Ho & Kane in which the phenotype of Zebrafish spt-1b104 (spadetail) mutants express an important 
genetic trait solely autonomous to the paraxial mesoderm trunk precursors, which failed to converge 
during gastrulation (Ho & Kane 1990). Likewise, cell autonomous expression of the receptor 
neuropilin 2 (Npn2) in mouse trunk neural crest cells is required for the repulsion of crest cell 
migration by the posterior half of the somites in which the ligand semaphorin 3F (Sema3f) is 
expressed. Npn2 signalling forces NCCs to migrate separately through the mesoderm instead of 
remaining as a uniform cell sheet (Gammill et al. 2006).  
To our knowledge, there are no publications concerning about the cell autonomous function of the 
Hippo pathway in particular tissues during development. However, unpublished data from a previous 
colleague working with the hirame mutant suggests a non-cell autonomous role for YAP during 
cuvier´s duct formation and the invagination of the lens into the retina of the developing eye 
(Porazinski 2013). The cuvier´s duct is an early circulatory system defined by a superficial vasculature 
sitting on top of the yolk sac, which plays an important role in yolk absorption to provide nutrients 
during early teleost embryogenesis (Fujita et al. 2006). It consists out of two merged sets of 
endothelial progenitor cells. The primary stream originates posteriorly near the developing somites 
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and the secondary population arises anteriorly close to the otic vesicle rudiment. Both streams unite 
at around stage 23. Porazinski not only observed that in hirame both cell streams were truncated and 
did not fuse to form an entire cuvier’s duct, he also showed that as little as 15 wild type cells 
transplanted into hirame could partly rescue the endothelial cell migration and extend the anterior 
stream. Conversely, transplanted hirame cells into wild type embryos integrated fully in into the 
cuvier’s duct endothelial structures. Another example came from the same thesis, when as few as 5 
wild type cells were transplanted in the a region of the hirame developing eye, the lens, which 
normally is not invaginated within the retina tissue, could be rescued and resembled the wild type 
phenotype. This rescue was up to 100% when at least one cell was present within the lens and others 
remained in the retina (Porazinski 2013). These experiments suggest that at least in cuvier’s duct and 
eye formation, YAP has a non-cell autonomous role, as wild type cells are able to exert a rescue in 
hirame mutants and hirame mutant cells are behaving somewhat normal when transplanted into 
wild type hosts.          
Whereas most mosaic studies have been carried out by creating chimeric embryos through 
transplantation of tissue grafts or individual cells from a mutant into a wild type host or vice versa, 
cell autonomy can also be tested by overexpressing a target gene under a cell specific tissue 
promoter and examining whether phenotype is rescued. Similarly, non-cell autonomy can be 
assessed by overexpressing a gene of interest in a neighbouring tissue and investigating the 
behaviour of the mutant cells for instance after cell transplantation or YAP expression in other tissue. 
In this chapter we aimed to investigate if Yes-associated protein (YAP) plays a cell autonomous role 
within the melanocyte lineage. To test this hypothesis, I planned to establish transgenic lines 
overexpressing functional YAP protein under the Medaka dopachrome tautomerase (Dct) promoter, 
which would not only answer the question of the cell autonomy, but also provide a tool for 
monitoring cell behaviour through a fluorescent reporter eGFP in the future. Conversely, yap mRNA 
injections into the yolk sac were carried out as a complementary approach to test if melanoblasts can 
be rescued in a YAP non-cell autonomous fashion.  
 
4.1.2 Choice of eGFP as fusion tag reporter 
To investigate if Yes-associated protein (YAP) plays a cell autonomous role in melanocyte migration in 
embryos, I planned to increase the levels of YAP in MC protein and track this cell lineage with a 
fluorescent reporter. To accomplish this, I fused either wild type or an activated version of yap C-
terminally to the enhanced green fluorescence protein (eGFP). In Medaka, the activated version of 
YAP, S87A, corresponds to the designed mutation S127A in human yap, which abolishes 
phosphorylation; thereby increasing YAP presence level within the nucleus (Basu et al. 2003). I 
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decided to use eGFP not only because it is available in the background pEGFP-1 plasmid generated in 
Chapter 3, which was suitable for expressing this fusion protein within melanocytes, but also because 
of its molecular properties.  
The wild type green fluorescent protein (GFP), an important marker in research, was originally 
derived from the jellyfish Aequorea victoria. The original sequence and its derived protein structure 
were below the sensitivity of standard reporter systems such as β-galactosidase which enzymatically 
amplifies colour labelling to a visual level. By substituting the amino acid threonine for serine at 
position 65 within the GFP sequence, the chromophore intensity could be improved by 35 times in 
mammalian cells (Zhang et al. 1996). The excitation was shifted to 490nm and emission to 509nm 
(Gines et al. 2014). This enhanced version of GFP (eGFP) is one of the brightest proteins available, 
and it exhibits both high photostability and low cell toxicity. One of many properties is that the 
enhanced GFP can be detected as early as 10-12h after infection of in vitro cultures when driven by a 
basal promoter (Ma et al. 2000). Others report signals later than 16-24h (Zhang et al. 1996) after 
infection of mammalian cell cultures. The protein half-life has been estimated to be around 26h 
(Corish & Tyler-Smith 1999). EGFP is predominantly monomeric, but has a weak tendency to dimerise 
(Arpino et al. 2012). Although eGFP can be sensitive to pH (Piston et al. 2013), it has not been shown 
to significantly affect cell physiology in many numerous studies that have used eGFP for establishing 
transgenic lines in Zebrafish and Medaka (Jung et al. 2010; Nakamura et al. 2007; Carney et al. 2006). 
Furthermore, the majority of publications describing yap fusions, also fused eGFP directly to the N-
terminal of the human yap sequence to monitor its subcellular location within in vitro cell cultures 
(Dong et al. 2005; Zhang et al. 2010; Liu-Chittenden et al. 2012; Zhao et al. 2011). Taken together, 
this means we could be confident in using the eGFP as a reporter for our N-terminal fusion with the 
yap gene.   
 
4.2 Results 
4.2.1 Constructing the fusion protein eGFP-YAP1 
The first step was to fuse a flexible linker to the cDNA of egfp that will later be connected to the yap 
gene. Linker sequences generally provide the fusion protein with structural flexibility, improve 
protein stability or increase biological activity. I decided to use a 15 aa repetitive sequence glycine-
and serine-rich linker  [GGGGS]3 Table 4.1), which had previously been shown to be a good linker 
sequence for fusion proteins used in various mammalian in vitro cell cultures (Trinh et al. 2004; 
Delacôte et al. 2013; Ito et al. 2011).  
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Table 4.1: Table: Sequence of the [GGGGS]3 glycine-serine-rich flexible linker in eGFP-YAP fusion 
protein 
 
Nucleotide sequence 5’- 3’: ggtggcggtggctctggcggaggtgggtccggtggcggcggaagc 
Amico acid sequence N-C-terminus:  GGGGSGGGGSGGGGS 
 
In theory, the egfp-linker sequence was then to be inserted into the pCS2 backbones (Figure 2.3) 
containing the wild type and activated version of Medaka yap1. The Medaka yap cDNA was present 
in its wild type (pCS2_yap(wt)) plus a mutated activated version S87A (pCS2_yap(S87A)) with an 
amino acid exchange in position 87aa that replaces serine with alanine. The activated version of yap1 
corresponds with the human S127A mutation, which in the mammalian context hinders the 
upstream kinase LATS and also Akt to phosphorylate YAP protein, thus increasing nuclear localisation 
and activity as a transcriptional co-activator (Dong et al. 2007; Basu et al. 2003). pCS2 constructs 
were kindly provided by Dr M. Furutani-Seiki. 
To achieve this, first, I designed primers which amplified egfp and would attach the [GGGGS]3 flexible 
linker (FL) sequence simultaneously on eGFP’s C-terminus during the amplification process. The eGFP 
stop codon sequence was removed to maintain the open reading frame (ORF) between egfp and yap. 
In addition I added the restriction enzyme sequence of ClaI and SpeI to the N-terminus of the 
forward primer and another ClaI site after the flexible linker to its reverse primer set (Table 2.2), 
which helped to subclone it into the pCS2_yap(wt/S87A) constructs afterwards. The exact expected 
sequence order included the 5’ restriction sites followed by egfp connected to a flexible linker with 
another restriction site attached (Figure 4.1). Finally, using the pEGFP-1 vector as a template (Figure 
2.2), the PCR amplified egfp sequence was then ligated into the pGEM®-T Easy vector resulting in 
pGEM_egfpFL (Figure 4.2).  
 
 
Figure 4.1: 5' and 3' nucleotide sequence of the egfpFL sequence  
One-step PCR amplification in which ClaI and SpeI endonuclease restriction sites were added 5’ 
to egfp and the flexible [GGGGS]3-rich linker plus an additional ClaI restriction site was added 
3’ to the egfp gene. All supplementary nucleotides to egfp were added within the PCR through 
a specially designed forward and reverse primer pair.  Note, egfp sequence does not contain a 






Figure 4.2: Plasmid map of pGEM_egfpFL  
PCR amplified egfp fused to the [GGGGS]3-rich linker nucleotide sequence inserted into 
pGEM®-T Easy cloning vector readily for subsequent cloning.  Map features eGFP (green), 
followed by flexible linker (pink), and additional endonuclease enzyme recognition sites 5’ and 
3’ of the PCR fragment. Other regulatory elements are the T7 and SP6 promoter (purple), 
ampicillin resistance gene (yellow), remaining LacO and LacZ alpha selection cassette (blue), F1 
bacteriophage origin (grey) for DNA replication of viral strand synthesis and termination 
allowing synthesis of single-stranded DNA (not needed in my case) and ColE1 origin (grey) for 
double-stranded bacteria vector replication.  
 
 
Next, I digested the pCS2_yap(wt) and pCS2_yap(S87A) with ClaI to open the backbone. Alkaline 
phosphatase incubation was carried out to remove the overhanging phosphate groups on the 5’end 
to prevent backbone self-ligation. In parallel, I digested pGEM_egfpFL with ClaI enzyme to extract the 
egfp-flexible linker sequence. Basically, I exploited the opportunity to insert my designed egfpFL 
sequence into the single-cut pCS2_yap vector through ClaI restriction site lying in front of the yap 
gene. Importantly, this left the open reading frame intact, thus creating a functional fusion protein. I 
then loaded the digestion onto agarose gels, extracted appropriate sized fragments, ligated together 
and transformed into DH5α. The purified construct was then analysed with SpeI/XbaI double 
digestion to check the orientation of the inserted egfpFL sequence on an agarose gel. In theory if self-
ligation occurred, I would expect to see a linear 5403bp backbone band, because pCS2_yap(wt) or 
(S87A) only contains the XbaI restriction site. If the egfpFL sequence was inserted in the right 
direction and the construct is digestible, I would expect a 4072bp and 2116bp band. In the event of 
an inverted insertion, the fragments size of 4843bp and 1345bp would be present. Figure 4.3 
represents a gel image taken after loading 18 digestions from 10 pCS2_egfpFLyap(wt) and 8 
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pCS2_egfpFLyap(S87A) mini-preps. Sample 2, 4, 7, 16, 17 and 18 represent constructs having egfpFL 
inserted in the right direction, whereas samples 1, 3, 5, 9, 10, 12 and 15 represent inverted inserts. In 
contrast, sample 6 and 14 represent double insertions of egfpFL where the first sequence is inserted 
in the right orientation and sample 8 and 13 picture double insertions of egfpFL where the first 
sequence was in the wrong orientation. Number 11 shows a linearised pCS2_yap backbone only. 
Clone 2 pCS2_egfpFLyap(wt) and clone 16 pCS2_egfpFL(S87A) were consequently chosen as 
successfully constructed plasmids, verified by sequencing and used for further experiments. A 
representative plasmid map is shown in Figure 4.4. 
 
 
Figure 4.3: Identification of egfpFLyap(wt/S87A) colonies in PCS2 backbones  
Agarose gel after electrophoresed DNA digests to check for egfpFL fragment insertion into 
both backbones, pCS2_yap(wt) and pCS2_yap(S87A) to create the fusion sequence 
egfpFLyap(wt or S87A). Seen are 10 digest reactions of pCS2_egfpFLyap(wt) and 8 of 
pCS2_egfpFLyap(S87A). The correct fragment size should show DNA bands at 4072bp 
(backbone, blue asterics) and 2116bp (insert, red asterics) band, which is the case with sample 
2, 4, 7, 16, 17 and 18 (red circled). Other bands show either self-ligation, double insertions or 






Figure 4.4: Representative map of pCS2_egfpFLyap (wt or S87A) plasmids 
The fusion sequence egfpFL (green, pink) was inserted via ClaI restriction enzyme sites into the 
pCS2_yapwt/S87A) backbone infront of the Medaka yap (dark red) cDNA sequence. The 
representative map of verified plasmid clone 2 of pCS2_egfpFLyap(wt) and clone 16 of 
pCS2_egfpFL(S87A) is shown above. The S87A mutation and the putative hirame single 
nucteotide exchange is indicated within the yap gene sequence. Other regulatory elements 
within the pCS2 plasmid backbone include the SP6 promoter and T3 (purple), ampicillin 
resistance gene (yellow), remaining LacO and LacZ alpha selection cassette (blue), F1 
bacteriophage origin (grey) for DNA replication of viral strand synthesis and termination 
allowing synthesis of single-stranded DNA (not needed in my case) and ColE1 origin (grey) for 
double-stranded bacteria vector replication.  
 
As a positive control, a separate pCS2 vector was constructed with egfp cDNA only. The egfp gene 
was extracted from pEGFP-C3 (Figure 2.4) with a double restriction enzyme digest of NheI and HpaI. 
In parallel, an empty pCS2 destination vector (Figure 2.3) was opened up with XbaI and SnaBI. The 
egfp insert was ligated into the pCS2 backbone as NheI and XbaI remained compatible cohesive ends 
after digestion and could be ligated together. HpaI and SnaBI form blunt ends which were also 
compatible. After ligation, transformation and colony screening with HindIII digestion, all 9 mini-
preps tested were positive for the right egfp insert orientation and number within the pCS2 host 
vector. Therefore I decided to purify clone 2 from pCS2_egfp in larger DNA quantities for further 
studies. A summary of this cloning process is reproduced in Figure 4.5. The complete fusion sequence 
of both pCS2_egfpFLyap(wt) and pCS2_egfpFLyap(S87A) was sequences to confirm the correct 
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nucleotide arrangements, but still needs to be tested in regard to its functionality in vivo. To 
accomplish that I aimed to assess synthesised synthetic messenger RNA of those two yap fusion 
genes in hirame mutant embryos. The presence of functional YAP would rescue mutants as would be 









Each component has and retains the same colour definition related to the map featured in 
each section and throughout the whole thesis. Section A-C features different stages in 
constructing plasmids containing the egfpFLyap(wt/S87A) fusion sequence. A) Isolation of the 
egfFL sequence from pGEM_egfpFL, which was fused to wild type (wt) or an activated version 
(S87A) of yap (both included in description “YAPs”) within the pCS2 backbone. This construct 
was taken for subsequent cloning as well as in vitro transcription to produce messenger RNA 
which verified the functionality of the YAP fusion proteins. B) Insertion of egfpFLyap fusion 
sequence into pEGFP-C3 backbone to obtain ubiquitous cell expression in vivo as positive 
control vector regards protein fluorescence and stability. C) Combining DNA fragments from A, 
C and Dct:eGFP (Chapter 3) to create the Dct:eGFP-YAP(wt/S87A) (here described as Dct:egfp-
YAPs) constructs used for transgenesis and later analysis of YAP cell-autonomy within the 
melanocyte lineage.     
 
4.2.2 mRNA rescue of hirame with egfpwtYAP1 and egfpS87A fusion 
proteins 
Rescue of mutant phenotypes either by DNA constructs or synthetic mRNA injections into the 
embryo mutants allows for rapid testing of gene identity and functionality. Whereas injected foreign 
DNA is spread in a chimeric fashion, mRNA and other small nucleotide sequences such as 
morpholinos are distributed more evenly throughout early embryonic development. When injected 
into the cytoplasm of 1-2 cell Medaka embryos RNA maintains its activity only up to 1.5 dpi making 
the rescue of later defects difficult and sometimes impossible (Wittbrodt et al. 2002).  
 
4.2.2.1 In vitro synthesis of messenger RNA  
One disadvantage of transient mRNA (or cDNAs under a ubiquitous promoter) is that the abundant 
manifestation is ectopic. This can either lead to developmental defects or unintended tissue rescue, 
which may obstruct estimates of the rescue rate. In addition, RNA is less stable than DNA and thus 
needs to be handled with more care to avoid degradation (Gilmour et al. 2002).  
Capped messenger RNAs of the egfpFLyap fusion sequences of wild type yap, activated yap, and egfp 
as a negative control were produced by in vitro transcription with the Ambion messenger kit. Firstly, 
pCS2_egfpFLyap(wt or S87A) and pCS2_egfp (all three vectors from section 4.2.2 were linearised 
with NotI restriction endonuclease cutting in its specific recognition site located after the SV40 polyA 
signal which follows the yap or egfp cDNA sequence. Genes of interest were transcribed in vitro with 
the SP6 RNA polymerase using the purified and linearised constructs and the Ambion messenger RNA 
kit (manufacturer’s instruction). The resulting RNA was measured with an RNA Nano 
spectrophotometer and diluted to a working concentration of 500ng/µl.  For quick visual testing, 1µl 
of RNA working solution was loaded onto bleach containing agarose gel in a bleached gel chamber to 
prevent RNA’s degradation. The gel was loaded with the 3 different messenger RNA´s: firstly egfp, 
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secondly egfpFLyap(wt) and lastly egfpFLyap(S87A) . The actual RNA size starting from the SP6 signal 
and ending with the NotI cut for the egfpFLyap(wt/S87A) fusion was 2387bp and for the egfp RNA 
1192bp, exactly what we see on the gel picture. Additionally, I re-measured the RNA concentration 
and purity with the Nano spectrophotometer to exclude the possibility of overlooked salt or protein 
contaminants as well as degenerated RNA. When measuring RNA, a ratio of A260/280 with an 
absorbance of around 2.0 is classified as “pure” RNA. Lower ratios may indicate the presence of 
protein, phenol, change of pH or other contaminants with strong absorbance around 280nm. The 
A260/230 represents a second value of nucleic acid and RNA purity and “pure” samples would be 
expected to reach values between 2.0-2.2. Lower ratios may be the result of EDTA, carbohydrate, 
TRIzol or phenol contaminations, all absorbing at 230nm (Nano Drop Technologies website 2007). 
Table 4.2 shows that all RNA concentrations were around 500ng/µl and that all RNA samples 
produced with in vitro transcription were very pure as indicated by the A260/280 and A260/230 ratios.  
Table 4.2: Duplet measurements of RNA with Nano spectrophotometer concentration and emission 
data to indicate quality ratios 
 
RNA sample Concentration [c] A260/280 ratio A260/230 ratio Quality 
egfp 554 ng/µl 2.022 2.216 Pure 
 546 ng/µl 2.053 2.238 Pure 
egfpFLyap(wt) 544 ng/µl 2.045 2.230 Pure 
 538 ng/µl 2.023 2.261 Pure 
egfpFLyap(S87A) 520 ng/µl 1.985 2.222 Pure 
 550 ng/µl 2.022 2.218 Pure 
 
Further to the above, I measured the RNA purity on a BioRad Experion™ Automated Electrophoresis 
System as the purity of messenger RNA is an extremely important factor for any mRNA injection 
experiments. I measured the concentration of diluted mRNA of all three samples on the BioRad 
following manufacturer´s instructions (Figure 4.6). The electropherogram in each of the of the three 
samples, egfp (A) egfpFLyap(wt) (B) and egfpFLyap(S87A) (C), revealed only a single mRNA peak 
indicating that the samples were very pure, did not include any RNS degradation, and therefore 





Figure 4.6: BioRad data of analysed egfp, egfpFLyap(wt) and egfpFLyap(S87A) mRNA samples 
 
Bioanalysis of synthesised capped mRNA for egfp (A), egfpFLyap(wt) (B) and egfpFLyap(S87A) 
(C) was carried out on the BioRad spectrophotometer and imaged gel electrophoresed RNA 
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molecule (left panel) and the relevant biospectrum (right graph) was obtained. All samples 
show a very low degree of RNA degradation shown by a straight mRNA peak within the 
spectrum as well as a very clear RNA fragment band on the RNA gel.    
 
 
4.2.2.2  Yap mRNA injection into the one cell stage rescues hirame mutants  
Our aim was to evaluate the functionality of our egfpFLyap fusion protein in vivo and proof that the 
fusion of eGFP to YAP does not interfere with each other. The first approach I took was mRNA 
injection, which would show that the assembled final protein is able to rescue the hirame phenotype. 
Functional mRNA injected into the cytoplasm of an embryo at one to two-cell stage can be active 
from the time of injection up to early organogenesis, which is roughly 1.5 dpf (Wittbrodt et al. 2002).  
Theoretically, a total rescue would include a restoration of the abnormal organogenesis, flattened 
body morphology, dislocation of several organs and defects in neural crest melanocyte pattern. The 
early degradability means that a phenotypic evaluation of any rescue in hirame body morphology, as 
described in Chapter 3 section 3.2.2 of 24-28 stage embryos, would be difficult. This is because 1.5 
dpf embryos still lack visual organ compartmentalisation such as lens and optic cup tissue as well as 
defined fore-, mid- and hind-brain structures. Therefore, precise distinctions between wild type and 
hirame embryos at stage 21-22 can be tricky especially after injections that might disrupt some 
developmental features. Because of these reasons, I decided to judge the rescued phenotype in 
hirame with the melanocyte patterning defect present on the yolk sac detectably via dopachrome 
tautomerase (Dct) in situ hybridisation, observed and described previously in hirame in great detail.  
A total of around 200-250pg egfp, egfpFLyap(wt) or egfpFlyap(S87A) mRNA was injected into 1-2 cell-
stage Cabj50-20C embryos, which were subsequently raised to stage 22 (9 somites, 1d14 hpf) and fixed 
in 4% paraformaldehyde. Fixed embryos were then hybridised with a Dct-antisense probe to visualise 
melanoblasts and early differentiated melanocytes in the body and on the yolk sac. Numbers of 
labelled cells in individuals were then counted, recorded and a random selection imaged. All embryos 
were then genotyped using the tetra-primer ARMS-PCR method to distinguish homozygous hirame 
and wild type sibling embryos.  
Visual examination of injected embryos at stage 22 showed no obvious sign of the hirame MC 
phenotype i.e. putative hirame mutants were indistinguishable from their wild type sibling embryos 
after injection with egfpFLyap(wt) (second column) and egfpFLyap(S87A) (third column) RNA (Figure 
4.7). In contrast, hirame embryos injected with the negative control RNA egfp exhibited typical 
abnormal melanocyte distribution as characterised previously, possibly due to the lack of functional 
YAP protein. This first impression provides an indication that the fusion constructs of egfp and yap 
variants leads to functional protein that are able to rescue the affected hirame melanocyte 





Figure 4.7: Injection of egfp, egfpFLyap(wt) and egfpFLyap(S87A) mRNA into 1-cell stage embryos 
rescues the hirame melanocyte defect 
Dopachrome tautomerase ISH was carried out on st. 22 embryos after injection of egfp, 
egfpFLyap(wt) and egfpFLyap(S87A) mRNA injection into 1-cell stage embryos to visualise the 
Dct melanoblast pattern within body and on yolk sac of hirame mutants and wild type sibling. 
Wild type siblings injected with egfpFLyap(wt) (n=57) and egfpFLyap(S87A) (n=37) resemble 
the same normal melanoblast pattern as siblings injected with negative control mRNA egfp 
(n=43). However, hirame embryos injected with the egfpFLyap(wt) (n=13) and 
egfpFLyap(S87A) (n=11) show wild type melanoblast patterning especially on the yolk sac area 
which remains affected in egfp (n=7) injections only indicating a functional rescue with the YAP 
fusion protein in vivo. Scale bar = 500µm.   
 
Manual cell counts of Dct positive melanoblasts were carried out after taking images and before PCR 
genotyping was performed for individual embryos. In total 168 embryos were injected in triplicates 
within each RNA group, 50 embryos were injected with the negative control RNA egfp, 70 embryos 
were injected with the egfpFLyap(wt) fusion gene and 48 embryos were injected with the activated 
version of yap in form of egfpFLyap(S87A) RNA. Our first observation reflects the ratio of 
homozygous recessive hirame mutants to its wild type siblings. Theoretically, we should expect 
around 25% hirame in each group as per Mendelian genetics. In fact, within the egfp category 7 
embryos turned out to be hirame resembling 14% of its total injections after genotyping. In the 
egfpFLyap(wt) population, 13 embryos were hirame which is 18.6%. Within the egfpFLyap(S87A) 
pool, 11 (20.8%) embryos were identified to be of hirame genesis. While at first glance, it seems 
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surprising that the hirame mutants were underrepresented in our sample, there is a simple 
explanation. During the experimental procedures, the eggs were scratched with sandpaper to aid 
dechorionation, incubated in hatching enzyme followed by fixation, which led to decreased survival 
rates in especially hirame embryos due to its soft and fragile tissue structure. This would adequately 
explain the deviation from Mendelian expectations for the homozygous recessive hirame mutant 
population. 
Table 4.3: Dct cell of egfp, egfpFLyap(wt) and egfpFLyap(S87A) wild type and hirame embryos 
 egfp (n = 50) egfpFLyap(wt) (n = 70) egfpFLyap(S87A) (n = 48) 
WT   # of embryos 43 57 37 
        Body MC # 81.8 82.9 87.6 
        Yolk MC # 54.2 59.3 51.6 
        Total MC # 133.2 142.3 139.2 
    
Hir   # of embryos 7 (14% out of 50) 13 (18.6% out of 70) 11 (20.8% out of 48) 
        Body MC # 102.7 97.5 105.4 
        Yolk MC # 36.6  61.5 53.5 
        Total MC # 130 (% baseline) 158.9 (22.2% increase) 158.8 (22.15% increase) 
 
Our second observation and analysis focuses on the Dct+ cells in the body and on the yolk sac of 
embryos in each individual injection group respectively. Hereby cell counts are represented in Graph 
4.1 which are based on the data shown in Table 4.3. The three left groupings represent wild type 
genotypes in the body, on the yolk sac and total numbers, whereas the three right units signify 
hirame in those same classes. Each section comprises RNA injections either of egfp, egfpFLyap(wt) or 
egfpFLyap(S87A) and is analysed in regards to melanocyte numbers.      
Within wild type embryos we did not observe any significant changes in terms of melanocyte 
patterning or numbers after injection of egfpFLyap(wt) or egfpFLyap(S87A) compared to egfp mRNA 
negative control in any of these three areas, body, yolk sac and total Dct cell numbers. Both yap 
injections show that increased levels of abundant YAP protein in wild type embryos did not have any 
significant effect on melanoblast numbers within the body nor on the yolk sac itself, therefore total 
numbers were unaffected. All values for the body location were between 81.8-87.6 Dct positive cells 
and 51.6-59.3 for the yolk sac region, showing no significant differences within those categories 
(Table 4.3). Again, there were no alterations seen in any of those three categories in embryos 
overexpressing yap in comparison to the negative control of egfp RNA injections.  
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On the other hand, mRNA injection of functional YAP protein into hirame embryos resulted in an 
altered and seemingly rescued phenotype as melanocytes were able to migrate away from the body 
axis onto the yolk sac. All hirame embryos injected, either with wild type (wt) or the activated version 
of YAP (S87A), exhibited increased numbers of Dct positive cells in which between 53.5-61.5 
melanoblasts/melanocytes were located on the yolk sac itself. In comparison with 36 cells in egfp 
injected hirame where the melanocyte pattern remained abnormal. This meant that the injection of 
yap genes translating into functional YAP protein could restore the number of Dct positive cells on 
the yolk sac to normal wild type levels. Inevitably, the incline in Dct cells on the yolk sac resulted 
automatically in a 22% rise in total cell quantities within the yap- injected group. The data implies 




Graph 4.1: Melanoblast quantification in body and on yolk sac in st.22 embryos after Dct ISH of 
egfp, egfpFLyap(wt) and egfpFLyap(S87A) injected 1-cell stage embryos 
Manual cell counts of Dct positive cells in stage 22 embryos after egfp, egfpFLyap(wt) and 
egfpFLyap(S87A) mRNA were carried out to evaluate the rescue achieved by YAP fusion protein. 
None of the overexpressed form of YAP had an effect on normal wild type melanoblast pattern in 
the body nor on the yolk sac in wild type siblings resulting in no difference in total Dct positive cell 
numbers. However, wild type and activated YAP´s did increase significantly the cell number of 
melanoblasts on the yolk sac of hirame embryos compared to negative control mRNA egfp, 
ultimately leading to an incline in total Dct positive cell numbers. This means that sufficient levels of 
YAP fusion protein in a transient ubiquitous fashion are able to rescue the hirame melanoblast 
defect when administered at one-cell stage. All data are means ± SEM. 2-Sample-t-test: *p<0.05, 




After demonstrating that the fusion of eGFP to YAP does not interfere with YAP’s functionality in 
vivo, we were ready to carry on and use this fusion of egfpFLyap(wt/S87A) for our non-cell 
autonomous and cell autonomous studies. Non-cell autonomy was tested by injecting the mRNA into 
the yolk sac, whereby the cell autonomy was assessed by expressing yap under the Dct melanocyte-
specific promoter.  
 
4.2.3 Analysis of YAP cell-autonomy within the yolk sac environment 
As mentioned earlier we hypothesised that a non-cell autonomous function of YAP within the 
syncytial layer could rescue the failure of melanocyte migration on the yolk sac of hirame embryos.  
Our idea was based on previous findings whilst carrying out melanoblast cell counts within 
consecutive resin sections presented in chapter 3 section 3.2.2.3, whilst observing those resin 
sections, we found numerous fragmented nuclei in the yolk sac membrane of st.21 hirame embryos 
not present in wild type siblings. In normal embryos, approximately two to three 15-40µm oval 
shaped nuclei are spread over a distance of 100µm within the yolk sac membrane (Figure 4.8 left 
panel). In hirame, while we observed a similar distribution, some of those were fragmented, spot-like 
neutral red stained nuclei (Figure 4.8 right panel).  
 
 
Figure 4.8: Fragmented nuclei within the yolk sac membrane of st.21 hirame embryos  
Neutral Red labels nuclei in resin sections carried out after Dct WISH at st.21 in wild type 
(n=19) and hirame (n=18). Top) represents a cross section of a WT embryo to give a broad 
overview of the tissue morphology and scale. Bottom) pictures represent nuclei of wild type 
(left panels) and hirame (right panels). Note, in hirame a subset of nuclei are fragmented 
(arrow head) compared to wild type siblings in which all nuclei are oval and stretched in shape. 




We were wondering if those anatomical features might contribute or may even be the cause for the 
melanoblast migration defect in hirame.  Our hypothesis was that injection of yap mRNA may rescue 
those dying membrane cells and re-establish a suitable environment required for successful cell 
migration. However, to that date we did not knew anything about the structure of the yolk sac 
membrane in Medaka. What we knew was, that the yolk sac membrane must consist of at least two 
different membranes: the inner yolk syncytial and the outer enveloping layer (EVL), thoroughly 
described during early gastrulation (Carvalho & Heisenberg 2010). Yet, images taken from those 
stained resin sections could not produce high enough magnifications to provide a conclusive answer 
about the layer in which those abnormal nuclei reside. Neither could it provide an answer about the 
state in which they are in; for instance, if they are apoptotic or necrotic as light microscopic 
appearance of nuclear structure staining may be seen in both (Corcoran et al. 1994). Therefore, we 
performed transmission electron microscopy of st. 21 wild type and hirame embryos to solve the yolk 
sac structure and identify abnormal cell structures in hirame.  
TEM images showed that first of all the Medaka yolk cell is surrounded by three membranous layers, 
possibly the inner yolk syncytial layer, a middle epidermal and an outer enveloping layer (EVL) in 
which individual cell nuclei are inherent (Appendix 10). In regard to hirame, residing nuclei appeared 
to be oval wave-like, an indication of nucleus condensation (pyknosis) (Figure 4.9B, arrows, n=7) 
compared to more smooth and stretched-like nuclei in wild type siblings (A, n=7).  Interestingly, we 
could indeed find three examples of fragmented nuclei (karyorrhexis) (Figure 4.9C, asterics) in hirame 
seemingly surrounded by apoptotic bodies in which organelles such as mitochondria remained. We 
could also see condensed chromatin in form of apoptotic nuclear inclusions (Figure 4.9D, arrows) 
found in late stage apoptotic cells within one cell residing within mesodermal tissue just beyond the 
somites. Despite these remarkable differences, there were similarities as well, for instance 
protruding tight junctions in the EVL as well as inclusions and lipid droplets within the yolk cytoplasm 





Figure 4.9: TEM of nuclei in wild type and hirame embryos 
Transmission electron microscopy (TEM) highlighting the differences in nuclear shape. A) wild 
type embryos represent oval stretched nuclei with a smooth surrounding membrane. B-D) 
Nuclei in hirame present a variety of shapes including those found wild type siblings. B) 
Condensation of chromatin leads to shrinkage of nuclei (pyknosis) indicated by wave-like 
membrane (arrows). C) Fragmentation (asterics) of nuclei into small apoptotic bodies in which 
cell organelles such as mitochondria remain (arrow heads). D) Densely compact chromatin 
shown as dark inclusions (arrows) within the actual nuclei of an apoptotic cell. Scale bar: A-C = 
2µm, D = 1µm 
 
These data would link to the method of injecting yap mRNA directly into the yolk sac. The idea 
behind it is, that injected yap mRNA would be taken up by the most inner membranous layer during 
the processes of yolk absorption whilst “feeding” the embryo with nutrition (Fujita et al. 2006). 
Through this uptake, it might rescue dying cells and influence melanoblast migration indirectly in a 
non-cell autonomous manner. To test our hypothesis, we needed to be sure that our injected mRNA 
solely localises to the yolk sac and is excluded from any other embryonic tissue. As described earlier, 
injections into Medaka differ from Zebrafish. To manipulate gene expression or establish transgenic 
lines in Zebrafish, microinjection of RNA, DNA, morpholino oligonucleotides or tracer dyes can be 
carried out by injecting solutions deep into the yolk cytoplasm of 1-8-cell embryos (Detrich et al. 
1998). The easier method of inserting the capillary into the yolk sac instead of into the cell directly is 
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possible because cytoplasmic streaming pushes components within 15 min completely from the yolk 
sac into the cell cytoplasm. The reason behind this is the fact that until the 8-cell stage, there is no 
physical barrier between the blastoderm and the yolk, thus solutions can be exchanged. The first 
membrane separating the developing blastomers completely from the yolk appears at 16-cell stage 
(Kimmel et al. 1995). However in Medaka, microinjection has to be carried out through the chorion 
directly into the cytoplasm of the 1-cell stage embryo rather than the yolk, as yolk cytoplasmic 
streaming has not been seen  in Medaka early embryogenesis (oral communication with Dr M. 
Furutani-Seiki, Kinoshita et al. 2009). Although the chorion hardens after fertilisation, injections 
performed up to 64-cell stage are possible with great care (Porazinski et al. 2010). However, 
injections between 1-2 cell stage is not as variable and more accurate, because the hard chorion at 
later stages is likely to break the needle which then alters the injection volume after each injection 
attempt.  
We first wanted to test if it was true that Medaka does not exhibit any cytoplasmic streaming within 
the yolk sac pushing substances towards the embryonic cells, as this could lead to an exchange with 
the one cell cytoplasm once we inject RNA into the yolk. To assess this, we injected rhodamine 
dextran either into the cell cytoplasm or into the yolk sac cytoplasm of one-cell stage embryos. 
Indeed, when rhodamine was injected purely into the yolk, we could not observe any exchange of 
dye at any stage during embryonic development (Figure 4.10, 2nd row) and rhodamine dextran 
retained well distributed within its specific destination up to 9 somite stage. When we injected the 
dye into the 1-cell, we noted a red glow around the yolk sac, which was not observed in the other 
experiment (Figure 0.8, 1st row).  Higher magnifications indicated that when rhodamine dextran was 
administered into the embryonic cell, the dye distributed throughout some of the yolk membrane 
layers (Figure 4.11) surrounding the entire yolk sac. It means the layer surrounding the yolk cell is 
directly connected to the blastoderm and acquires the same DNA or RNA after injections. Whereas in 






Figure 4.10: Visualisation of dye diffusion of injected one cell or yolk sac exclusively through 
rhodamine dextran dye  
One-cell cytoplasm or yolk sac were exclusively injected to test cytoplasmic yolk streaming in 
Medaka embryos. Up to 9 somite stage red fluorescence stays uniformly distributed within 
either the embryonic cells (upper row) or yolk sac exclusively (middle row) and did not fuse 
with each other. However, when injected into the embryo we could observe a fluorescence 





Figure 4.11: Rhodamine dextran does not diffuse in neighbouring body and cell compartments  
Higher magnification revealed that the most outer layer of the yolk sac was labelled with 
rhodamine dextran dye when injected directly into the one-cell embryo (arrow heads). This 
was not found in others.  Scale bar = 50µm 
 
Next, we attempted injection of yap mRNA into the yolk sac to finally test if it could rescue the 
hirame melanoblast patterning defect on the yolk by restoring an environment in which 
melanoblasts can migrate. For injections we utilised the capped mRNA of egfp, both fusions 
egfpFLyap (wt) and egfpFLyap (S87A) which we have previously synthesised in section 4.2.1 and 
tested successfully its functionality in section 4.2.2. A total of around 200-250pg was injected solely 
into the yolk sac of 90 one cell stage Cabj50-20C embryos. 32 embryos were injected with the negative 
control RNA egfp, 27 embryos were injected with the egfpFLyap(wt) fusion gene and 31 embryos 
were injected with the activated version of yap in form of egfpFLyap(S87A) RNA. Those embryos 
were then raised to stage 22 (9 somites, 1d14hpf) and fixed in 4% paraformaldehyde. Subsequently, 
fixed embryos were hybridised with the dopachrome-tautomerase (Dct) anti-sense probe to visualise 
melanoblasts and early differentiated melanocytes in the body and on the yolk sac. Numbers of 
labelled cells in individuals were then counted, recorded and imaged. 
When we examined those embryos, we could not see any phenotypic difference between wild type 
embryos injected either with the wild type or activated version of yap compared to the negative 
control egfp only (Figure 4.12 upper row). There was no noticeable decrease or increase neither in 
cell number nor in the distance of migration towards the ventral pole. When observing hirame 
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embryos we came to the same conclusion as we could not identify any obvious difference of yap 
injected embryos compared to the negative control (Figure 4.12 lower row). All embryos developed 
in a hirame-like fashion with abnormal body morphology. Melanoblasts did not populate the yolk sac 
in normal numbers and remained close to the body comparable to the negative control injected with 
egfp only. In summary, there was no effect on the melanoblast migration on the yolk sac and the 
hirame phenotype was not rescued when we injected yap mRNA exclusively into the yolk sac.  
 
 
Figure 4.12: egfp, egfpFLyap(wt) and egfpFLyap(S87A) mRNA injection into the yolk sac does not 
rescue hirame and/or increase the melanocyte population in wild type embryos   
Dct ISH was carried out on st. 22 embryos after injection of egfp, egfpFLyap(wt) and 
egfpFLyap(S87A) mRNA directly into the yolk sac of one cell stage embryos. This visualised the 
melanoblast pattern within the body and on yolk the sac of hirame mutants and wild type 
sibling. Wild type siblings injected with egfpFLyap(wt) (n=22) and egfpFLyap(S87A) (n=27) 
mimicked the normal melanoblast pattern as siblings injected with negative control mRNA 
egfp (n=28). The same takes effect in hirame embryos when injected with either egfpFLyap(wt) 
(n=5) or egfpFLyap(S87A) (n=4) as they remained the melanoblast patterning defect 
comparable to the negative control section of egfp (n=4) injectants. Scale = 500µm 
 
Manual cell counts of Dct positive melanoblasts were carried to quantify cell numbers within the 
body and on the yolk sac of each mRNA group (Graph 4.2.). Graph 4.2 represents cell counts in which 
the three left groupings represent wild type genotypes in the body, on the yolk sac and total 
numbers, whereas the three right units signify hirame in those same classes. Each section comprises 
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RNA injections with egfp, egfpFLyap(wt) and egfpFLyap(S87A) and are evaluated in regards to 
melanocyte numbers respectively. While we could not detect any obvious phenotypical difference in 
melanoblast distribution in wild type embryos injected with yap fusion RNA, there was a statistical 
significant decrease in melanoblast numbers on the yolk sac of embryos injected with 
egfpFLyap(S87A) compared to the egfp negative control injection (p<0.001, 2T-test). Similar 
phenotypical and statistical results were obtained for hirame embryos. Again, we could not observe 
any phenotypical rescue (as described above), but Dct+ cell quantifications revealed significant 
changes. Melanocyte numbers on the yolk sac of egfpFL yap(wt) injected embryos were significantly 
lower compared to the negative control egfp only. This change caused a significant decrease of total 
melanoblasts for egfpFLyap(wt) embryos as well (p<0.05). Unexpected, rather than increasing the 
cell number, yap injection into the yolk sac decreased the melanocyte number statistically in both, 
wild type and hirame. A possible explanation for the mathematical significance could be caused by 
low sample repetitions as no hirame mutants seemed visually rescued.  
Either those changes are not visible by eye or it is an artefact of low embryo numbers in each 
category. The latter possibility is perhaps more likely, because phenotypically none of the hirame 
embryos seemed to be rescued.   
This could mean that at least in this particular experiment YAP is not able to act non-cell 
autonomously to influence upper layers or maybe the assembly of extracellular matrix through the 





Graph 4.2: Melanoblast quantification in body and on yolk sac in st.22 embryos after dct ISH of egfp, 
egfpFLyap(wt) and egfpFLyap(S87A) injected directly into the yolk sac of embryos 
Manual cell counts of Dct positive cells in stage 22 embryos after egfp, egfpFLyap(wt) and 
egfpFLyap(S87A) mRNA were carried out to assess Dct+ cell quantifications. Overall, yap 
overexpression in either form, wt or S87A did not increase melanoblast cell numbers nor their 
migration in wild type or hirame embryos. Despite the fact that no visual difference in each 
group was observed, a significant decline in melanoblast numbers was obtained on the yolk 
sac of wild type embryos injected with egfpFLS87A and on the yolk sac of hirame embryos 
injected with egfpFLyap(wt). The latter resulted in decreased total numbers as well. All data 
are means ± SEM. 2-Sample-t-test: *p<0.05, **p<0.01 or ***p<0.001 .     
 
 
After we have demonstrated that our fusion protein is functional in vivo and rescues the hirame 
phenotype, we wanted to test if it also retained eGFP fluorescence properties, which we intended to 
do with a promoter yielding widespread tissue expression.  
 
 
4.2.4 Making the positive control vector CMV:eGFP-YAP(wt/S87A) 
To validate the functionality and capability of our fusion protein egfpFLyap(wt/S87A), I now wanted 
to evaluate whether the fused eGFP is able to emit a fluorescent signal in vivo. To proof that, I 
created a CMV:eGFP-YAP(wt/S87A) construct, in which the human cytomegalovirus (CMV) 
immediate early enhancer and promoter can drive its target gene expression. The human 
cytomegalovirus (CMV) is a member of the herpesvirus superfamily and causes different diseases 
including encephalitis, gastrointestinal diseases, pneumonitis, hepatitis, and retinitis (Mella-Alvarado 
et al. 2013). The immediate early gene of the human cytomegalovirus is essential to the viral 
replication in its host. This constitutively active promoter is commonly used for transient expression 
of transgenes by in vitro and in vivo research in mouse, stem cell, Zebrafish and Medaka fish, but less 
common for stable transgenesis approaches (Barrow et al. 2006; Hasegawa et al. 2009; Iwai et al. 
2009; Langenau et al. 2005). However, in an attempt to validate the spatial and temporal activity of 
the cytomegalovirus in Zebrafish transgenesis Mella-Alvardo et al. discovered in 2013 that the 
CMV:eGFP construct was expressed in a tissue-restricted manner. These expression sites 
corresponded to targeted sites resulting from CMV infections usually found in humans such as the 
spinal cord, olfactory organs, central nervous system, retina, skeletal muscles and hepatocytes 
(Mella-Alvarado et al. 2013). The strength and nearly ubiquitous expression profile gave us enough 
confidence to use the CMV promoter as a widespread transcriptional driving element. The 




The construction of the CMV:eGFP-YAP(wt/S87A) vectors was achieved by a two-step cloning 
process. Again, a summary of the whole cloning process outlined in this chapter is presented in 
Figure 4.5. Firstly, the fusion sequence either of clone 2 pCS2_egfpFLyap(wt) or clone 16 
pCS2_egfpFLyap(S87A) described in Chapter 4.2.1 (Figure 4.4) was extracted in a double digest with 
SpeI and SnaBI restriction endonucleases. At the same time a pEGFP-C3 (Figure 2.4) plasmid was 
double-digested with NheI and SmaI to obtain the backbone including the CMV promoter sequence 
upstream of the cut. This resulted in a loading pattern (Figure 4.13 A), where digested pCS2 
constructs end up with 4049bp backbones and 2139bp egfpFLyap inserts and the pEGFP-C3 plasmid 
with a desired 3936bp backbone containing the CMV promoter and an excised 791bp egfp sequence. 
After DNA extraction, the appropriate fragments were ligated together, whereby the backbone 
underwent dephosporylation to prevent self-ligation. However, this step can be ignored in this case 
because each double digest produces non-compatible ends, which cannot be ligated to each other. 
The straightforward ligation was possible, because NheI and SpeI restriction endonucleases produce 
compatible cohesive ends for each other that can be ligated together. SmaI and SnaBI restriction 
enzymes both cut blunt end and can therefore be bound to each other. The ligation product was 
transformed into E.coli DH5α, plated out onto an antibiotic resistant medium and individual colonies 
were tested the correct plasmid and insert orientation. All colonies picked and tested with a double 
digest of SnaBI and EcoRI were found to be positive and inserts were rightly placed without forming 
concatamers. Therefore one of each CMV:eGFP-YAP(wt) and CMV:eGFP-YAP(S87A) was amplified 





Figure 4.13: Plasmid backbone and DNA inserts on agarose gel (left) and complete map of CMV:eGFP-
YAP(wt/S87A) construct 
A) Agarose gel showing DNA digests of pEGFP-C3 (third lane), pCS2_egfpFLyap(wt) (fourth 
lane) and pCS2_egfpFLyap(S87A) (fifth lane), an intermediate step of the cloning process. 
Digestion reaction produces the 4049bp backbone containing the CMV promoter and the 
2139bp egfpFLyap DNA fusion inserts for subsequent ligation step.  
B)  Representative complete map of CMV:eGFP-YAP(wt/S87A) showing the CMV promoter 
(brown) driving EGFP (green), flexible linker (pink) and YAP together as fusion protein. Other 
regulatory elements of the plasmid are the simian virus SV40 polyA signal (blue) for 
termination of transcription, F1 bacteriophage origin (grey) for DNA replication of viral strand 
synthesis and termination allowing synthesis of single-stranded DNA and ColE1 origin (grey) for 
double-stranded bacteria vector replication. SV40 early promoter driving expression of 




To test the construct, I injected both plasmids as 15ng/µl working solution in a volume of 1-2nl 
estimated to contain 15-30pg total DNA. Out of 39 embryos injected with CMV:eGFP-YAP(wt) 18 
individuals survived and could be examined. In those chimeras eGFP was expressed in various cell 
types such as retinal and muscle but mainly in epithelial cells (data not shown). The intracellular 
fluorescent molecules could be seen within the nucleus and cytoplasm, whereas the nuclear signal 
was slightly stronger than the surrounding cytoplasm in epithelial cells on the body or yolk sac. When 
injecting the CMV:eGFP-YAP(S87A) construct, out of 38 embryos 22 survived and the transgene 
expression pattern could be analysed. The majority of cells identified expressing eGFP were again 
body and yolk sac epithelial cells (data not shown). This time the nucleus exhibited a much stronger 
nuclear signal than the cytoplasm, which was only faintly detectable by visual observation under the 
microscope. I also detected a high number of circled shaped GFP conclusions and aggregates in 
unknown cell types within the body. Those aggregates disappeared one by one after 3 dpf leaving no 
visual trace of enhanced green fluorescent protein behind. From this injection experiment we 
concluded that the egfpFLyap(wt/S87A) sequence fusion is capable of folding into a secondary 
protein structure able to emit green fluorescence and could therefore be used for subsequent 
studies . Table 4.4 summarises this short study. 
 
Table 4.4: Summary of CMV:eGFP-YAP(wt/S87A) plasmid injection into one-cell stage embryos to 
verify the eGFP signal of YAP fusion protein in vivo to confirm its functionality 
Injected construct Embryo survival/injected 
ratio 
Fluorescence pattern observed 
CMV:eGFP-YAP(wt) 18/39 Medium nuclear + weak cytoplasmic 
fluorescence mainly in small epithelial cells on 
body + large epithelial cell on yolk sac; other 
cell types include retinal optic cup epithelial 
and internal muscle cells  
CMV:eGFP-YAP(S87A) 22/38 Strong nuclear + very weak cytoplasmic 
fluorescence only in epithelial cell on body and 
yolk sac observed; mainly GFP aggregates 
detected seemingly in and on the body which 





4.2.5 Designing the overexpression construct Dct:eGFP-YAP(wt/S87A) 
Our final goal of this chapter was to overexpress both wild type and mutated activated versions of 
yap in melanocytes. This should yield insights into the cell specific autonomous role of YAP within the 
melanocyte lineage by showing whether yap can rescue melanocyte migration in a cell-autonomous 
fashion in hirame embryos. To establish this construct, I again decided to use a classic subcloning 
strategy. All steps are depicted within the summary Figure 4.5, in which the egfp and yap(wt or S87A) 
sequence including the flexible linker sequence connecting both genes were inserted together into 
the Dct:eGFP-1 destination vector created in chapter 3. 
In detail, I tried to avoid PCR amplification of the egfpFLyap(wt/S87A) fusion gene in pCS2 from 
chapter 4.2.1 as I was sure that this sequence is exactly as required. Therefore, I aimed for a cloning 
strategy using restriction endonucleases. In general, PCR-based cloning carries a much higher risk for 
mutation than restriction enzyme based cloning. DNA replication by PCR has error rates that range 
from roughly 1 per 500bp to 1 per 10 million base pair depending on the polymerase used. Because 
of this, no matter which taq polymerase you use, it is important that you sequence the final product 
(Addgene 2014), which is more time consuming.  
I carried out a two-step cloning process in which I digested out the egfp gene with SpeI and BsrGI 
from Clone 2 pCS2_egfpFLyap(wt) and clone 16 pCS2_egfpFL(S87A) (section 4.2.1). In parallel I 
isolated the FLyap(wt/S87A) sequence from both CMV:eGFP-YAP (section 4.2.4) constructs with the 
restriction enzymes BsrGI and MfeI. The destination vector Dct:eGFP was cut with SpeI and MfeI, 
extracting the egfp sequence and opening up the vector downstream of the Medaka dopachrome 
tautomerase vector (Dct). In this way, egfp-BsrGI can be re-ligated to BsrGI-FL-yap(wt/S87A) and SpeI 
upstream of egfp-BsrGI can get re-ligated to SpeI within the destination vector. Also, MfeI 
downstream of BsrGI-FL-yap(wt/S87A) can be ligated to the compatible ends of the MfeI digest in the 
open Dct promoter backbone. This digest had to be done in this way, because the destination vector 
Dct:eGFP itself contained two BsrGI restriction enzymes sites, one in egfp and the other one within 
the promoter sequence itself, which meant a straightforward insertion of the FLyap(wt/S87A) 
sequence of either plasmid was not possible. Because the backbone was cut with two different 
restriction endonucleases producing non-compatible cohesive ends, it did not need further alkaline 
phosphatase treatment to prevent self-ligation. Following the digestion reaction, all desired 
fragments were extracted from the gel and purified. Therefore the ligation reaction contained one 
backbone Dct-SpeI-MfeI and two inserts, SpeI-egfp-BsrGI and BsrGI-FL-yap(wt/S87A)-MfeI.  
10 colonies of each version of yap were screened with a triple restriction digestion of ClaI, SpeI and 
MfeI to identify the correct insert orientation and reveal any double insertions. Briefly, if both inserts 
were ligated once and in the correct orientation we would see a 6860bp, 1479bp and 779bp band. If 
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only egfp was inserted the SpeI enzyme would linearise the fragment leaving a 7639bp band. If Fl-yap 
was only inserted we would obtain a 6917bp and 1479bp band. Contamination in our backbone with 
undigested Dct:eGFP-1 plasmid it would result in a 6874bp and 913bp double band when screening 
such colonies. I screened 10 colonies from each ligation containing either the wild type or activated 
form of yap. In both cases I got 5 positive colonies containing both inserts in the correct orientation 
evaluated from its digestion pattern. The remaining 10 colonies were proven to be the original 
undigested Dct:eGFP-1 backbone with its specific two 6874bp and 913bp bands, indistinguishable 
from the backbone control, which was linearised only. I decided to purify Clone 3 of Dct:eGFP-
YAP(wt) and Clone 5 of Dct:eGFP-YAP(S87A) and use those two constructs for further studies. The 
map of Dct:eGFP-YAP(wt/S87A) is shown in Figure 4.14. 
 
 
Figure 4.14: Representative map of Medaka Dct:eGFP-YAP(wt/S87A) 
Dct:eGFP-YAP(wt/S87A) plasmid featuring the fusion protein of Medaka YAP wild type and the 
activated version S87A) with fluorescence reporter EGFP under the control of the Medaka 
melanocyte lineage specific dopachrome tautomerase promoter. Other regulatory elements of 
the plasmid are the simian virus SV40 polyA signal (blue) for termination of transcription, F1 
bacteriophage origin (grey) for DNA replication of viral strand synthesis and termination 
allowing synthesis of single-stranded DNA and ColE1 origin (grey) for double-stranded bacteria 
vector replication. SV40 early promoter driving expression of selectable marker kanamycin 
resistance gene in E.coli.   
 
With the final plasmid, we decided to establish transgenic lines in which cell-autonomy of wild type 




4.2.6 Establishing and screening Dct:eGFPwt and Dct:egfpS87A Medaka 
transgenic lines 
We attempted to establish transgenic lines overexpressing the wild type form of Medaka yap and an 
activated version. Again, the mutated form of yap leads to an serine-to-alanine amino acid exchange 
hindering cytoplasmic YAP protein phosphorylation by Lats1 and degradation though 14-3-3 proteins; 
therefore increasing nuclear co-transcriptional activity of Hippo pathway downstream target genes. 
In chapter 3 we have shown that the Medaka dopachrome tautomerase (Dct) promoter drives 
reporter genes such as eGFP exclusively in the melanocyte neural crest lineage without any ectopic 
expression in any other cell type. Furthermore, in chapter 4 section 4.2.2 we have shown that the 
fusion proteins of egfpFLyap(wt) and egfpFLyap(S87A) translate into functional proteins capable of 
rescuing the hirame mutant melanocyte phenotype by stage 22 (1d 14h). On account of those two 
substantial experimental findings, we were confident in using the created Dct:eGFP-YAP(wt) and 
Dct:eGFP-YAP(S87A) transgene constructs (section 4.2.6) to establish our transgenic lines.  
The plasmid backbone was first linearised with BglI to increase the chance of sequence integration 
into the genome as we did before for the Tg(Dct:eGFP) lines. This was done because, if not linearised 
at a specific point away from our fusion gene and promoter region, endogenous DNA nucleases may 
cleave within the region of our transgene. The cleaned construct was then injected as 15ng/µl 
working solution (total amount of 15-30pg DNA) into the cytoplasm of one-cell stage embryos 
obtained by crossing Cab heterozygous carrier for the hirame allele. All results are tabulated in Table 
4.5 below. In total 1641 embryos were injected for Dct:eGFP-YAP(wt) from which 441 embryos 
survived the first 48hpf. This high death rate of 73% is comparable with the 71% death rate when 
establishing the Dct:eGFP transgenic lines. Surviving embryos showed no clear melanocyte eGFP 
pattern comparable to Dct:eGFP transgenic lines, but some did show green aggregates on and within 
the body (data not shown) comparable to the CMV:eGFP-YAP(S87A) transient expressions (section 
4.2.4) which seem to disappear after 2 dpf and/or prolonged excitation. As the origin of this signal is 
not clear, I selected 99 embryos out of 441 survivals expressing any eGFP signals and grew them up 
as chimeras out of which 98 larvae were transferred into the facility system. 75 chimeric fertile adults 
were screened after 4-5months from which only 1 founder visibly expressed enhanced green 
fluorescent protein within the melanocyte lineage. Two months after the initial fluorescence 
screening the same pool of F0 chimeras was taken and 47 adults were screened for offspring 
harbouring the Dct:eGFP-YAP(wt) transgene by targeted polymerase chain reaction (PCR). This 
genotyping approach revealed another 6 founders transmitting the transgene to their F1 progeny. 
However, the actual eGFP signal was not visually detectable by microscopy.  
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On the other hand when establishing the Dct:eGFP-YAP(S87A) line, I injected 1791 embryos of which 
293 survived resembling a slightly higher death rate than previously at 83.6%. The minority of 
surviving embryos seem to express or accumulate eGFP in the same aggregate-like fashion as 
described in CMV:egfpFLyap(S87A) transient expression. Here however it lasted for less than 2 dpf 
before disappearing. Because of this peculiar expression profile, I decided to grow up all surviving 
embryos, from which 97 survived. I decided to immediately genotype the pools of progeny of F0 
adults and managed to do so in 77 adults. At the end 3 founders were positive for the Dct:eGFP-
YAP(S87A) transgene, but did not show any sign of eGFP within the melanocyte lineage. However, I 
did observe a small amount of tiny GFP aggregates appearing only around 1d 7h up to 1d 14h in a 
fraction of offspring in one founder (data not shown). This was however difficult to visualise and 
evaluate further, because the signal seemed to photobleach rapidly.  
All offspring of founders with the Dct:eGFP-YAP(wt) and Dct:eGFP-YAP(S87A) were grown up to F1 
generation. F1 adults must be genotyped again, backcrossed into heterozygous Cab hirame allele 
carriers and offspring grown up. The pool of genotyped F2 adults will need to be analysed in future 
for any yap cell-autonomy within the melanocyte lineage and evaluated for rescue and restoration of 
hirame melanoblast and melanocyte patterning.      
 
Table 4.5: Summary of the F0 Medaka fish Dct:eGFP-YAP(wt/S87A) generation from microinjection 
until the finding of founders carrying the transgene 




Chimeras of Dct:egfp-yap(S87A) 
Injected embryos 1641 1791 
Survival after 2dpi 441 293 
Grown up to 8 dpf  99 (eGFP selected) 293 (all taken) 
Survived 1st months  98 97 
eGFP screened founder: 
founders/total screened 
1/75  - 
PCR screened founders: 







4.3.1 Testing fusion protein functionality via hirame MC pattern 
rescue after mRNA injection into one cell stage 
In section 4.2.1 we designed a fusion protein of Medaka yap and an egfp reporter gene, which we 
intended to test and validate by mRNA injections into hirame 1-cell-stage embryos.  
It is essential for any kind of fusion to maintain the open reading frame, which was achieved by 
deleting the stop codon from egfp and adding additional nucleotides to keep both genes in-frame. 
The connection of those two genes was done by designing a fragment of egfp via PCR amplification 
which included 5’ and 3’ endonuclease recognition sites plus an glycine-serine linker (GGGGS)n 
sequence on its 3’ end.   Subsequently this fragment could be ligated onto the pCS2_yap(wt/S87A) 
backbone without interfering with the reading frame. We managed to obtain high quality capped 
mRNA from both constructs, clone 2 pCS2_egfpFLyap(wt) and clone 16 pCS2_egfpFL(S87A), which 
was in the range of 1.985-2.053 for A260/280 and 2.216-2.261 for A250/230. This indicated that our mRNA 
was of very high standard and purity as values around 2.0 for A260/280 and 2.0-2.2 for A260/230 are 
normally classified as “pure” RNA samples. Lower ratios can be due to contaminations in our case 
such as protein, phenol, EDTA or even change of pH (Nano Drop Technologies website 2007). Once 
high-purity mRNA was obtained, I injected around 200pg into the cytoplasm of 1-cell-stage embryos 
of heterozygous Cabj50-20C. 
As described in the previous chapter 3 section 3.2.2 hirame develops a specific melanoblast pattern, 
in which, as early as stage 20 (4 somites, 1d7h30min), some individual melanoblasts are not able to 
move away from the lateral body axis and onto the yolk sac. Because the Dct pattern is a reliable 
criterion for distinguishing hirame from wild type embryos throughout embryonic development, I 
decided to evaluate the functionality and effect of the fusion protein by analysing Dct after in situ 
hybridisation. The analysis of transient mRNA injections itself was aimed at early stages up to 1.5 dpf, 
as this is a time window where mRNA seem to be stable (Wittbrodt et al. 2002). Embryos identified 
genetically as hirame mutants injected with either egfpFLyap(wt) or egfpFLyap(S87A) fusion 
constructs, all seemed phenotypically like wild type embryos at stage 22, revealing a normal 
melanocyte pattern (Figure 4.7) compared to the negative control egfp RNA individuals.  
Dct cell quantifications confirmed that melonoblasts in hirame mutants were indeed able to migrate 
away from the body axis onto the yolk sac area in similar quantities to its wild type siblings; 
supporting the notion that ubiquitous restoration of functional YAP protein to wild-type levels 
rescues the hirame phenotype. This confirmed that our designed fusion construct yields in functional 




4.3.2 Analysis of YAP´s non-cell autonomous function within the 
hirame yolk sac layer on melanocyte migration 
Our overall goal was to test the existence of a non-cell autonomous role for YAP to influence the 
migration of the yolk sac residing melanoblast population by injecting functional mRNA of egfp, 
egfpFLyap(wt) or egfpFLyap(S87A) directly into the yolk sac. 
 
4.3.2.1 Characterisation of yolk sac membrane nuclei 
Our approach of direct yolk sac injection was supported by previous observations we made in neutral 
red stained resin sections of wild type and hirame embryos. In hirame embryos, a set of mainly yolk 
membrane cells exhibited fragmented nuclei next to microscopically normal oval shaped nuclei 
(Figure 4.8). Such interesting finding led us wonder if those dying cells, either necrotic or apoptotic, 
may be one of the contributing factors to the melanocyte migration defect on the yolk sac. Our 
hypothesis was that those dying membrane cells could not contribute to environmental stability 
required for successful melanoblast movement. However, at that time we had very little 
understanding of Medaka yolk sac anatomy at stage 21 during embryogenesis. Numerous studies 
have described developmental processes occurring earlier during gastrulation. Scientists have 
documented in great detail on how the blastoderm engulfs the yolk sac during epiboly and how the 
hypoblast involutes and extends underneath the epiblast to set up the basic plan for the developing 
embryo (described in Introduction chapter 1 section 1.2). However, to our knowledge there are no 
existing studies describing which layers remain after gastrulation and neurulation. There must be at 
least two layers, the yolk syncytial and the enveloping layer. We wanted to solve the anatomical 
structure of the yolk sac and characterise those fragmented nuclei in hirame. To do so, we performed 
transmission electron microscopy in st. 21 wild type and hirame embryos. Our results conclude that 
the Medaka yolk sac consists of three layers:  the most inner yolk syncytial, the middle epidermal and 
the outermost enveloping layer. We observed nuclei in all three layers. One of the questions we 
wanted to answer was if those fragmented nuclei in hirame are necrotic or apoptotic cells. Apoptosis 
is the programmed active cell death, a fundamental physiological process during development as it 
tightly regulates the number of cells within the whole organism. This controlled internal death is 
mediated by an intracellular proteolytic signalling where enzymes such as caspases are involved 
(Alberts et al. 2002). In marked contrast, necrosis is an uncontrolled cell death in which dying cells 
swell and burst for instance after viral infections (Pierce 2012). During that process, they spill their 
contents over neighbouring cells potentially triggering a local inflammatory response characterised 
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by, for instance, histamine producing white blood cells causing redness and pain (Alberts et al. 2002). 
Both processes apoptosis and necrosis are characteristically different. However, the initiation of each 
can have overlapping origin. Indeed, numerous in vitro culture studies have shown that a variety of 
events, which cause necrosis, can also lead to apoptosis. For example, severe insults to cells with 
injurious agents lead to necrosis whereas milder drug administration caused apoptosis (Lennon et al. 
1991). This opens up the possibility that we could potentially observe necrotic and apoptotic cells in 
hirame embryos. Our TEM data revealed that in hirame, a large number of nuclei were irregular 
shaped indicating cell shrinkage compared to smooth-like oval nuclei in wild type siblings. Cell 
shrinkage is accompanied by chromatin condensation (pyknosis) which alters the form of the 
nucleus. In addition, we were able to find characteristic black inclusions within the nuclei in the form 
of dense chromatin. This particular example was found within the mesodermal tissue leading 
towards the yolk sac membrane just beyond the somite structures. More frequently, we would 
observe nuclear remnants retained in apoptotic bodies of varying size. These apoptotic bodies 
retained cell organelles such as mitochondria and were separated as small entities from each other. 
It presents a case for apoptosis in which the cell undergoes controlled disassembling into multiple 
pieces, each retaining cell organelles to control its further degradation (Corcoran et al. 1994). 
However, we could not determine in which layer those fragmented nuclei are located, because of our 
small sample size. Taken together, we conclude that those fragmented nuclei found in the yolk sac 
membrane would be either epithelial or yolk syncytial layer cells that had undergone programmed 
cell death.   
Those findings strengthened our experimental approach of injecting yap mRNA directly into the yolk 
sac to test if it could rescue apoptosis and therefore re-installing melanoblast migration within those 
layers.   
 
4.3.2.2  Yolk sac injection to test non-cell autonomous rescue of hirame melanoblast 
migration defect 
To test a non-cell autonomous function for YAP within the yolk membrane, we needed to verify that 
cytoplasmic streaming as seen in Zebrafish does not occur in Medaka embryos (Detrich et al. 1998). 
Our additional tests confirmed that during Medaka embryogenesis yolk cytoplasmic streaming 
towards the blastoderm does not occur. It seems that a physical boundary appears between the 
embryonic cell and the yolk sac as soon as the egg is fertilised. This membranous separation 
separates injected solutions into the yolk sac from the embryo (Figure 4.11). With this knowledge in 
mind, we carried out injection of synthesised capped mRNA from egfpFLyap(wt), egfpFLyap(S87A) 
and a negative control egfp into the yolk sac and performed Dct in situ hybridisation on those st. 22 
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embryos. Surprisingly, injection of yap mRNA into the yolk sac did not alter the melanoblast pattern 
phenotypically in the wild type nor hirame embryos. However manual cell counts revealed 
statistically significant differences in terms of a decrease in melanoblast numbers on the yolk sac of 
embryos injected with egfpFLyap(S87A) compared to wild type siblings (p<0.001, 2T-test). It also 
revealed a profound decrease of melanocyte numbers on the yolk sac of egfpFL yap(wt) injected 
embryos and consequently a decline in total numbers in egfpFLyap(wt) embryos compared to the 
negative control egfp only. Although those quantifications revealed a significant difference in those 
categories, they are likely to be caused by deviations originating from variations of small sample 
sizes.  Taken together, there was no biologically striking difference and phenotypical rescue of yolk 
sac melanoblast migration in hirame embryos, which could indicate that YAP does not exhibit any 
function within the yolk syncytial layer and therefore does not act non-cell autonomously towards 
melanoblast migration. However, our experimental approach has a major caveat. We are not certain 
if the injected mRNA was able to enter the yolk syncytial or other yolk sac layers in the first place 
which would be a fundamental requirement for translational processes and YAP functionality. One 
way would be to perform in situ hybridisation for egfp and microscopically dissect the pattern. 
However, the yolk sac cell layers are too small to distinguish. Therefore, another approach would be 
to test the mRNA integrity by quantitative real-time PCR. What we might be able to do is separating 
pieces of yolk sac at around stage 22 and isolate mRNA. We could then quantify and test for common 
YAP protein downstream target genes such as itgb2 or cyclinD (Zhao et al. 2007; Hao et al. 2008), 
which would indicate activity of YAP within the yolk sac membrane.    
 
Our results obtained in this experimental section could also explain the rescue of cell migration after 
mRNA injection into the cytoplasm one-cell embryos . As demonstrated with rhodamine dextran 
injected RNA, DNA or dye into the cytoplasm of the one cell embryo did not mix with the yolk sac, 
but distributed within the membranous layers surrounding the yolk sac. This could mean, that the 
rescue of yolk sac melanocyte migration might have occurred through rescuing the yolk epidermal 
layer configuration, as functional YAP protein was abundant throughout the whole body including 
the yolk sac epidermis. Specifically, YAP might have re-installed an extracellular environment suitable 
and required for successful cell movement. For instance, components such as laminins, fibronectin, 
collagen I and collagen IV, proteoglycans, vitronectins and hyalurons have all been shown to play 
important roles during neural crest migration (Duband & Thiery 1987; Sternberg & Kimber 1986; 
Trainor 2013)(detailed descriptions in introduction section 1.6.3). Supporting data comes from 
Porazinski`s thesis, in which he described that already as early as st.18 (26 hpf) fibronectin assembly 
was perturbed in hirame embryos. It seemed hirame formed either longer fibronectin fibrils or a 
shorter punctuated fibronectin pattern on the basal surface of the epithelia and mesenchyme 
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compared to the much finer fibrilious mesh found in wild type siblings (Porazinski 2013). Strikingly, 
when he performed knockdown experiments of 70kDa fibronectin, he could mimic the cuvier´s duct 
migration defect he observed in late stage hirame embryos, strongly suggesting that a defect in 
extracellular fibronectin polymerisation compromises directed cell migration through a non-cell 
autonomous role of YAP.  
Taking his data into account, the rescue we have achieved might imply that extracellular matrix 
components such as fibronectin have been restored and guidance of neural crest cells re-installed. To 
test this possibility, we could perform whole-mount immunohistochemistry with an anti-fibronectin 
antibody to assess its polymerisation status before and after the hirame rescue. To widen our 
analysis, we could include other ECM components such as laminins, collagens and vitronectins to 
assess their functional status in our mutants. Knocking down individual ECM components via oligo-
morpholino injection would if it could mimic the melanoblast migration defect on the yolk sac and 
confirm YAP’s non-cell autonomous role.   
 
4.3.3 Undetectable eGFP expression in newly established Dct:eGFP-
YAP(wt/S87A) transgenic lines 
4.3.3.1 Non-detectable eGFP levels as a result of intracellular toxicity levels 
To evaluate YAP´s cell autonomy within the melanocyte lineage we attempted transgenesis with our 
designed constructs Dct:eGFP-YAP(wt/S87A) overexpressing either the wild type version or the 
activated form of Medaka yap under the Medaka dopachrome tautomerase (Dct) promoter. We 
expected a melanocyte specific expression pattern of the fusion protein with no ectopic cell 
expression elsewhere, as this was achieved in 6 out of 8 transgenic Dct:eGFP lines. In addition, we 
predicted a nuclear/cytoplasmic eGFP distribution similar to the results obtained from the 
CMV:eGFP-YAP transient expressions. As a reminder, wild type yap fusion resulted in weak 
cytoplasmic and moderate nuclear eGFP accumulation and the yap S87A version exhibited very weak 
cytoplasmic retention plus very strong nuclear presence. In addition, we expected a transgenesis 
frequency of around 23% similar to the obtained Dct:egfp transgenic line. With some difficulties I 
managed to obtain 7 founders within the Dct:eGFP-YAP(wt) population, in which one expressed eGFP 
strongly within the melanocyte lineage of some offspring, while 6 others were positively identified by 
PCR genotyping, yet fluorescence was not detectable in any offspring after 2 dpf. The second line 
produced using linear DNA injections of a Dct:eGFP-YAP(S87A) construct gave rise to 3 chimeric 
founders, only identifiable through genomic PCR genotyping approaches. Again, no fluorescent 
molecules could be detected after 2 dpf in any of the offspring descended from those parents. All 
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progeny of the founders identified were therefore grown up as F1 generation and will need in depth 
analysis once an F2 generation has been established from these. 
Only in one Dct:eGFP-YAP(S87A) founder’s progeny I could see weak but distinct tiny green 
fluorescent GFp aggregates between stage 20 and 22 (1d 7h to 1d 14h). It seemed that those 
fragments were sensitive to photobleaching and were undetectable after that period, making it 
difficult to image (mention in results section). The areas where conclusions of intracellular eGFP 
molecules occurred was only seen once before in the case of transient CMV:eGFP-YAP(S87A) DNA 
injection (section 4.2.4). One possibility is that this could have been a result of toxicity caused by high 
transgene levels. The strong human cytomegalovirus (CMV) promoter regulatory region drives 
constitutive protein expression levels as high as 1 mg/L in COS cells. For less potent cell lines, protein 
levels are typically ~0.1 mg/L (Sigma-Aldrich website 2014). Most basal promoters have fairly 
consistent strengths across different cell types, but the CMV promoter can vary considerably from 
cell type to cell type (Qin et al. 2010). Furthermore, the dopachrome tautomerase (Dct) promoter 
used in to transcribe yap fusion proteins is also thought to be a strong promoter in driving high levels 
of Dct expression in melanocytes (Kelsh unpubl. data). Therefore, strong promoter activity might 
explain the ectopic GFP aggregates due to toxic levels of yapS87A, which seem to either result in 
protein missfolding and subsequent damage of individual cells.  
Overall, we could not clearly identify which cell type transiently emitted eGFP signals, but we 
expected from the start, that our transgene would be expressed within the melanocyte lineage. 
Therefore, one possibility could be that committed melanoblasts might have been affected and 
underwent apoptosis once they have acquired a toxic level of transgene. However, this would mean 
that embryos would lack melanocytes either completely or to a high percentage before hatching 
stage. A comparable phenotypical example might be the kitb5 Zebrafish mutant, in which the majority 
of melanoblasts fail to leave primary sites and undergo apoptosis (Parichy et al. 1999) resulting in a 
dramatic loss of melanocytes throughout the body. A more dramatic example is provided by the 
sox10-/- (colourless) Zebrafish mutant lacking melanocyte differentiation, migration and survival 
(Kelsh & Eisen 2000; Elworthy 2003). However, in our case, I could not observe a lack of melanocytes 
nor melanogenesis when growing up those individual embryos exhibiting eGFP aggregating, which 
dismisses the idea of early melanoblast death.    
 
4.3.3.2 Changes of eGFP signals due to transcriptional errors through silencing 
Another possibility for the seemingly complete loss of green fluorescent protein in the Dct:eGFP-
YAP(wt/S87A) transgenic lines could be through silencing mechanisms. I previously mentioned partial 
silencing of melanocytic clones in 2 out of 8 Dct:egfp transgenic lines (chapter 3), which showed an 
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incomplete spatial eGFP-melanocyte pattern. Plant research demonstrated that in tobacco 
protoplasts insertion of transgenes could lead to an expected full or incomplete patterning resulting 
from partially silenced transgenes. Those studies showed that DNA methylation occurs specifically in 
newly inserted DNA resulting in low transcription levels through partial silencing (Day 2000). In this 
chapter, variable gene expression levels or a complete loss of gene activity might have occurred 
when the Dct:eGFP-YAP(wt/S87A) transgene was randomly inserted into regions with close proximity 
to heterochromatin instead of euchromatin, the latter of  which is loosely packed chromatin 
associated with high transcriptional activation. Heterochromatin on the other hand is thought to be 
closely packed, thus inaccessible to the transcriptional machinery. It is also correlated with cytosine 
hypermethylation and specific histone hypoacetylation (Huck-Hui & Bird 1999). This would mean our 
transgene is either expressed at low levels and fluorescent molecules are not present in sufficiently 
detectable quantities, or our transgene is completely shutdown inside an inactive region of 
chromatin.  
In addition to silencing mechanism of transgenes inserted into non-active chomatin regions, inverted 
short multi-copies or polymeric DNA concatemers of repeated transgene sequences can also cause 
gene silencing, which is often seen in mice transgenesis. Calero-Nieto encountered a subset of 
previously active transgenes that became specifically silenced, which was accompanied with 
epigenetic changes such as increased methylation and decreased acetylation of histone H3K9. 
Transgenic silenced lines also experienced a loss of DNase I hypersensitive sites and lacks the ability 
to recruit DNA polymerase II for DNA repair (Calero-Nieto et al. 2010). A proposed role for the repeat 
sequences is to induce DNA–DNA interactions that lead to changes in chromatin conformation and 
epigenetic silencing (Matzke & Matzke 1998). Unfortunately we have not been able to test copy 
numbers of the transgene in our transgenic lines, which can be done by southern-blotting.  
In our case 5 out of 6 for Dct:eGFP-YAP(wt) and 3 out of 3 for Dct:eGFP-YAP(S87A) founders lacked 
detectable levels of fluorescent signals, which would indicate that the majority of transgene 
insertions became silenced. This would mean that the frequency of a silencing mechanism would be 
very high. Unfortunately, I cannot tell how frequently silencing normally happens in a Medaka 
transgenesis approach. Nor I cannot make any assumptions if I might have missed silenced founders 
in the non-eGFP expressing screened F1 offspring when I established the previous Dct:egfp 
transgenic line (chapter 3). Even so there are studies in which unexpectedly nearly half of the 
insertions failed to give a full spatial pattern of the transgene (Day 2000), my feeling is that our 
problem of non-detectable eGFP signals might be a consequence  of other errors. As future tests of 
the silencing hypothesis, I would propose using in situ hybridisation with an anti-sense gfp probe in 
the F2 generation embryos of all Dct:eGFP-YAP(wt) and Dct:eGFP-YAP(S87A) lines showing no 
fluorescence signal to ask whether the transgene is transcriptionally active. A more unfavourable 
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option would be to amplify the eGFP signal histochemical with an anti-GFP antibody. The 
amplification of GFP signal has been routinely done in previous Zebrafish studies and antibodies are 
readily available from commercial companies such as Invitrogen and CellSignalling. However, despite 
being able to reach an amplification amplitude by 1000, the immunohistochemical protein 
amplification is based on the recognition of available GFP protein antigen, which is unlikely due to 
the lack of any GFP signal beyond 3 dpf as in our case.  
 
4.3.3.3  Non-detectable eGFP levels due to post-translational errors 
Another possible cause of undetectable eGFP might be at the translational levels. Fusion proteins 
have been constructed and used successfully for subcellular function analysis in the past, yet this 
does not mean that a successful fusion applies for every gene fused or tagged to a reporter gene. 
Therefore, the order in which both genes are fused could make a difference in gene stability and/ or 
intracellular localisation. It is conceivable that the N-terminal eGFP protein may destabilise YAP 
resulting either missfolding and/or rapid degradation leading to decreased fluorescence signals. 
Although, we did not expect this to be a problem, because most previous publications used not only 
eGFP, but also fused this reporter gene N-terminally to the YAP sequence (Dong et al. 2005; Zhang et 
al. 2010; Liu-Chittenden et al. 2012; Zhao et al. 2011) to monitor YAP’s subcellular location in 
mammalian in vitro cultures. Palmer & Freeman (2004) approached a general analysis to test if the 
order of reporter fusions matters. They showed that tagging the GFP C-terminally to the gene of 
interest results in subcellular location more in accordance with previous studies and/or 
bioinformatics predictions. Fusing eGFP to the N-terminus of gene, which we did in our case, resulted 
in less than half of the fusion proteins localising incorrectly (Palmer & Freeman 2004). This 
imperfection or mislocalisation is because GFP emerges first from the ribosomal subunit followed by 
the amino acid sequence of our protein of interest. Then, cytoplasmic chaperones prevent the amino 
acid sequence from folding into a three-dimensional structure unless an amino acid chain of 
approximately 50-300aa has emerged. Therefore, when tagging GFP N-terminally to the gene of 
interest, it would cause GFP to get folded first, possibly disrupting correct folding and localisation of 
the second protein (Hartl & Hayer-Hartl 2002). It is possible, that the YAP protein disrupted the GFP 
folding itself giving rise to incomplete protein expression. Tagging the yap gene N-terminally to eGFP 
remains another possibility, which we could try.  
Furthermore, the protein turnover and degradation of both fused genes might be different, leading 
to pre-mature degradation. Enhanced GFP has been reported to have a half-life of around 26h 
(Corish & Tyler-Smith 1999), whereas YAP1 seems to have a much shorter half-life of 3h, as tested in 
cycloheximide (CHX)-human embryonic kidney (Levy et al. 2008). Others show that the half-life of 
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wild type YAP is over 24h, much longer than a mutated activated version of YAP which halves below 
24h when treated with cycloheximide (Liu-Chittenden et al. 2012), whereas its human paralogue TAZ 
is shown to have a half-life of 1-2h. The protein stability of both Hippo pathway members is 
dependent upon cell density levels. YAP as well as TAZ seem to be more stable in low densities in 
which hypophosphorylation seems to accumulate and stabilise both proteins (Oren & Aylon 2013). 
The true half-life of the YAP protein is yet to be determined in our model organism Medaka, but in 
the case of a short half-life of YAP we would need to try and overcome the difference in protein half-
life of those fusion partners. For instance, I could use an eGFP version, which has a short maturation 
time and is suitable for fusion to transcriptional factors such as YAP. In that case the company 
evrogen supplies TurboGFP an improved variant of the green fluorescent protein CopGFP cloned 
from copepod Pontellina plumata  (Evrogen 2014). 
Finally, the use of protein linkers to link proteins can also harbour issues in protein folding. I decided 
to use a 15 aa repetitive sequence of the glycine-and serine-rich linker [GGGGS]3. The (GGGGS)n 
linker provides structural flexibility and improved protein stability, and its biological activity for 
protein fusions has been successfully demonstrated in other studies, mainly mammalian in vitro 
culture systems (Trinh et al. 2004; Delacôte et al. 2013; Ito et al. 2011). However, stable peptide 
linkers do not allow separation of the two fusion proteins after translation. This can cause in some 
cases rigid secondary structures, leading to missfolding or wrong subcellular localisation of the fusion 
protein. Even so, we did not anticipated this to be happening in our case, because transient 
expression of our fusion protein egfFLyap under the CMV promoter resulted in widely distributed 
eGFP signal within endothelial cells, we cannot dismiss this possibility to 100%. It might still be an 
explanation for those intracellular eGFP aggregates seen in the F1 generation of Dct:eGFP-
YAP(wt/S87A) transgenics.  
To overcome the likelihood for such pitfalls, researchers are increasingly utilising gene linkage 
systems which ultimately lead to two separate individual proteins. The expression of more than one 
gene bicistronically or multicistronically under the control of one promoter can be achieved by using 
vectors comprising the internal ribosomal entry site (IRES) or the 2A-peptide. IRES is a nucleotide 
sequence added between two cistrons with an approximately 100bp-spacer after the first gene, 
which enables co-translation of two proteins from the same RNA transcript. Initiation of translation 
occurs exclusively at the 5’ cap in eukaryotic mRNAs; though with an IRES sequence from HTLV-1, 
poliovirus or encephalomyocarditis virus (EMVC) ribosomes are recruited simultaneously at a second 
internal site (Jang et al. 1988; Pelletier & Sonenberg 1988). However, recent advances point out that 
the yield of protein from the 3′ cistron is usually much lower than from the 5′ gene due to cryptic 
promoters or splice sites within various IRES sequences, and at around 500bg, the sheer  size of the 
linker can cause complications during gene comparative studies (Kozak 2005). IRES motifs are 
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available as an in vitro tool expressing antibiotics or fluorescent reporter genes bicistronic with lower 
intensity (Clontech Takara Bio Company 2014), but are less commonly used in in vivo studies as they 
require additional experiments and controls (Sampath & Sudipto 2010, Nikaido & Kelsh unpubl. 
data). In contrast, the viral 2A peptide, a multicistronic gene expression system is starting to appear 
in Zebrafish and Medaka research (Sampath & Sudipto 2010). The 2A peptide is a self-cleaving motif 
with an average length of 18-22 amino acids first isolated from the foot-and-mouth disease virus 
(FMDV), a member of the picornavirus family (Ryan et al. 1991). Through creation of a transgene 
with a single, long open reading frame, stoichiometric expression of multiple proteins either side of 
the 2A peptide is achieved by ribosome skipping. Ribosomes skip the synthesis of the glycyl-prolyl 
peptide bond at the C-terminus of the 2A peptide, leading to cleavage between the 2A peptide and 
its immediate downstream peptide. As a result, the 2A peptide sequence remains C-terminally on the 
upstream protein and a proline amino acid at the N-terminus of downstream proteins (Donnelly et al. 
2001). 2A peptide sequences have been used widely in the production of Induced Pluripotent Stem 
Cells (iPS cells or iPSCs) (Takahashi & Yamanaka 2006; Kaji et al. 2009), in gene therapeutic studies 
and mice in vivo transgenesis (Holst et al. 2006) or in in vitro bioimaging techniques co-expressing 
fluorescent proteins to target different sub-cellular sites (Amrani et al. 2004). However to date it has 
not been used widely in in vivo studies and detailed analysis of different 2A peptides used were 
missing until Kim et al. (2011) addressed this issue for the first time using human cell lines, Zebrafish 
embryos and adult mice. They generated and compared four different 2A peptide sequences from 
foot-and-mouth disease virus, equine rhinitis A virus, Thosea asigna virus and porcine teschovirus-1, 
respectively, and demonstrated the highest cleavage efficiency when using the porcine teschovirus-1 
(P2A) (Kim et al. 2011). This means that one possibility could be to exchange the (GGGGS)n linker with 
a porcine teschovirus-1 (P2A) 2A peptide sequence between egfp and yap sequence  to produce a 
bicistronic expression under the Dct promoter. In that way YAP would only carry the N-terminal 
additional proline amino acid and would not be constrained by a large upstream fusion 260 aa  GFP-
linker sequence, which harbours the possibility to inhibit YAP’s accurate three dimensional folding. 
In summary, there are changes we could apply to our fusion protein. Firstly, we could swap the order 
of the fusion sequences itself and place yap upstream of egfp. Secondly, we could exchange the egfp 
to a Turbo-GFP sequence to minimise protein turnover and equalise the protein half-life to YAP. 
Thirdly, we could use an alternative linker sequence such as 2A peptide instead of a flexible linker, as 




4.3.4 Future characterisation of the Dct:eGFP-YAP(wt/S87A) 
transgenic lines and investigation of YAP’s autonomy within 
melanocytes 
Because we were not able to distinguish individual transgenics from founder’s progeny pool of both 
lines, Dct:eGFP-YAP(wt) and Dct:eGFP-YAP(S87A), I decided to grow up all the offspring. Once this F1 
generation is older than 3 months, we would need to fin clip and PCR genotype each adult fish to re-
find carriers of our transgene. Then we would cross F1 carriers with heterozygous HB32Cj50-20C to 
obtain the J50-20C hirame allele, in case the carrier does not already have one. Once the F2 
generation has been established, we would hope to have a sufficient number of adult fish to start 
and analysing those two lines. Again, first, we would need to re-genotype individual adults to identify 
carriers, because I assume that we would still not see any eGFP expression. Then, we could attempt 
to answer the following questions: 
1.) Why can we not see detectable levels or eGFP in our transgenics? 
2.) Does YAP play a cell-autonomous role in melanocytes and can it rescue the hirame 
melanocyte-patterning defect? 
The first question as discussed above, can have multiple possibilities ranging from errors in a 
transcriptional level up to translational protein missfolding and/or degradation. To check, if our 
transgene is transcribed, one could perform in situ hybridisation with an anti-gfp antisense probe, 
which would bind to the first part of the transgene mRNA. Another way to test transcriptional levels 
would be via qPCR. mRNA of whole embryos could be isolated, retro-transcribed to cDNA, amplified 
and compared to non-transgenic embryos. The difference in expression would then indicate if the 
transgene is active or not. However, the presence of mRNA does not automatically mean protein 
translation as most mRNAs undergo decay by deadenylation mechanisms or through RNA 
interference (RNAi) by micro RNAs (miRNAs) or short interfering RNAs (siRNAs) (Valencia-Sanchez et 
al. 2006; Garneau et al. 2007). Even so, we took care in designing our constructs with a well-validated 
polyA sequence; we still need to test what happened to our fusion protein on a translational level. 
One possibility is to perform immunohistochemical GFP amplification in whole-mount embryos, 
which is unfavourable due to the lack of even low levels of GFP signal (as explained above). Another 
option could be to extract protein and perform Western-Blotting using and anti-GFP antibody, which 
might be able to detect even low levels of GFP protein presence not detectable by fluorescence 
microscopy. We did not consider using an anti-YAP antibody, because none of the available and 
tested antibodies so far were specific enough in Medaka (D H. Davies observation). As discussed 
above, we could also attempt to re-design the construct either by swapping the order of our genes or 
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even exchanging the linker sequence to a possibly bicistronic 2A peptide sequence. Separate protein 
folding might allow eGFP to fold correctly preventing aggregation or degradation, but it would not 
provide any evidence about the correct folding of YAP neither its functionality (discussed below). 
To answer our second question, if YAP might exhibit a cell-autonomous role in melanocytes, we 
would observe the melanised melanocyte pattern as well as the melanoblast distribution after Dct 
ISH in j50-20C progeny of transgene carriers. If we would then observe a rescue in hirame embryos, it 
would mean YAP acts cell-autonomous. In case we cannot find a melanocyte rescue it could mean 
either YAP does not act cell-autonomous, or YAP protein is not present or functional within the 
melanocyte lineage in our Dct:eGFP-YAP(wt/S87A) transgenic lines. To test the latter, we could 
isolate melanised melanocyte by FACS sorting and qPCR downstream targets of YAP such as cyclinD 
or itgb2 (Zhao et al. 2007). This would show us if YAP is still active and present in functional levels, 
therefore confirming the presence in melanocytes. Automatically it would make a strong argument 
that YAP does not act cell-autonomous hirame melanocyte, thus unable to rescue the melanocyte 
defect. It would also strengthen unpublished data from our collaborator, who showed that YAP acts 











































The induction of the neural crest involves bone morphogenetic proteins (BMPs) and Wnt signalling 
within the non-neural ectoderm during gastrulation. Other neural crest induction genes start being 
expressed during neurulation which include zic, pax3 and pax7 expressed within the neural plate, 
msx1/2in the neural fold and non-neural ectoderm, and dlx solely located within the non-neural 
ectoderm. They together fulfil a function as neural plate border specifiers (Huang & Saint-Jeannet 
2004; Donoghue et al. 2008; Sauka-Spengler & Bronner-Fraser 2008). Those border specifier genes 
prompt the activation of neural crest specifiers such as Foxd3, Slug/Snail, Sox9 and Sox10 during 
delamination of premigartory neural crest cells (Mayor & Theveneau 2013). Neural crest cells (NCCs) 
are multipotent stem cells that give rise to neurons, glia, pigment cells and endocrine cells (Le 
Douarin et al. 2004). In our first results chapter, we have demonstrated that hirame displays a unique 
early melanoblast migration defect especially on the yolk sac, before any anatomical body 
abnormalities appear and after maternal yap transcripts were undetectable. This means that within 
this time window the defects observed were entirely due to the loss-of-functional YAP protein. This 
made us wonder if other highly migratory neural crest cell types might feature similar defects in cell 
movement. Therefore, we aimed to analyse a wide range of NC marker and compare some of them 
to hirame to answer key question of YAP requirement in those cell lineages.    
 
5.2 Results 
5.2.1 Investigation of the xanthophore pigment cell lineage in wild 
type and hirame mutants 
As mentioned previously in this thesis, one of the affected NC derivatives in hirame were pigment 
cell melanocytes. To remind, pigmentation of Medaka is derived from four different pigment cell 
markers; brown melanocytes, silverfish iridophores, orange xanthophores and white autofluorescent 
leucophores; making Medaka an equivalent model for studying pigment cell specification, 
proliferation, survival and migration (Kelsh et al. 2004).  
To address whether hiramej50-20C affects xanthophore and leucophore specification, as well as 
proliferation and differentiation, we examined the expression pattern of GTP cyclohydrolase I (gch), 
known to be the earliest marker within the xanthophore lineage. GTP cyclohydrolyse I converts 
guanosine triphosphate (GTP) to dihydroneopterin triphosphate and later to tetrahydrobiopterin 
(BH4), a required substrate for pterine pigments in early xantophores (Pelletier et al. 2001). 
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Additionally BH4 also functions as a cofactor for phenylalanine hydroxylase, converting phenylalanine 
to tyrosine during melanin synthesis in melanocytes (Ziegler 2003; Pelletier et al. 2001). Furthermore 
it has been reported that gch is transiently expressed in xanthophores and a subset of the population 
of melanophores in Zebrafish (Parichy & Ransom et al. 2000). However, Nagao et al. (2014) cloned 
the Medaka gch (XM_004085058) fragment and demonstrated that its expression pattern between 
24 to 34 somite stage (st. 27-30, 58–74 hpf) does not overlap with the dopachrome tautomerase 
(Dct) melanophore pattern. However, it is expressed in all xanthophores and leucophores at all 
stages during development. Therefore in analysing the gch expression pattern, we should be able to 
examine both xanthophore and leucophore pigment cell distribution in Medaka.      
Whole-mount in situ hybridisation using a gch anti-sense probe was carried out in stage 24 and 28  
progeny on a Cabj50-20C background to visualise spatio-temporal changes in leucophore and 
xanthophore pigment cell population (Figure 5.1). At stage 24 mainly head leucophores were visible 
similar to hirame and wild type siblings despite morphological differences in general organogenesis. 
Cell quantifications showed no significant difference in cell numbers at that stage (Figure 5.1 B). As 
xanthophores become specified and differentiate, we observed a dramatic increase in gch positive 
labelled cells in the head, and dorsal, lateral and ventral stripes of the trunk region within wild type 
siblings at stage 28, not seen in hirame. Due to the pronounced xanthophore pattern, we were not 
able to distinguish these two cell types at any later stage, therefore cell counts (Figure 5.1 B) 
represent a combination of leucophore and xanthophore cell numbers within the body. However, the 
slight increase in hirame gch+ cells at stage 28 is likely due to proliferation in leucophores, which 






Figure 5.1: GTP cyclohydrolyse I (gch) WISH and cell counts in developing Medaka hirame and wild 
type embryos 
Medaka hirame and wild type embryos after gch WISH at stage 24 and 28 showing changes in 
leucophore and xanthophores lineages. A) Head leucophores at stage 24 of hirame show to be 
in similar spatio-temporal positions as in wild type siblings (top panel). At stage 28 the number 
of gch positive cells is dramatically increased within the head and trunk region, whereas in 
hirame no visual increase in gch cells appeared. B) Gch cell quantification suggest no significant 
difference in leucophores within the head region at stage 24, whereas at stage 28 significant 
increase in gch+ cell numbers was observed in wild type siblings, but not in hirame. The 
difference in hirame gch+ cells between those two stages might be solely due to an increase of 
leucophores indicating an absence in xanthophore specification. All data are means ± SEM. 2-
Sample-t-test: *p<0.05, **p<0.01 or ***p<0.001.     
   
 
5.2.2 Analysis of neuronal marker elavl3/HuC within the head and 
trunk dorsal root ganglia within wild type and hirame  
Zebrafish trunk NCCs also give rise to sensory neurons and dorsal root ganglia (DRG) of the peripheral 
nervous system (PNS) (Le Douarin et al. 2004). Herein their correct specification and migration is 
essential during PNS development.  
To form DRGs they migrate as partially committed neural crest cells along the medial pathway 
between somites and the neural tube to then coalesce initially as two to five neurons (Raible et al. 
1992). This originally small pool of cells differentiates into compact DRG neurons and associated 
ganglia cells, located between the lateral edge of the spinal cord and each somite pair. DRGs contain 
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the sensory neurons of the PNS receiving and transmitting sensory information to the dorsal horn of 
the spinal cord, such as touch, perception of pain, temperature and limb movement (McGraw et al. 
2008). In Zebrafish, different from mouse, neurogenin 1 (neurog1) controls the spatial and temporal 
development of dorsal root ganglia, as knockdown of neurog1 with anti-sense morpholino’s led to a 
complete loss of DRG neurons as well as non-NC neurons of the cranial ganglia (Andermann et al. 
2002). In comparison, in mouse neurogenesis the development of DRGs is regulated through the 
activity of neurogenin 1 and neurogenin 2 followed by Krox20 expressed in boundary cells. In 
addition, the transcription factor Sox10 is required for initiation of DRGs from the migrating trunk 
neural crest (Carney et al. 2006). After completion of neurogenesis survival, DRG expansion is 
regulated by soluble neurotrophins before the end of mammalian embryogenesis (Ma et al. 1999). 
 
DRG’s can be labelled by elavl3. Elavl3 encodes the ELAV-like neuron-specific RNA binding protein 3, 
one of several Hu antigens (neuronal-specific RNA-binding proteins) and is recognised by the 
neuronal anti-HuC antibody, also described as elavl3/HuC. HuC is one of the earliest molecular 
markers for differentiating neurons. It first appears in the neural plate directly after gastrulation, 
after which high levels continue to be expressed throughout most regions of the developing nervous 
system (Kima et al. 1996).  
 
In order to ask whether neuronal patterning and especially DRG numbers are modified in yap 
mutants, we analysed the differential expression of HuC in hirame and WT siblings. We carried out 
whole-mount in situ hybridisation in sibling progeny at stage 24 and 28 using digoxygenin-labeled 
anti-sense probes to Medaka elavl3/HuC (Figure 5.2). The expression pattern of HuC in hirame and 
wild type embryos at both stages was clearly distinguishable. Expression of HuC in the three cranial 
ganglia (arrow heads) was present in hirame embryos at st. 24, but mainly in atypical, ectopic 
pattern. Even so cranial ganglia are largely derived from neurogenic placodes (epibranchial and 
dorsolateral) and not from neural crest we wanted to embark on it as it was one of the spatio-
temporant differences we could observe. The HuC positive cranial ganglion cell populations were 
much smaller, and seemed unstructured and dislocated, as parts in the posterior as well as anterior 
ganglion does not seem to be associated within a close range of the body, which was the case in wild 
type siblings. This defect seemed partially normalised by stage 28 because posterior ganglia and 
ganglia arising from rhombomere 4 are in close proximity to the body axis despite the much smaller 
HuC positive ganglion in the hindbrain region. Rhombomeres 1 to 7 (indicated by white numbers) are 
labelled in wild type embryos at stage 24 and 28, where we would expect them to be in hirame. We 
were not able to distinguish individual rhombomers because the neuronal zones are ill-defined and 
small. Furthermore, the hindbrain ventricle opening zone in hirame is much narrower compared to 
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wild type, an effect even more pronounced at stage 28. Note, it also seems that HuC expression is 
either absent in the (presumably) upper rhombic lip (URL) underneath the cerebellum and the mid-
hindbrain-boundary (MHB) (asterisks) at stage 28 or the URL is completely missing in hirame 
compared to wild type. In addition, HuC positive forebrain seems to be dramatically reduced or even 
absent in hirame at both stages.  
 
 
Figure 5.2: elavl3/HuC expression in head and anterior trunk of st. 24 and st. 28 shows differences in 
hirame embryos 
Whole-mount in situ hybridisation of anti-elav3/HuC in st. 24 and st. 28 wild type and hirame 
embryos. Cranial ganglia (arrow heads) in hirame were much smaller in size and observed in 
ectopic positions (B) compared to wild type siblings in which cranial ganglia are closely 
associated with the body (A). This defect seemed partially normalised  by stage 28 as some 
cranial ganglia structures can be observed in expected regions (D). The hindbrain ventricle 
opening is much narrower in hirame (more pronounced at st. 28) and presumptive upper 
rhombic lip (asterisks) is absence as well as rhombomers 1 to 7 are not well distinguishable in 
hirame (D) compared to wild type (C). Note, forebrain also seems smaller in hirame (bot 
stages). fb = forebrain. Scale bar = 100µm 
 
To investigate if the absence of functional YAP affects the formation dorsal root ganglia from the 
trunk neural crest, we performed whole-mount in situ hybridisation with anti-elavl3/HuC on st. 32 
embryos, one of the latest stages in which some hirame embryos are still alive. At stage 32 normal 
embryos have around 30 pairs of dorsal root ganglia (Figure 5.3 A) positioned laterally to the 
elavl3/HuC expressing neural tube, beginning from the first somite and extending to the tip of the tail 
(arrows Figure 5.3 B). However, we observed a significant reduction of complete dorsal root ganglia 
structures in hirame with an average number of 9.75 (Figure 5.3 A). DRGs in hirame migrate and 
differentiate next to the first 10 somites (arrows Figure 5.3 B). We could not observe any type of 
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DRGs beyond somite 11, despite the fact that hirame mutants develop the similar numbers of 
somites compared to its wild type siblings at stage 32 (data not shown). Our observations imply that 
YAP is required to determine the initiation of DRG pairs therefore might be required for peripheral 





Figure 5.3: Dorsal root ganglia in hirame at st.32 are quantitatively reduced  
In situ hybridisation to visualise elavl3/HuC expression in dorsal root ganglia (DRG) of late 
stage hirame embryos. A) Counts of DRGs in wild type and hirame embryos represents a 
significant decrease in hirame mutant siblings. B) Elavl3/HuC labels neural tube in both 
genotypes. DRGs in wild type are present between all, from first to the last somite blocks 
(arrow heads), in hirame however DGRs were only detectable until 10 somits (arrow head). 
Scale bar = 100µm. All data are means ± SEM. 2-Sample-t-test: *p<0.05, **p<0.01 or 
***p<0.001. 
 
5.2.3 Sox9b early neural crest marker analysis in hirame  
The family of Sry -related high-mobility group (HMG) box proteins play important roles in 
developmental processes, such as CNS neurogenesis, germ layer formation, organ development, and 
cell type specification (Cui et al. 2011). The family member Sox9b is expressed  in a subset of neural 
plate border cells which specify premigratory neural crest cells (Donoghue et al. 2008). Together with 
RUNX3 and the influence of EGR1, it manipulates BMP-signalling required for NCCs to differentiate 
into pharyngeal cartilage, therefore influencing cranial cartilage development in Zebrafish (Dalcq et 
al. 2012). Furthermore Sox9b plays an essential role during chondrocyte differentiation in mice 
(Akiyama et al. 2002), and is next to Sry (sex-determining region on Y chromosome) as of the most 
important genes during male gonad determination in mammals (Jiang et al. 2013; Clarkson & Harley 
2002). Zebrafish carries two orthologues of Sox9 in its genome Sox9a and Sox9b both with 
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overlapping and distinguishable features. Sox9a is expressed in testis, while sox9b occurs in the 
ovaries and the neural crest population (Chiang et al. 2001). Both are expressed in developing 
craniofacial cartilage, pectoral fin buds and central nervous system (Li et al. 2002).   
Before Medaka´s whole genome was sequenced in 2002 by the National Bio Resource Project 
Medaka Genome Project, only one Sox9 gene was thought to exist (Yokoi et al. 2002). In 2005 Klüver 
et al. isolated a second Sox9 confirming that both orthologues are derived from the teleost-specific 
genome duplication (Meyer & Schartl 1999). They described how during embryogenesis, both are 
expressed within the craniofacial cartilage and pectoral fin buds, but differ considerably in other 
tissues. Medaka Sox9a is expressed in ceratobranchial arches, mandibular and hyoid arches. Sox9b is 
positive within the early neural crest and otic placode initiation and is generally switched on earlier 
than Sox9a within the otic placodes. After 2 dpf it is expressed around the eyes, within the forebrain, 
somites and the mid-hindbrain-boundary (MHB). Around 4 dpf Sox9b is also expressed within the 
tectum, roof and floor plate, within the heart and the anus sphincter.  
Our aim was it to investigate the expression pattern of Sox9b during embryogenesis of hirame 
mutants whilst focusing on the neural crest lineage. To achieve that I conducted a series of whole-
mount in situ hybridisation experiments at different stages with a sox9b anti-sense riboprobe (a gift 
by Dr H. Hashimoto).  
Our first observations were that at early stage 20 (1d 7.5h) wild type embryos exhibited strong sox9b 
expression within the preplacodal ectoderm that will develop into the otic placode (Figure 5.4 A’). It 
also showed expression in the neural crest within the hindbrain, i.e. the cranial neural crest which 
later contributes to the cranial cartilage, as well as more posteriorly, i.e, in trunk neural crest which, 
eventually develop into pigment cells and the peripheral nervous system (PNS). In contrast, sox9b 
expression in  hirame mutants showed a mixed cell distribution in which some sox9b+ cells could be 
seen in the hindbrain, otic placode and trunk neural crest locations, but at the same tissue, most cells 
still remained in ectopic yolk sac positions (Figure 5.4 B’). 13 hours later in Medaka embryonic 
development at stage 24 wild type embryos remained positive sox9b expression within the otic 
placode, within the forebrain, inner optic cup region of the developing eye and the mid-hindbrain 
boundary (MHB) (Figure 5.4 C’). Surprisingly, we observe the same sox9b expression pattern in 






Figure 5.4: Sox9b WISH in hirame and wild type at st.20 and st.24 reveals differences at early stages 
Whole-mount in-situ hybridisation of early neural crest marker Sry-box containing protein 9b 
(Sox9b). Left panels show whole embryo, right panels represent higher magnification. A-B) 
During early embryogenesis at st.20 sox9b is expressed within the hindbrain neural crest, the 
presumptive otic placode population and neural crest within the trunk region (WT A, A’ n=39). 
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In contrast hirame demonstrates a mixed pattern in which some sox9b+ cells are already 
within the expected regions and some are located ectopically on the yolk sac region close-by 
(red asterisks) (n=12). C-D) At st.24, 13h later, sox9b was strongly expressed around the 
developing eye, forebrain, mid-hindbrain-boundary (MHB) and otic placodes (n=23), an 
expression pattern also found in hirame (n=6). It seems despite morphological differences the 
areas of sox9b expression is the same as in WT siblings at that stage. Abbreviation: e, eye; fb, 
forebrain; hnc, neural crest in hindbrain; MHB, mid-hindbrain boundary; o, otic placode; tnc, 
neural crest in trunk. Scale bar A-D=500µm, A’-D’=100µm. 
 
It is possible that the ectopic sox9b+ cells in hirame at stage 20 were created by a slower conversion 
process during gastrulation of hirame causing them to remain on the embryonic mesenchyme. To 
address this, I carried out resin sectioning (Figure 5.5). This revealed that the sox9b positive cell 
population seen in hirame stage 20 embryos are possibly ectodermal cells that remain on top of the 
existing mesenchyme, possibly at the end of gastrulation, as compared to wild type siblings in which 
those cells have already migrated to the presumptive otic placode. Supporting, when we analysed 
earlier embryonic developmental stages between st.17 and st.19 (Figure 5.6) we could observe a 
developmental delay in sox9b+ cell migration during hirame embryogenesis. The migration of sox9b+ 
cells towards the hindbrain, otic placodal and prospective trunk neural crest cell seemed persistently 
delayed in hirame mutants. It appears that the cell migration was around 5.5 hours delayed, e.g. 
st.20 hirame mutants looked similar to st.17/18 wild type siblings. Genotyping with tetra-ARMS 
primer PCR confirmed the genotype of individual embryos. These findings from st.17 to st.19 hirame 
embryos coincided with observations we made during gastrulation in which the speed of epiboly 
closure was behind in hirame mutant embryos (Appendix 12), wherein the blastoderm migrated 





Figure 5.5: Trunk cross sections of st.20 embryos shows sox9b labelled cells remain on the yolk sac in 
hirame 
Resin sections of stage 20 wild type and hirame representing the tissue morphology and sox9b 
staining within the trunk region. A) sox9b+ cells are strongly expressed within the presumptive 
otic placode and a gradient of sox9b expression runs from the dorsal towards the ventral side 
of the neural tube. B) In hirame mutants sox9b+ cells remain above the extending mesoderm 
on top of the yolk sac and are not yet accumulated within otic placodal region. The gradient of 
sox9b expression within the neural tube is similar although the dorsal part is slightly thicker. 





Figure 5.6: Sox9b expression during gastrulation between st.17 and st.19 in wild type and hirame 
highlights the convergence defect in hirame 
Series of images representing cell migration at the end of gastrulation at st.17 (1d 1h) (A,A’), 
st.18 (1d 2h) (B,B’) and st.19 (1d 3.5h) (C,C’) in wild type and hirame embryos. Sox9b+ cell 
migration in hirame embryos is slower than its wild type sibling. Whereas in wild type sox9m 
expressing cells within the presumptive cranial neural crest, otic placode and trunk neural 
crest are located within their specified body region, in hirame those cell pools are still 
remaining on top of the mesenchyme above the yolk sac. All embryos were genotyped with 
tetra-ARMS primer PCR. Abbreviations: hnc, neural crest within the hindbrain region (cranial 




Next we wanted to investigate if expression of sox9b is affected during later stages. We chose to 
examine 3 dpf embryos and expected to find sox9b labelling within somites and dorsal trunk neural 
crest precursors as described in Zebrafish (Li et al. 2002).  Lateral views of whole-mount in-situ 
hybridisations show that Sox9b is expressed in somites within wild type embryos as well as hirame 
mutant siblings (Figure 5.7). The overall expression in somitic mesoderm was relatively week which 
made a clear description of each somite impossible. We also observed a strong expression within a 
dorsally-located, caudal cell population in the wild type, which we could not identify clearly in 
hirame. Dorsal views of those embryos provide a clearer sight of this area which presumably labels 
neural crest precursor cells. As previously mentioned hirame embryos are generally very weak and 
the yolk sac membrane seems to have problems with mechanical tension, making these embryos 
difficult to work with. This can in some cases lead to an ingrown tail end, at later stages (chapter 1  
Figure 1.4). Because we could not observe any neural crest-like dorsal cell population at the tail end 
of hirame mutants, we wondered whether tail curling might have masked the signal and given us a 
false-positive image in Figure 5.7 A’ and B’. Therefore we attempted to remove all embryo bodies 
from the yolk sac after sox9b WISH, embedded them in resin and subsequently sectioned them. 
Sections revealed that within the trunk region (Figure 5.8 A, A’) Sox9b is expressed within the medial 
pathway lining the most inner region along the neural tube, notochord and somites. In wild type 
embryos sox9b also marked a region within the dorsal midline, which we could not clearly identify in 
hirame embryos as the whole dorsal side was labelled. Cross sections from the tail end revealed a 
distinctive layer of strong sox9b+ cells  within wild type (Figure 5.8 B), which we could not clearly 
distinguish in hirame (B’). Meanwhile in hirame, the sox9b riboprobe labels a broad area within the 




Figure 5.7: Sox9b expression within the trunk of 3 dpf old wild type and hirame embryos 
Lateral and dorsal view of the trunk region in 3dpf embryos after WISH with anti-sense sox9b. 
Lateral view shows weak expression of somites (asterisks) in wild type and hirame. Noticeable 
wild type embryos indicate strong sox9b expression within the dorsal stripe especially at the 
tail end presumably labelling neural crest precursors (A, arrows) not observable in hirame (A’). 
Dorsal view highlights the extent of sox9b+ cells at the tail in wild type (B) not present in 





Figure 5.8: Localisation of sox9b within the body of 3 dpf wild type and hirame embryos 
Trunk (top row: A, A’) and Tail (bottom row: B, B’) resin cross sections of sox9b WISH in 3dpf 
old wild type and hirame embryos. Trunk cross sections show sox9b was expression within the 
medial migration path in both embryos; however the dorsal midline was clearly sox9b+ in wild 
type (A) which was difficult to identify in hirame mutants (A’). Tail sections highlight the layer 
of strong sox9b expression dorsally of the neural tube (B) which could not be found in hirame 
(B’). In hir mutants sox9b marked broad regions within the neural tube rather than a specific 
location. Sections = 8µm, Scale bar = 50µm 
 
To complement these observations, we obtained the Sox9b:gfp transgenic line originally established 
to analyse morphological reorganisation of the gonads during gonadal development in Medaka fish 
(Nakamura et al. 2007). The aim was to validate the expression pattern seen with the sox9b 
riboprobe, and monitor in real time the neural crest cell migration during early embryogenesis in wild 
type and hirame. We especially wanted to see if it would be possible to highlight dorsal early neural 
crest migrating populations within the trunk, as we could not clearly labels those cells in WISH in 
hirame.  
Up to now, we were able test this transgenic line in late stage embryos and in wild type only and 
could confirm the sox9b expression pattern within the craniofacial cartilage and forebrain region 
(Figure 5.9). We could also see expression within the epiphyseal and possibly the basihyoid as 
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described previously in early st.32 (4 dpf) embryos (Klüver et al. 2005). In addition we were able to 
see Sox9b expression within the cartilage of the spine vertebrae (initiated from somites), pectorial 
fins, the anus sphincter and the atrioventricular canal of the developing heart (Figure 5.10) (Klüver et 
al. 2005), confirming the sox9b in situ expression pattern already published. Unfortunately, we were 
not able to obtain data from earlier stages yet and investigate the possibilities to highlight dorsal 
trunk sox9b cells, which we would have compared to hirame mutants in vivo. However, these 
findings demonstrate the usefulness of this fluorescent transgenic line, which we are likely to use for 
further studies in earlier developmental stages with the j50-20C hirame genetic background.  
 
 
Figure 5.9: Sox9b:gfp in 7 dpf wild type embryos highlighting the head region 
Transgenic line sox9b:gfp shows fluorescence expression within the craniofacial cartilage, 
forebrain, epiphyseal and possibly the basihyoid at 7dpf. Red channel represents 
autofluorescence of leucophores and possibly medial rectus. Abbreviations: cf, craniofacial 






Figure 5.10: Sox9b:gfp transgenic wild type at 7dpf whole embryo 
Sox9b:gfp transgenic embryos at 7pf labelling the cartilage of spine vertebrae, pectorial fins, 
the anus sphincter and the atrioventricular canal of the developing heart. Abbreviations: ac, 
atrioventricular canal; as, anus sphincter; pf, pectorial fin; sv, spine vertebrae. Scale bar = 
500µm 
 
5.2.4 Analysing the CNS and PNS marker mbp in wild type as potential 
marker for neural crest derivatives 
The major function of Oligodendrocytes in the central nervous system (CNS) and Schwann cells in the 
peripheral nervous system (PNS) is to provide myelination to axons by repeatedly wrapping their 
membranes around axons to form densely compacted myelin sheaths. This allows rapid and efficient 
conduction of action potentials along axons. Schwann cells and Oligodendrocytes also aid nerve 
development and regeneration, and provide trophic support for neurons, production of the nerve 
extracellular matrix and the modulation of neuromuscular synaptic activity. Despite similar functions 
these two cell types differ from each other in several ways. Oligodendrocytes are a type of neuroglia 
residing within the central nervous system which provides around 1µm myelin wrapping for up to 50 
axons, compared to Schwann Cells which myelinate one axon only (Sherman & Brophy 2005). 
Oligodendrocytes develop from oligodendrocyte progenitor cells (OPCs) which migrate to their final 
destination where they differentiate and become fully matured. OPCs are located in the 
subventricular zone of the cerebrum or cerebellum and in the spinal cord, and arise from ventral 
regions of the neural tube. Extrinsic factors such as platelet derived growth factor (PDGF) or 
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fibroblast growth factor (FGF) released from neurons or astrocytes have been shown to play a role in 
oligodendrocyte proliferation (Kettenmann & Verkhratsky 2011). In contrast, Schwann cells can be of 
myelinating or nonmyelinating type. They are the main glia within the PNS and support neurons such 
as satellite cells, olfactory ensheathing cells, enteric glia and glia that reside at sensory nerve endings, 
for instance Pacinian corpuscle. The migration and differentiation of developing Schwann cells  from 
the neural crest is controlled by Sox10 (Carney et al. 2006), whilst the initiation of myelination has 
been shown to require G protein-coupled receptor (GPCR) Gpr126 (Monk et al. 2011), in addition to 
the transcription factor Egr2, also known as Krox20 (Svaren & Meijer 2008). Neuronal neuregulin 1 
type III specifically directs Schwann cell migration (Perlin et al. 2011). Disruption of myelination can 
cause a wide range of neuropathies. In the CNS disruption of oligodendrocyte myelination leads to 
Multiple Sclerosis, Pelizaeus-Merzbacher disease and other forms of leukodystrophies (Kettenmann 
& Verkhratsky 2011). Defects in Schwann Cells can result in Guillain-Barré syndrome (GBS) and 
schwannomatosis, and acute inflammatory demyelinating polyradiculopathy. Because the failure in 
glia development can cause such dramatic neurological diseases, it is vital that we understand the 
mechanisms involved in functional cell development and subsequent myelination (Reeves & 
Swenson 2008) .  
Because markers for glia in the CNS and PNS are not yet published in Medaka, we aimed to 
investigate myogenic basic protein (mbp) expression in wild type embryos, and then to analyse glia 
differentiation and myelination in hirame mutants later. The myelin basic protein (mbp) is the most 
abundant protein in CNS myelin and is responsible for adhesion of the cytosolic surfaces of multi-
layered compact myelin. It has been shown to be a robust marker for differentiated Schwann cells in 
the peripheral nervous system and oligodendrocytes within the CNS (Jung et al. 2010). 
Mbp in situ hybridisation was carried out on 5 dpf, 7 dpf and 9 dpf wild type embryos (Figure 5.11, 
left panel) with the probe provided by Dr H. Hashimoto. Mainly Mbp+ oligodendrocytes were clearly 
labelled within the head in which nerve branching was detectable. Nerves from cranial ganglia (black 
arrow) seemed thicker and fully matured at 9 dpf and anterior cranial ganglia have migrated towards 
the anterior optic cup. Individual cell bodies (white arrow heads) and axial processes of 
oligodendrocytes (white arrows) were most visible at 7 dpf and 9 dpf within the CNS midbrain region. 
In addition the development and branching of the presumably reticulospinal neurons could be 
followed from individual cell bodies to a refined network at 9 dpf (asterisks) within the hindbrain. 
Resin sections (Figure 5.12 A) showing the eye region in  which nerves of cranial ganglia (black arrow) 
are present at 7 dpf. Furthermore, spinal cord oligodendrocytes within the posterior hindbrain 
strongly expressed mbp from 5 dpf onwards (black arrow head). In addition, Schwann cells were 
clearly visible at 7dpf within the posterior lateral line (red arrow heads). 
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Within the trunk region the mbp+ oligodendrocytes developed within the spinal cord from 5 dpf 
onwards (Figure 5.11, right panel). Hereby ventral spinal cord oligodendrocytes are higher in 
numbers than dorsal nerve cells (black arrow heads). Oligodendrocyte cell density increases during 
development, so that a strong nerve line is visible at 7 dpf. Slight thickening innervating this line 
especially at 9 dfp might show individual sensory organs (neuromast) (black arrow heads). Fine 
Schwann cell nerves are visible at 5 and 7 dpf extending ventrally from the spinal cord (red arrow 
heads) Schwann cells within the posterior lateral line (pLL) were undetectable, because their location 
was out of focus plane within those images.  The oligodendrocyte and Schwann cell distribution is 
better visualised in resin sections (Figure 5.12 B). Herein, at 7 dpf mbp labels ventral and dorsal spinal 
cord oligodendrocytes (black arrow head) and posterial lateral line (pLL) residing Schwann cells (red 
arrow head).    
 
Figure 5.11: Mbp expression in oligodendrocytes and Schwann cells of Medaka embryos at 5, 6 and 9 
dpf 
Myogenic basic protein (mbp) WISH within the CNS and PNS of wild type Medaka embryos at 
5, 6 and 9 dpf. Left panel) shows the central nervous system (CNS) at different stages of 
embryonic development in which cranial ganglia (black arrow), reticulospinal neurons 
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(asterisks) and individual cell bodies (white arrow head) and long axial protrusions of individual 
oligodendrocytes (white arrows) are visible. Note oligodendrocyte branching extents to fully 
maturation by 9 dpf. Spinal cord residing oligodendrocytes are visible within the posterior 
hindbrain region (black arrow heads). Posterior lateral line Schwann cells (red arrow head) are 
detectable especially at 7 dpf (red arrow head). Right panel) labels trunk oligodendrocytes 
within dorsal and ventral spinal cord (black arrow heads). Individual Schwann cell axons are 
detectable in 5 and 7 dpf embryos extending ventrally from the spinal cord (red arrow heads). 
Left panels scale bar = 100µm, right panels scale bar = 500µm.    
 
 
Figure 5.12: Resin sections from 7 dpf wild type embryos after mbp WISH 
Resin sections from 7 dpf old embryos representing mbp+ cells within the eye (A) and trunk (B) 
region. A) Oligodendrocytes  (black arrow) in the anterior region of the optic cup. B) Trunk 
region showing morphological features such as neural tube (nt), spinal cord (sc), notochord 
(nc) and somites (s). Mbp+ oligodendrocytes (black arrow head) situated ventrally and dorsally 
of the spinal cord, whereas Schwann cells are located within the posterior lateral line region 
(red arrow heads. Resin sections = 8µm. Scale bar = 50µm 
 
In summary, we have successfully shown that CNS oligodendrocytes and PNS Schwann cells are 
labelled in Medaka embryos beyond 5 dpf. It would be interesting to analyse mbp expression pattern 
at 4 dpf and earlier and compare it to hirame at the same time. This would enable us to study 
hirame’s CNS and PNS development in detail for any defects. For instance, we could envisage that a 
defect in Schwann glia cells might be due to Neuregulin I type III (NrgI), as studies have shown that it 
regulates directed Schwann cell migration along the posterior lateral line nerve in mice (Perlin et al. 
2011). This migration herein was dependent on ErbB receptors. Signals from nrg1 ligand might 
therefore be essential to ensure that these glia are present in the correct numbers and positions in 
the developing nerves. A defect in migrating Schwann cells might connect the Hippo pathway to 
neural crest guiding signals such as NrgI expression and ErbB receptor. 
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5.2.5 Enteric nervous system progenitors  
Neural crest cells form the preganglionic neurons of the enteric nervous system (ENS) after they 
migrate into and colonise the entire gut primordium of the gastrointestinal tract (Le Douarin et al. 
2004).  
The migration distance NC enteric neurons and glia undertake, exceeds that of any other neural crest 
cell derivatives. Chick and mice studies have shown that ENS derived NCCs initiate mainly from a 
vagal (hindbrain) region in the head and a subset of neural crest from a sacral trunk region caudal to 
somite 28 in chick and 24 in mammals (Yntema & Hammond 1955; Douarin & Teillet 1987; Anderson 
et al. 2013). After colonising the gut, neural crest-derived cells within the gut wall then differentiate 
into glial cells plus many different types of neurons, and generate the most complex part of the 
peripheral nervous system (Anderson et al. 2013). Failure of NCCs to populate the entire gut with 
enteric neurons can lead to congenital diseases such as, Hirschsprung's disease (HSCR) leading to 
defects in which patients suffer from intestinal obstruction or severe constipation. 
The paired-like homeobox 2 protein (Phox2b) is a homeodomain neuronal-type-specific transcription 
factor expressed in a pattern which suggests their involvement in neural fate determination. Pattyn 
et al. in 1999 demonstrated the requirement of phox2b for complete differentiation of the enteric 
nervous system (ENS). His study described enteric neurons in phox2b homozygous null mice failed to 
migrate beyond the anterior gut primordium leading to embryonic lethality between e10 and e13.5 
(Pattyn et al. 1999). Because of its involvement in neuronal development, studies have used phox2b 
to label the following structures in Zebrafish: enteric nervous system, epibranchial ganglion, 
epibranchial placode, facial ganglion, glossopharyngeal ganglion, hindbrain, pharyngeal arch 3-7, 
statoacoustic (VIII) ganglion, superior cervical ganglion, sympathetic chain ganglion and vagal 
ganglion (Elworthy et al. 2005; Z-Fin webpage 2014).  
To date there are no publications analysing the expression pattern of the paired-like homeobox 2 
protein (PHOX2b) in Medaka fish. Here, we attempted the optimisation of an anti-sense phox2b 
riboprobe via WISH (a gift from Dr H. Hashimoto) and a representative set of images of 4 dpf old 
embryos was analysed using comparison with the existing expression patterns found in Zebrafish. 
Within the head region (Figure 5.13) we were able to visualise epibranchial arch structures, especially 
the phox2b expressing facial placode or ganglion, glossopharyngeal placode or ganglion and vagal 
placode or ganglion.  Furthermore, a subpopulation of vagal neural crest cells could be visualised, 
known to contribute to the enteric nervous system (ENS) of the developing gut primordium. In 
addition we have seen strong phox2b-positive cells in regions in the hindbrain not comparable to the 
phox2b pattern in Zebrafish (Pei et al. 2013). This included the presumptive lateral rhombomeric lip, 
a region closely related to published data describing ventricular hindbrain opening (Wullimann et al. 
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2011) and presumably phox2b+ regions which might relate to the anterior and posterior trigeminal 
motor neuron and facial motor neuron (Ohata et al. 2009). Within the trunk of wild type embryos, 
neural crest cells completely populated the entire gut primordium up to the anus (Figure 5.14) by 4 
dpf. The dorsal aorta also expressed phox2b in a comparable fashion to Zebrafish (Elworthy et al. 
2005). 
    
         
 
Figure 5.13: Phox2b expression in the head of 4 dpf wild type embryos reveals new locations 
Images at different vocal planes after phox2 WISH. A) Dorsal focal plane of the head 
highlighting the presumptive lateral rhombomeric lip of the hindbrain ventricular opening 
(white asterisks) and an unspecified phox2b+ region within the midbrain B) Ventral focal plane 
of the head showing epibranchial arches C) lateral view labels head ganglion, including facial 
placode or ganglion (f), glossopharyngeal placode or ganglion (g) and vagal placode or ganglion 
(v). In addition neural crest derived vagal ganglion contributing to the enteric nervous system 
(ENS) are seen (nc) D-F) higher magnification of B respectively in different focal planes 
highlighting phox2b+ cells. D, highlighting the ventricular opening (white asterisks) of the 
hindbrain; E, representing presumably the anterior and posterior trigeminal motor neuron (Va 
and Vp) and facial (VII) motor neuron; F, epibranchial arches as described in C. Abbreviations: 
a, acoustic ganglion; al, anterior lateral line ganglion; e, ear; f, facial placode or ganglion; g, 
glossopharyngeal placode or ganglion; h, hindbrain; nc, neural crest population; pl, posterior 





Figure 5.14: Phox2b in enteric neurons and trunk region of 4dpf wild type embryos. 
WISH of 4 dpf embryos labelling phox2b+ cells within the trunk region. A) lateral view, enteric 
neurons (arrows) have fully penetrated the developing gut up to the anus. Inset showing single 
neurons within the posterior region of the gut.  Above the gut phox2b also labels the 
presumptive dorsal aorta (white arrow heads) B) Ventral view of the trunk showing enteric 
neurons (arrows) throughout the entire gut area. Scale bar = 100µm   
 
The expression profile of Medaka phox2b matches the one of Zebrafish, in which enteric neurons in 
the gut including the ventral aorta (Elworthy et al. 2005). This suggests that despite any dissimilarity, 
the phox2b anti-sense probe labels neural crest enteric gut derivatives in both Zebrafish and Medaka. 
Based on this, it should therefore be possible to investigate further neural crest migration towards 
the gut primordium in hirame mutants at 4 dpf (st.32) and earlier, which could provide insights into 






5.3.1 Reduction of xanthophores in hirame mutants 
Analysis of a second pigment cell marker GTP cyclohydrolyse I (gch) labelling the leucophore and 
xanthophore pigment cell lineage in Medaka revealed that gch positive cell numbers and distribution 
at stage 24 is similar in hirame to wild type sibling embryos. At that stage it is likely we observed only 
leucophores present within the fore- and hindbrain area as the onset of xanthophore differentiation 
in Nagao's study was only detected later around 27 somite stage (st.27), meaning that leucophore 
development at stage 24 in hirame is not compromised by the loss of functional YAP protein.   
In contrast, as soon as xanthophore lineage specification occurs, we could observe a dramatic 
increase in gch positive cells within the whole body of wild type embryos, not detectable in hirame 
siblings at stage 28. Although at this stage the marker labels both leucophores and xantophores, we 
speculate that this significant difference in cell numbers most likely reflects an abolishment of the 
xanthophore lineage only. We could speculate that the defect in xanthopore proliferation might be 
caused by altered PAX3 levels as pax3 is one of the earliest known marker for NC in Zebrafish and 
plays an important role for NCC EMT delamination from the neural tube, and is necessary for 
subsequent NC lineage specification in Zebrafish (Donoghue et al. 2008). 
To test the possibility of a complete xanthophore absence, we need to analyse both cell types 
separately. First we could image and quantify autofluorescent leucophores within living stage 28 
embryos, then substract this number from totals obtained after gch WISH, resulting in separation of 
leucophore and xanthophore populations. Secondly, we could analyse the expression pattern of 
another xanthophore specific marker like xanthine dehydrogenase (xdh) known to be lineage specific 
in Zebrafish (Parichy & Ransom et al. 2000). However Nagao et al. showed in his study that xdh also 
labels leucophores and xanthophores underpinning the fact that both cell types contain pteridines 
(sepiapterin in xanthophores and drosopterin in leucophores), making xdh non-specific marker of 
xanthophore lineage. Indeed their observations indicate that a xanthophore-specific marker may be 
very difficult to identify in Medaka. Furthermore, Nagao´s data strengthens our assumption of a lack 
of xanthophore formation as the hirame gch cell counts in stage 28 are comparable to leucophore 
counts obtained by Nagoa in 5dpf wild type embryos suggesting that we were only quantifying 
leucophores in stage 28 hirame embryos and not xanthophores.  
One hypothesis is hirame decreased xanthophore proliferation. This idea is based on the assumption 
that the gch+ cell incline in st.28 is due to a slight increase in leucophore numbers. We could 
speculate that the defect in xanthopore development might be caused by altered PAX3 levels. Pax3 is 
the earliest known marker for NC in Zebrafish and plays an important role for NCC EMT delamination 
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from the neural tube, and is necessary for subsequent NC lineage specification in Zebrafish 
(Donoghue et al. 2008). Mutations in PAX3 cause human congenital pigmentation disorders such as 
Waardenburg syndrome type I leading to a pigmentary disturbances of the iris, hair, and skin, along 
with hearing loss (Milunsky 2001). In mice, the pax3 mutant Splotch exhibits a reduced melanocyte 
pigment cell phenotype. However, melanocyte precursors (melanoblasts) develop and migrate 
normally, suggesting a role for pax3 in the expansion of melanoblasts (reviewed by Tremblay and 
Gruss, 1994) (Tajbakhsh et al. 1997). In fact another study by Gee et al. in (2011) demonstrated in 
Xenopus that YAP directly regulates pax3 via the TEAD DNA-binding domain and is able to expand the 
pax3+ neural plate border zone (pax3+) when overexpressed, indicating a direct relationship. 
Contributing data comes from recent studies in Zebrafish by Minchin & Hughes (2010). They have 
shown that knockdown of pax3 led to specific xanthophore and enteric neuron reduction especially 
in the trunk along with a dramatic increase of melanocytes in later stages after an initial reduction in 
melanoblast numbers and migration at early stages. The decrease in xanthophores later strongly 
correlated with an increase in the numbers of melanocytes at later stages. This correlation has not 
been observed in homozygous hirame mutants as melanocyte numbers seem to be reduced and do 
not recover until embryonic lethality at 4 dpf. The melanophore development and migration failure 
prior to 48 hpf Minchin & Hughes have observed, could reflect either a cell autonomous requirement 
for Pax3 in early NC cells, or an environmental effect on NC initiation and migration. In splotch mouse 
mutants however, it is not clear if the observed melanocyte defect might have recovered as splotch 
homozygous mice die at E14, but it is shown that heterozygous mice do exhibit melanoblast 
migration defects, and humans with Wardenburg Syndrome I with dominant PAX3 loss of function 
mutation show pigmentation alterations. In fact another study by Gee et al. in (2011) demonstrated 
in Xenopus that YAP directly regulates pax3 via the TEAD DNA-binding domain and is able to expand 
the pax3+ neural plate border zone (pax3+) when overexpressed, indicating a direct relationship. 
Therefore, it might be possible that YAP influences or controls PAX, thus resulting in early 
melanoblast migration defects. Because hirame is embryonic lethal, we cannot know if this defect 
would recover later or not. Our data however firmly suggests that loss of YAP in hirame before 4 dpf 
ablates xanthophore development and reduces later melanocyte numbers dramatically as previously 





5.3.2 Abnormalities of elavl3/HuC expression within the head and 
developmental defects within DRG’s in hirame mutants 
Aspects of Zebrafish sensory neurogenesis are controlled by a single neurogenin 1 (neurog1) gene 
compared to two neurog1 and neurog2 in mammals and birds. In Zebrafish, neurogenin1 is 
expressed in all neurogenic placodes including trigeminal, lateral line, epibranchial placodes and otic 
vesicle, which will later form the acoustic ganglion and in neural crest precursors for DRGs. In mouse 
studies, even so the expression of ngn1 was transient, and knockdown of ngn1 blocks differentiation 
of all Zebrafish cranial ganglia as well as trunk dorsal root ganglia (Ma et al. 1999; Andermann et al. 
2002). The early neuronal marker HuC antibody recognises Hu antigens encoded by elavl3. It marks 
neuronal precursors and the differentiated peripheral nervous system, and has been used to analyse 
neuronal structures in the hirame mutant at different stages of embryonic development.    
Our findings in section 5.2.2 indicate that loss of YAP leads to misplaced cranial ganglia in stage 24 
hirame embryos, which seem partially recovered by stage 28, in which posterior cranial ganglia and 
ganglia arising in the region of rhombomere 4 are positioned more closely to the body axis. However, 
the size and overall structure is still dissimilar from its wild type siblings. We also observed that the 
hindbrain ventricular zone opening is much narrower in hirame mutants in which rhombomeric 
structures 1 to 7 were hardly distinguishable due to smaller neuronal boundaries. The hindbrain also 
seems to lack expression of elavl3/HuC within the presumptive upper rhombic lip underneath the 
cerebellum and the mid-hindbrain-boundary (MHB). Determining whether this structure is 
completely missing or just lacking neuronal expression requires further investigation. Two 
possibilities present themselves for this: firstly to section st.32 embryos and analyse morphological 
differences, and secondly label the individual hindbrain regions. The hindbrain ventricle opening 
could be labelled with ZIC family member 1 and 4 (zic1 and zic4) (Elsen et al. 2008), upper rhombic lip 
and dorsal neural progenitors could be specifically labelled with atonal homolog 1a-c (atoh1) and the 
underlying ventricular zone with pancreas specific transcription factor 1a (ptf1a) (Kani et al. 2010). 
This would more reliably determine which tissue structures are partly or fully present, or absent.  
Another observation was the absence of complete forebrain structures throughout both stages in 
hirame, which might be analysed through morphological structure examinations as well. 
Furthermore we observed a significant reduction in the number of dorsal root ganglia within the 
trunk region in hirame mutants. Our somite counts at stage 32 revealed that hirame develops similar 
quantities of somite pairs to wild type embryos, which excludes the possibility of general 
developmental retardation. This suggests that the defects seen within the DRGs are likely to reflect a 
real role for YAP in DRG neural development. We hypothesise that the level of neurogenic factors 
such as ngn1 driving DRG specification and migration could be affected. Analysing the expression 
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levels of ngn1 with in-situ hybridisation could be taken into consideration. We have recently 
obtained and tested the ngn1 anti-sense probe for Medaka (gift from Dr H. Hashimoto), however the 
purity and specificity of the signal remains to be optimised fully (Appendix 13). Even after 
optimisation, such as altering permeabilisation time or probe length, the background levels were still 
high and neurogenic signal remained weak, making the Medaka ngn1 a difficult probe to use reliably. 
Another possibility would be to quantify expression levels in separate trunk sections of st. 32 hirame 
embryos, as we would assume a drop in neurogenin levels. The same experimental approach could 
be taken when analysing Sox10 levels in hirame mutants to investigate whether defects in neural 
crest derivatives investigated so far could be due to altered levels of the early NC marker.       
 
5.3.3 Sox9b expression analysis within wild type and hirame   
In 2005 Klüver et al. identified the second sox9 orthologue in Medaka through sequence analysis and 
linkage mapping as well as expression pattern. Our aim was to investigate the sox9b expression in 
hirame mutants at different stages of development to establish any links between the loss of YAP 
and the expression of early neural crest marker sox9b. In general the expression pattern we have 
observed with the sox9b anti-sense probe made by Dr H. Hashimoto matched the published data 
from Klüver et al. which means we have successfully labelled the same orthologue of sox9.   
Our in situ hybridisation at early stage 20 (1 day 7.5 hpf) showed strong expression within the 
craniofacial neural crest in the hindbrain region, otic placode precursors and trunk neural crest along 
the lateral body axis. Our finding affirm the sox9b expression pattern found in early zebrafish 
development (Li et al. 2002) in which the neural crest and otic placode lineage was marked. In wild 
type this expression pattern was very distinct. However, in hirame siblings we observed additional 
sox9b+ cells still situated on top of the yolk sac. Because the ectopic cell expression in hirame was 
diminished in later stage 24 embryos, we conducted cross sections in the region of the preplacodal 
ectoderm and analysed in situ hybridisation at earlier stages of embryonic development. Whole-
mount in situ hybridisation confirmed that between st.17 and st.19 hirame embryos exhibited a 5.5h 
delay in migration of sox9b+ prospective neuroectoderm towards the midline, and ectodermal sox9+ 
cells in hirame remained on top of the mesenchyme. We speculated that the migration delay is likely 
due to a slower convergence during gastrulation. A real-time imaging series confirmed that in hirame 
embryos the migration of the enveloping shield of the blastoderm seem to be delayed, resulting in 
slower sox9b expression in cells towards the embryonic shield.  
However, the migration delay of sox9b+ cells within the blastoderm seen in hirame mutants is 
possibly a secondary effect of the delay in epiboly closure itself caused by a migration delay in 
underlying cell layers. It is likely that deep cells (mesodermal and endodermal) migrate slower, which 
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consequently delays epiblast (ectoderm) migration. This would indicate that the sox9b+ ectodermal 
neural crest and placodal precursors are migrating slower on top of the hypoblast, an arrangement 
we have seen in our resin sections (Figure 5.5).   
Studies of sox9b at later stages in Medaka and Zebrafish have shown a sox9- expressing neural crest 
population within the trunk region (Klüver et al. 2005; Li et al. 2002; Chiang et al. 2001). Our findings 
using in situ hybridisation for sox9b at 3 dpf confirmed these data. Additionally we were able to 
observe sox9b expression within somites and neural crest cell populations at the dorsal midline 
region. Noticeably, at the tail end sox9b is strongly labelled in wild type embryos (Figure 5.8), a signal 
which seemed to be weaker towards the anterior trunk region. As well as this, in hirame we could 
not clearly identify a distinctive sox9b+ region above the neural tube, unlike its wild type siblings. In 
Zebrafish, Li et al. argue that this region in the caudal-most proximal part of the dorsal midline is 
where  sox9b cells mark the formation of the median fin. However, my speculation is that this marks 
premigratory trunk neural crest cells emerging from the dorsal part of the neural tube, a similar 
pattern observed in the neural crest marker foxd3 (Kelsh & Dutton et al. 2000). Supporting this, 
studies in Xenopus have shown that sox9b and foxd3 are downstream targets of transcription factors 
of PAX3 and ZIC1, both essential to specify the NC fate in the amphibian ectoderm (Hong & Saint-
Jeannet 2007; Sato et al. 2005; Bae et al. 2014).  
Liu et al. have shown in 2013 that Sox9b is not only important for NC fat specification, but also for NC 
delamination in its phosphorylated state, which is induced by morphogenetic protein (BMP) and 
canonical Wnt signalling. This could indicate that the sox9b+ cells in the proximal posterior region of 
the trunk close to the tail end are present during events of NCC delamination. As we could not see 
any of these regions more upstream anteriorly, it could mean that sox9b is only transiently switched 
on during epithelia-mesenchymal transition events and downregulated after NCCs have left 
premigratory positions, as low expression in the anterior wild type trunk sections confirmed. Our 
observed sox9b+ pattern within the dorsal trunk neural crest region at the tail end was supported by 
Zebrafish records (Li et al. 2002). We concluded, that the sox9b:gfp transgenic line established by 
Nakamura et al. in 2008 would provide a valuable tool for analysing neural crest processes in vivo in 
real-time. Our examination of 7 dpf embryos revealed GFP expression within the craniofacial 
cartilage, pectoral fin buds, the heart and the anus sphincter, confirming previously published sox9b 
expression patterns in Medaka (Klüver et al. 2005). Future experiments could include the cross of 
sox9b:gfp transgenics with Cabj50-20C or HB32Cj50-20C to analyse the neural crest delamination process 
in vivo as we were not able to produce conclusive results of this event in hirame with in situ 
hybridisation followed by resin sectioning.    
In this chapter we analysed various neural crest markers to draw conclusion about the role of YAP 
during neural crest development. Our previous melanocyte studies revealed two major findings: 1.) 
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Hirame exhibits an early yolk sac specific melanoblast migration defect and 2.) Hirame displays a 
drastic melanocyte reduction in later stages of development. Our aim was to complement our 
findings with further NC cell type defects. During early stages, the only abnormality we could find 
was a slower cell convergence during epiboly resulting in delayed sox9b+ cells arriving to their 
destination sites. Other than that, all other NC defects were observed beyond st.28 (~ 3dpf). Herein, 
the lack of functional YAP results in a possibly complete lack of xanthophore lineage and dorsal root 
ganglia formation is compromised. Therefore, defects observed here cannot simply be explained by 
cell migration deficiencies. Late stage defects by be a result of missing YAP protein, but it might also 
be a secondary effect due to changed body morphology of hirame mutants. For instance, the shape 
of somite structures might influence the DRG development in some aspects. In addition, novel 
marker including the myogenic basic protein 1 (mbp) and  paired-like homeobox 2 protein (phox2b) 



























































During a random mutagenesis screen carried out in 2004, Furutani-Seiki et al. discovered a unique 
Medaka mutant named hirame. This embryonic lethal mutant carries a point mutation within the 
first WW domain in the Yes-associated protein exchanging leucine to a stop amino acid codon in the 
164th position in allele j54-20C (L164X). In teleosts maternal yap transcripts are ubiquitous until mid-
blastula-transition. After that zygotic yap is enriched in tissues such as notochord, brain, eyes, 
branchial arches and pectoral fin (Jiang et al. 2009). Hirame mutants exhibit defects in convergent 
cell movements resulting in reduced dorso-ventral thickening. Later in development hirame mutants 
remain flat bodied including a flattening of the CNS, and develop liver abnormalities due to a failure 
in endodermal convergence and rod formation. Furthermore, the mutants also present mislocated 
tissues such as heart and the lens (Furutani-Seiki et al. 2004; Watanabe et al. 2004; Kitagawa et al. 
2004). YAP is a transcriptional co-activator downstream of the Hippo Signalling Pathway which 
promotes cell survival, proliferation and maintenance of the 3-dimensional tissue structure (Jiang et 
al. 2009a; Sudol et al. 1995; Lian et al. 2010; Huang et al. 2005). Disturbance of the Hippo pathway 
downstream effector YAP has been described in great detail. Impressive studies demonstrate the 
oncogenic potential of YAP in liver enlargement (Camargo et al. 2007) and hepatocellular carcinoma 
(Dong et al. 2007) as well as epidermal stem cell proliferation and tissue expansion (Schlegelmilch et 
al. 2011). In addition overexpression in mammalian in vitro cultures revealed features of oncogenic 
transformation such as anchorage-independent growth, epithelial-mesenchymal transition and  
accelerated cell migration (Overholtzer et al. 2006; Fu et al. 2014) suggesting that overexpression of 
YAP in these tumours alters cell physiology causing increased primary melanoma tumour growth and 
metastasis formation (Lamar et al. 2012; Nallet-Staub et al. 2014). In regards to the neural crest, YAP 
seems to regulate the proliferation of neural progenitors within the dorsal neural tube and controls 
Pax3 expression (Milewski et al. 2004; Gee et al. 2011). 
Our initial microscopic observations of 3 dpf (st.28) hirame embryos hinted towards a reduction of 
neural crest melanocyte numbers on the yolk sac (RN Kelsh personal communication). 
However, those very limited studies of YAP function in neural crest left many questions unanswered, 
so that we felt that we have been given a unique opportunity with the hirame mutant to analyse the 




6.2 YAP regulates melanoblast migration during early 
embryogenesis 
Our initial microscopic observations of 3 dpf (st.28) hirame embryos hinted towards a reduction of 
neural crest melanocyte numbers on the yolk sac (RN Kelsh personal communication). We began by 
examining this phenotype in some detail. We have shown using dopachrome tautomerase (Dct) in 
situ studies that the first detectable melanoblast alteration in hirame occurs as early as st.20 (1d 
7.5h). Up to stage 21 total melanoblast numbers are unaffected, however their distribution is altered 
and cells seem to rest and accumulate alongside the embryonic body axis rather than migrating 
proportionally onto the yolk sac. This is the earliest neural crest defect after maternal yap transcripts 
were undetectable and before the hirame body collapses (st.22) (Porazinski 2013), indicated that this 
melanoblast defect is likely directly due to the lack of functional YAP and not because the three-
dimensional body structure has been compromised. Beyond st.21, the number of melanocytes 
stabilises or gradually decreases in hirame mutants, compared to wild type in which those numbers 
increase dramatically. To date, we are not sure if a lack of proliferation or apoptosis causes the 
reduction of melanocytes observed in hirame. To test the possibility of low cell survival, a terminal 
transferase dUTP nick end labelling (TUNEL) assay could be performed in parallel to Dct in situ whole-
mount hybridisation. This approach would reveal if melanoblast survival is limited in hirame 
embryos. Another hypothesis is that melanoblast proliferation in hirame is reduced. Cell proliferation 
can be tested with 5-bromo-2´-deoxyuridine (BrdU) and possibly could be connected with Dct whole-
mount in situ hybridisation. The idea is to treat embryos with BrdU, which incorporates into newly 
synthesized DNA during cell proliferation. After BrdU treatment over a 24h period, embryos could 
then be fixed and Dct in situ hybridisation will be carried out. Anti-BrdU antibody staining will follow 
to obtain double staining and determine proliferation within the melanoblasts cell population.  
Hirame mutants provide a currently unique model in which to assess the role of Hippo signalling in 
melanoblast migration during early embryonic stages. This may be of particular relevance to address 
key aspects of cancer migration as well. Both, NC and cancer cells are known to migrate alone or as 
collective groups (Woods et al. 2014; Wong et al. 2014). In addition, active and highly migratory 
neural crest cells exhibit features during development similar to cancer cell progression, starting 
from epithelial-mesenchymal transition to active migration into distant sites of the body which 
requires the need to adapt to numerous tissue environment (Uong & Zon 2010).  Because of those 
similarities, it has been suggested that some tumours might recapitulate parts of NC development in 
a dysregulated manner (Duband, 2010; Kerosuo and Bronner-Fraser, 2012; Lim and Thiery, 2012; 
Theveneau and Mayor, 2012; Thiery et al., 2009).  
174 
 
6.3 Future potential of the novel Medaka Dct:eGFP 
transgenic lines  
To broaden our analysis of the melanocyte defect observed in hirame, we aimed to utilise a 
promoter under which we could one hand label melanoblasts and track their in vivo progression and 
on the other hand express target genes in future studies. We do know of another Medaka fish line 
expressing GFP in melanocytes under the control of Medaka tyrosinase promoter (Martinez-Morales 
et al. 2009). However, the expression pattern in this line has not been published in detail. In addition, 
we were not able to obtain the tyr anti-sense probe for comparison studies to Dct.  
We characterised and validated a Medaka Dct promoter fragment recapitulating endogenous 
expression in melanocytes, which we utilised to establish Dct:eGFP transgenic lines. Germline 
transmission was achieved in 8 lines revealed melanocyte-specific eGFP expression up to larvae 
stage, although 2 of these lines melanocyte expression was mosaic, likely due to clonogenic silencing 
mechanisms. None, of the lines showed ectopic cell expression making our construct remarkably 
reliable for transgenesis studies. Although not achieved in this work due to time constraints, a 
natural next step would be to use these Dct:eGFP transgenic lines to analyse the in vivo melanocyte 
patterning defect in hirame mutants in real-time during embryonic development by time-lapse 
microscopy. This would nicely complement the proliferation and TUNEL experiments suggested 
above, as well as providing direct evidence of the proposed melanoblast migration defect.  
During polarised cell migration, molecular events at the leading edge of the cell are coordinated with 
those at the trailing edge, an organisation which is well characterised, especially in regards to the 
actin cytoskeleton and adhesion molecules (Ridley et al. 2003). Actin assembly at the leading edge of 
the cell is associated with the filopodia formation required for directed migration, whereas at the 
back molecules connecting to actin get disassembled and retract from the surface the cell migrates 
on (Le Clainche & Carlier 2008).  The formation of filopodia is a result of the cell acting to external 
stimuli. This leads to an asymmetric redistribution of cell-surface receptors, internal cytoskeleton 
arrangement and establishment of a leading protruding edge (Ridley et al. 2003). If the internal 
polarity network is inhibited, the cell cannot perform directed cell migration, resulting in decreased 
migration speed and increased filopodia number. With our new Dct:eGFP transgenic lines we now 
have a platform with which to track individual melanoblast cells in vivo in hirame and wild type 
embryos as early as st. 20 to determine the polarity of individual melanoblasts during yolk sac cell 
migration. Widespread cytoplasmic eGFP would label the entire cell, highlighting cell protrusions and 
the position of the nuclei. Consequently, they should permit assessment of the amounts and 
direction of protrusions, allowing us to establish whether in hirame mutants melanoblasts undergo 
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directed migration, or if polarity is lost. The Medaka Dct:eGFP transgenic lines would also provide a 
valuable tool for pigment cell researchers studying other Medaka pigment cell mutants (Kelsh et al. 
2004). For example, it could be a used to determine at what stage and region neural crest cells 
become committed to the melanocyte lineage in Medaka embryos, as this has not been done to our 
knowledge. In addition, the promoter now provides a well-characterised tool for transgenesis 
purposes and could be combined with pigment cell mutants to answer questions about their genetic 
influence on the melanocyte lineage. The Dct:eGFP line could also be utilised to isolate cells for 
instance with FACS sorting. Once the pigment cell population is isolated it can then be individually 
analysed for instance for its transcriptional finger print or proteomics.   
 
6.4 Yolk sac membrane cells undergo apoptosis  
We unexpectedly observed fragmented nuclei within the yolk sac membrane in hirame embryos, 
which we hypothesised could contribute to why melanoblasts do not migrate onto the yolk sac. 
Transmission electron microscopy revealed that karyorrhexis is accompanied by apoptotic bodies 
separated by a membrane, one of the characteristics of programmed cell death compared to 
necrosis (Corcoran et al. 1994).  
We hypothesised that, if YAP action in melanoblast migration is non-cell autonomous to the 
melanoblast, yap mRNA injection into the yolk sac would rescue the melanoblast migration defect 
through restoration of environmental factors in the yolk sac membrane. The principle of this 
experiment is insofar attractive, because it might propose another way of introduce mRNA or other 
substances into the embryonic tissue.  Sadly, this experimental method yielded no success, either 
due to biological uncertainties with the experimental approach, or because YAP functions cell-
autonomously within melanoblasts. So far, we are not sure, if yap mRNA was taken up by the 
syncytial layer and translated into functional protein to exhibit any non-cell autonomous function. 
One approach to help resolve this issue would be to extract cells of the yolk sac layers and then 
perform quantitative PCR for YAP downstream target genes to evaluate if functional YAP protein was 
present.  
In addition, yap mRNA injection into the cytoplasm of one-cell stage embryos restored the 
melanoblast migration defect an astonishing frequency. The rescue was aided by the fact that in 
addition to the blastoderm, injected solutions distribute widely within the membranous layers 
surrounding the yolk cell as well, in which yolk sac melanoblasts migrate. Our additional data 
confirms that solutions do not mix between the yolk sac cytoplasm and the blastoderm, because 
cytoplasmic streaming does not occur in Medaka. One of the possibilities discussed is that functional 
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YAP protein restores the extracellular matrix components that provide cues for migrating 
melanocytes (Duband & Thiery 1987; Sternberg & Kimber 1986; Trainor 2013). To test that, we could 
perform immunohistochemical analyses for ECM components to assess their polymerisation status.  
 
6.5 Drawbacks and potential of a Dct:eGFP-YAP 
transgenic line 
One of our interests was to investigate if overexpression of YAP within the melanocyte lineage driven 
by the Medaka Dct promoter could rescue the melanocyte patterning defect in a cell-autonomous 
fashion. We successfully established an overexpression cassette in which an egfp reporter gene is 
linked to either a wild type or a mutated activated form of YAP (S87A). Unfortunately, we came 
across some major setbacks when we established those overexpression lines. We did not observe 
evenly distributing and lasting eGFP expression within cells. EGFP-YAP fusion protein seemed to 
aggregate and photobleach within some cells, whereas the majority of melanoblasts remained 
unlabelled. In general, most transgenic embryos exhibited this phenotype and further investigations 
need to be carried out to explain this phenomenon. Our favoured explanation is that the error might 
be due to protein misfolding or toxic fusion protein levels. 
The important question is whether we obtained any functional YAP fusion protein within the 
melanocyte lineage. This could be assessed by qPCR for altered expression of YAP downstream target 
genes. The opportunities given by a successful transgenic line, even if we are not able to see eGFP, 
would be immense. It would first answer the question whether YAP can act cell-autonomously for 
melanocyte migration and possibly could influence their numbers as well. It might also have the 
potential to alter the melanocyte physiology and might generate melanocytes of a precancerous 
state. This would be a feature to look out for as overexpression of YAP has been reported to have 
oncogenic potential and transform epithelial cells as well as accelerate metastatic melanoma growth 
(Overholtzer et al. 2006; Nallet-Staub et al. 2014). In that case, our transgenic line could turn into a 
another teleost melanoma model to already existing well know ones available to date (Patton et al. 
2005; Michailidou et al. 2009; Anelli et al. 2009; Feng et al. 2010; Schartl et al. 2010).   
One general setback on which we have not embarked before, was that we do not have a refined YAP 
anti-sense in situ probes, which would clearly label the spatio-temporal expression of yap either in 
normal melanocytes or within the melanocyte pattern of our Dct:eGFP-YAP transgenic lines. ISH 
analyses in Zebrafish have demonstrated that yap is nearly ubiquitous without distinctive melanocyte 
pattern (Jiang et al. 2009b). This could mean that either YAP is not present within melanocytes or the 
transcription level is below the detection threshold. Alternatively, we could consider an antibody 
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detection method. However, so far we could not manage to find an optimal antibody without 
background noise, as Western Blotting using Medaka cell extractions included non-specific antibody 
binding (Dr H. Davies personal communication; data not shown),  
 
The potentials of this transgenic line lay towards drug screening models and models to study cancer 
initiation and progression in vivo. If it could be shown that these lines in some way promoted 
melanoma formation, we could face a potential drug screening system in which we could test YAP 
specific targeting in a live in vivo melanoma model. Some of the drugs, we might be able to use are to 
limit oncogenic YAP activity are: Verteporfin, Latrunculin A/B/C, Blebbistatin, ML7, Botulinum and 
Y27632. Verteporfin (brand name Visudyne) inhibits the YAP–TEAD interaction and subsequently 
transcriptional activity mammalian in vitro culture studies. It also reversed the liver expansion and 
development of hepatocellular carcinoma caused by YAP overexpression or Nf2 deletion in mouse 
livers (Liu-Chittenden et al. 2012) (Wada et al. 2011).  YAP is regulated by the amount of F-actin 
stress fibers, the mechanical tension through extracellular force and the cell geometry (Dupont et al. 
2011). The disruption of F-actin stress fibers or actin polymerisation with F-actin targeting Latrunculin 
A/B/C indirectly inhibited YAP nuclear localisation as well as YAP/TEAD activity in numerous in vitro 
cell lines, as (Dupont et al. 2011; Wada et al. 2011). Some other less well studied drugs which might 
indirectly inhibit YAP`s nuclear presence are Blebbistatin which targets through the non-muscle 
myosin tested in various cell lines (Johnson & Halder 2014; Dupont et al. 2011). The same applies to 
ML7 actin through MLCK, Botulinum toxin C3 through RHO and Y27632 (Dupont et al. 2011) having 
an impact on YAP activity by effecting with RHO kinases (Johnson & Halder 2014). 
 
 
6.6 YAP regulates the development of late stage 
xanthophores and dorsal root ganglia 
We demonstrated that the number of late deriving melanocytes was compromised. Similar results 
were obtained in xanthophores, the second pigment cell type, using the marker GTP cyclohydrolyse I 
(gch). Gch is the enzyme converting  guanosine triphosphate (GTP) to dihydroneopterin triphosphate 
and later to tetrahydrobiopterin (BH4), a required substrate for pterine pigments in early 
xantophores. Compared to Zebrafish gch does not label early melanocytes (Parichy & Ransom et al. 
2000), but has been reported to include leucophores (Nagao et al. 2014). We observed that the early 
population of leucophores within the ventral head and the anterior trunk is not affected in hirame 
embryos before xanthophore differentiation occurs. In contrast, the xanthophore numbers are 
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dramatically reduced or even completely lacking in hirame beyond 3 dpf. A complete loss of 
xanthophore differentiation would have major implications of the requirement of YAP for 
xanthophore commitment and would identify YAP as a potential specifier of this lineage. To establish 
the complete loss of xanthophore differentiation, we would need to find a way to distinguish 
leucophores and xanthophores. Studies suggest that xanthophores can be visualised via UV (Nagao 
et al. 2014), whereas leucophores exhibit strong autofluorescence when excited within the 
wavelength of green to red light (equivalent to 488-564nm). This might be one way to separate those 
two cell types. Within the trunk region, we observed a reduced number of peripheral dorsal root 
ganglia in late stage embryos.  Just like the melanocyte phenotype, this defect may result directly 
from a lack of YAP, rather than simply a result of developmental retardation since somite counts are 
normal in stage-matched embryos. Despite the fact that somite pairs were deformed, the actual 
numbers were very similar to wild type embryos.   
 
6.7 YAP regulates migration of sox9b positive cells 
during gastrulation 
We have shown that the Medaka sox9b isoform we obtained matched the early expression profile in 
wild type embryos described in published records (Klüver et al. 2005).  At st. 20 wild type siblings 
exhibited strong cranial and trunk neural crest labelling as well as otic placodal precursor. It also 
highlighted that in hirame those ectodermal cell populations showed a pattern consistent with 
slower convergent-extension movements. At later stages, sox9b marks premigratory trunk neural 
crest in wild type embryos, which we were not able to visualise in hirame, possibly to the collapsed 
body morphology and weak sox9b expression.  
 
6.8 Expression pattern of novel Medaka neural crest 
markers mbp and phox2b 
We also attempted an initial analysis of novel Medaka neural crest markers myelin basic protein 
(mbp) and the paired-like homeobox 2 protein (phox2b). When we examined the spatio-temporal 
expression pattern of mpb, we could observe striking similarities to those in Zebrafish. It clearly 
labelled the branchial arches within the lateral region of the head. It also revealed some anatomical 
structures we have not been able to find in the Zebrafish literature. We observed individual cell 
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bodies and axonal branching, which might be reticulospinal neurons within the hindbrain region. 
Within the trunk region, characteristic mbp+ Schwann cells were clearly labelled as well as individual 
oligodendrocytes. Because Schwann cells have already fully migrated along the posterior lateral line 
towards the tail end and oligodendrocytes within the spinal cord are formed by 5 dpf, we 
hypothesise that it might be possibly to assess the mbp expression pattern in hirame embryos to 
assess whether there may be an effect on the peripheral nervous system in this mutant.  
The phox2b expression pattern turned out to label structures comparable to those seen in Zebrafish 
as well as ones. It labelled clearly facial placodes or ganglion, glossopharyngeal placode or ganglion 
and vagal placode or ganglion, as well as vagal neural crest cells known to contribute to the enteric 
nervous system (ENS) of the developing gut primordium. All of those structures can be found in 
Zebrafish as well (Elworthy et al. 2005; phox2b on Z-fin database). We also observed phox2b 
expression in new locations, not described in Zebrafish before. This included the presumptive 
rhombomeric lip (Wullimann et al. 2011) and a population of trigeminal and facial motor neurons. 
Within the trunk we observed close similarities to the phox2b expression pattern seen in Zebrafish, in 
which the enteric neurons and ganglia are labelled as well as the ventral aorta.  
The difference we have found especially within the head region might be due to evolutionary 
convergence between Zebrafish and Medaka placing them 115-200M apart from each other 
(Furutani-Seiki & Wittbrodt 2004) . Zebrafish has two duplicates of phox2 genes, phox2a and phox2b 
(ensemble). Medaka seems to have different duplicates or isoforms of phox2b transcripts, however 
only one phox2b has been annotated (ensemble). Our hypothesis is that the distant placement of 
Medaka and Zebrafish in evolution might have provided enough time for Medaka to develop gene 
duplications within the phox2b gene. In that case either fragments of duplicates might have been 
transferred or other gene fragments might have been inserted into the phox2b gene location. In the 
latter, a gene fragment required for rhombomeric lip development might have been inserted, 
explaining the additional expression pattern.  
Overall, those two newly described neural crest markers provide another great tool for the Medaka 
community to study the cellular development of the central and peripheral nervous system, including 
neural crest derived glia.  
 
6.9 Impact of this work 
The novel findings and potentials within this work can be summarised as follows:  
1. YAP regulates melanoblast migration during early stages of development and is 
responsible for the increase of melanocyte population beyond 1 day and 10 hours after 
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fertilisation. Therefore, the migration defects can be seen as a specific effect caused by 
lack of functional YAP protein as phenotypicall defects are not present before 1d10h. 
This means, cellular mechanisms involved in cell migration can be studied excusively in 
vivo in real-time during this time window.     
 
2. YAP is required for the cell survival of yolk sac cells. This observation to our knowledge is 
novel and suggests that YAP is required for the extra-embryonic tissue in Medaka. 
Therefore, analysis of this particular type of tissue, including the syncytial layers during 
early gastrulation would give an interesting insight into the involvement of the Hippo 
pathway during gastrulation. In that regard, the delayed epiboly closure during 
gastrulation, we have observed, would provide additional results strengthening this 
proposed experimental direction. 
 
3. YAP controls the differentiation of xanthophores as well as dorsal root ganglia. The 
specific hinderniss of complete xanthophore development in hirame is very interesting 
insofar any other pigment cell lineage has not been compromised in its initiation. This 
could hint towards the requirement of YAP in the xanthophore cell specification process 
originating from a pigment cell precursor. Therfore, one hypothesis could be that the loss 
of xanthophores could compromise for the low decrease of melanocyte numbers beyong 
3dpf.  
 
4. Dct:eGFP transgenic lines have been established expressing eGFP in a melanocyte 
specific expression as early as 1 day and 7.5 hours after fertilisation. The establishment 
of this transgenic line is providing a valuable tool for the wider Medaka research 
community. It contributes to future research output, as we are now able to investigate 
and monitor pigment cell development in a living Medaka fish.   
 
5. Novel Medaka neural crest markers elavl3/HuC, mbp, phox2b and have been 
characterised via in situ hybridisation. The establishment of those probes and their 
thorough evaluation provides indeed another very useful tool for the wider research 
community wanting to utilise easy-handable neural crest markers. The availability of 
those markers would safe valuable time and expenses for future studies. In addition, it 
makes Medaka an equal model organism to work with compared to the widely-used 































Appendix 1: Zebrafish embryo pigmentation pattern 
Dark coloured melanin-rich melanophores develop three distinct body stripes and an 
additional fourth stripe on the ventral side of the body. D, dorsal stripe; L, lateral stripe; V, 
ventral stripe and YS, yolk sac stripe. In addition, silver iridophores are present in dorsal, 
ventral and within the yolk sac stripe and xanthophores appear yellowish mainly in the dorsal 




Appendix 2: Methods 
In-house mini-prep DNA purification 
Inoculate bacteria and grow overnight at 37°C, 225rpm  
↓centrifuge at 15000 rpm, 1min 
Precipitation: 
↓ 100µl Sol I  vortex 
↓ 200µl Sol II  invert 3-4 times 
↓ 150µl Sol III  invert 3-4 times 
↓ 100µl Phenoly/Chlorophorm  vortex 
↓ centrifuge 15000 rpm, 3min  transfer upper layer into new tube 
↓ 500µl isopropanol  vortex 
↓ centrifuge at 1500rpm, 10-20min  remove supernantant 
↓ was with 70% Ethanol 
↓ add 20µl TE or water including 1µl RNAseA  
 
Sol I = 50mM Glucose, 25mM TrisHCl pH 8, 10mM EDTA (autoclave) 
Sol II = 0.3M NaOH, 1% SDS 
Sol III = 60ml of 5M KOAc, 11.5ml acetic acid, 28.5ml ddH2O 
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Preparation of resin samples 
Day 1: Agarose block preparation 
- Wash embryos in PBS to remove residues of glycerol 
- Prepare 1.5% agarose in dH2O  
- Place embryo on clean 10cm petri dish  
- Cover the embryo with a few drops of warm, but not hot agarose 
- Orientate embryos quickly with forceps so that area of interest faces up and embryo is 
centered  
- Cut out agarose blocks after solidification in the width of the mould later used   
- Place blocks in acetone overnight at RT, wrap in foil  
Day 2: Hardener I 
- Take 0.06g of Hardener I and fill up to 10ml with cold curin resin, dissolve completely 
- Exchange prepared Hardener with acetone 
- Leave overnight at RT, wrap in foil 
Day 3: Hardener II and embedding 
- Premix 0.06g Hardener I in 10ml of cold curin resin, dissolve completely 
- Take 3ml of premix and add 100µl of Hardener II (with cutted pipette tip) 
Now work fast! – once the Hardener II mix turns brown it should not be used anymore 
- Place agarose block with embryo in premix (rinsing) and place it subsequently up-side-down 
into the well of the mould and adjust orientation with forceps  
- Add Hardener II mix to the mould to cover the agarose block completely 
- Seal the resin with film (if it swims on solution, take off a bit of Hardener II solution to make 
it air-tight) 
- Place mould gently into 4°C fridge overnight 
Day 4: Clean blocks – ready for use 
- Remove film from mould  
- Remove blocks from mould and clean with tissue 
Note: blocks should be solid and transparent; if brown and jelly-like, the resin was exposed 




Neutral Red counter staining 
Resin sections are dried on Superfrost Plus slides (Menzel, Germany) overnight at RT 
Rehydrate: 100% Ethanol rinse 
  100% Ethanol 5 min 
  90% Ethanol 1-2 min 
  70% Ethanol 1-2 min 
  50% Ethanol 1-2 min 
  dH2O  30 min 
- Stain with 1% Neutral Red (Sigma Aldrich, Cat# N7005, in dH2O) for 3 min 
Dehydrate:  dH2O  rinse 
  50% Ethanol rinse 
  70% Ethanol rinse 
  90% Ethanol rinse 
  100% Ethanol 5 min 
- Dry on air or heater at 37°C 
- Was with Xylene to remove oil pen (if applied on slides) 
- Dry on air 
- Mount in DePex 
 
Transmission electron microscopy sample preparation 
Pre-fix:  4% PFA in phosphate buffer, incubate overnight at 4°C, then embed, fix again  
Fixation: 2.5% Glutaraldehyde + 2% PFA + 0.05% CaCl2 in 0.1M Sodium Cacodylate Buffer pH 7, 
  incubate overnight at 4°C 
Rinse 1: 0.1M Sodium Cacodylate buffer pH 7.4 
Postfixation:  1% Osmium tetroxide + 1.5% Potassium Ferricyanide in distilled water, leave for 1h 
  at RT 
Rinse 2:  Distilled water 4x over 15min 
Stain:  1% aqueous Uranyl Acetate, incubate for 1h in the dark 
Dehydration: in acetone: 
  50% - 15 min at 4°C 
  70% - 20 min with 2 changes at 0-4°C 
  80% - 20 min with 2 changes at 0-4°C 
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  90% - 15 min aith 2 changes at 0-4°C 
  95% - 15 min with 2 changes at RT 
  100% dry – 30 min with 2 changes at RT 
Infiltration: 1:1 Acetone 100% dry: LV Epoxy Resin for 1 hour 
  100% Resin – overnight 
  100% Resin – 1 hour 
Embedding:  Embedding in LV Premix Epoxy Resin for  
Polymerisation:for 24 hours at 60°C 
 
 
Preparation of Competent Cells  
Streak DH5-alpha stock in LB plate (no antibiotics) 
- Culture at 37°C overnight 
- Pick single colony and seed into SOB medium 
- Culture at 18°C for 19-60 hours  
(DH5a 17:30 on Sunday – 11:30 on Wednesday = OD 0.67 (66 h) 
(Stbl3 19:00 on Sunday – 14: 00 on Tuesday = =D 0.54 (43 h) 
- Check OD600 (until 0.4 – 0.8) 
- Place culture on ice for 10 min 
- Centrifuge at 3000 rpm for 15 min at 4°C 
- Discard supernatant 
-  Suspend bacteria in 67ml of chilled TB gently 
- Centrifuge at 3000 rpm for 15 min at 4°C 
- Discard supernatant 
- Suspend bacteria in 16ml of chilled TB gently (TB can be reduced to make appropriate 
density) 
- Add 1.2ml DMSO (= final 7%) and leave on ice for 10 min 
- Bring tools and suspension to cold room 
- Prepare liquid nitrogen 
- Dispense 50µl of suspension into 1.5ml tubes and put into liquid nitrogen immediately 




Appendix 3: Comparison of resin section adherence on a selection 
of Menzel slides 
During Neutral Red staining procedure resin section are likely to come off. Therefore, a comparison 
of resin sections was made on Polysine, Superfrost Plus, Superfrost Ultra Plus and Superfrost Excell 
slides. Pictures (above) and table (below) represent the outcome in which Superfrost Plus indicates 










Appendix 4: Staging of Zebrafish embryos before free-feeding stage 
Images according to developmental stages during Zebrafish embryonic development according to 
Kimmel et al. (1995) when embryos are bred at 28°C. Note hatching period in Zebrafish is around 48 
















Appendix 5: Stages of Medaka development 
Drawings according to developmental timing during Medaka embryogenesis. Staging is according to 
Iwamatsu (2004) when bred at 26°C. Note, hatching takes place at 9 dpf after which the larvae is able 












Appendix 6: Temperature shift graph for Medaka developmental 
To manipulate the timing required to reach a certain developmental stage during Medaka 
development, a temperature shift in a viable range can be carried out. Lower temperatures slow 
down development and higher temperatures accelerate embryogenesis taking less time to obtain a 
certain stage. Left y-axis displays days and hours it takes to reach a certain stage of development 
(right y-axis axis) depending on the temperature (x-axis) in which embryos were incubated. Graph 





Appendix 7: Hydrolysis times for probe fractioning (at 60°C) 
Both tables indicate the incubation time (column within) at 60°C required to fraction a certain 








Appendix 8: Dct at st.20 - st.32 in wild type and hirame mutants 
WISH with Dct in wild type and hirame embryos indicating location of individual melanoblasts and 
differentiated melanocytes between stage 20 to stage 32. Anterior head is left, posterior tail end is 
right. Wild type embryos in two left columns, hirame mutants in two right columns. Dorsal and 





Appendix 9: Renamed individual Tg(Dct:eGFP) lines  
Trangenic lines originated from individual Dct:eGFP founders have been renamed into line 1 to 8 for 
simplification. Second column shows the number ond gender of the F0 generation as reported in the 
database.   
Tg(Dct:eGFP) strain 
renamed 
Tg(Dct:eGFP) line originated 
from individually founders 
as named in database 
records 
Number of transgenic F1 progeny grown 
up 
line 1 line 1 33 
line 2 line 2 5 
line 3 line 3 17 
line 4 line 4 3 
line 5 line 5 2 
line 6 line 53 32 
line 7 line 58 27 
line 8 feline 5 28 
 
Appendix 10: TEM on Medaka yolk sac membrane 
Transmission electron microscopy (TEM) reveals a three layered membrane arrangement 
surrounding the yolk cell in st. 21 wild type (A) and hirame (B) embryos. A: Layers 1-3, in which 1 is 
the yolk syncytial layer, 2 is a middle epidermal layer and 3 is the most outer enveloping layer. B: 
Nuclei (asterics) could be located within the lower and middle layer as well as the top layer (not 




Appendix 11: TEM of yolk sac membrane structures in wild type and 
hirame st.21 embryos 
Common structures within both, wild type and hirame embryos. A, A’: tight juntions (black error) 
connecting outwards protruding cells within the enveloping layer, additional desmosome (A’, white 
error) visible. B,B’: Inclusions (arrow) within the yolk sac cell connected to the yolk syncytial layer. In 
hirame those reservoirs held various sized particles in it (B’). C, C’: Lipid droplets (arrow head) located 






Appendix 12: Epiboly closure during wild type and hirame 
gastrulation 
Live imaging of developing embryos to observe the difference of wild type (top row, n=4) and hirame 
(bottom row, n=3) embryos. The epiderm covers ¾ of the yolk sphere in wild type and the embryonic 
shield in visible. Blastoderm during epiboly closure migrates slower in hirame mutants towards the 
vegetal pole compared to wild type siblings (dotted lines). The blastopore (bp) at st.17 remains wider 
in hirame exposing the yolk syncytial layer (YSL). The difference between genetics was identified 












Appendix 13: Neurogenin 1 expression detected via whole-mount in 
situ hybrisidation in 3 dpf embryos 
WISH of neurogenin 1 (ngn1) to label developing neurons of 3 dpf Medaka embryos. Indicated 
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